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General Introduction
The Human Genome Project has provided the sequence of roughly 30 000 genes but did not 
provide direct information on their function. To carry out its function, a protein generally 
interacts with other molecules and therefore an understanding of function depends on our 
ability to map the interaction networks that exist in different cellular processes. Interactions 
are critical for the formation of complexes and the viability of a cell. Furthermore, regulatory 
mechanisms, which control the interactions between proteins, are often achieved through 
interactions. Assuming that there are on average 5 interactions per protein, one can expect 
a minimum of 150 000 possible interactions in human cells (Figeys, 2003). Understanding 
the molecular and functional interactions among macromolecular complexes, as well as 
their changes associated with time, cell type or disease state will be invaluable for human 
health, and will have direct implications, for example, in pharmaceutical research to identify 
and select potential targets, and design efficient and specific drugs.  Large-scale analysis and 
characterization of protein-protein interactions, i.e. the “interactome”, extends greatly our 
knowledge on macromolecular complexes and therefore on the proteome organization (Gavin 
and Superti-Furga, 2003). There are many ways to map and study macromolecular interactions 
that can vary from large-scale approaches at a cellular level to structural approaches at an 
atomic level. Large-scale approaches generally rely on two methods: molecular biology through 
yeast two-hybrid screening or tandem affinity purification to map interactions and mass 
spectrometry to identify the proteins involved (Figeys, 2003; Sobott and Robinson, 2002). 
A recent example of such a large-scale protein interaction mapping is the analysis of protein 
interactions in Drosophila Melanogaster (Giot et al., 2003) using yeast two-hybrid screening and 
probability statistics. This mapping identified with high confidence 4780 different interactions 
involving 4679 proteins. Biochemical and structural approaches, however, are only suitable to 
screen a small number of interactions, being part of a complete pathway, but they clearly give 
more insight into the molecular basis of these interactions. Mappings and structural studies 
of macromolecular interactions can therefore be performed in a complementary way: results 
of large-scale interaction mapping often provide a starting point for detailed biochemical 
and/or structural studies to gain more insight into interactions that are of particular relevance 
for medical and pharmaceutical research. Not all molecular interactions, however, can be 
approached by experimental structural studies of macromolecular complexes. Limitations of 
these methods are evident, especially in the case of weak and transient complexes. New and 
complementary methodologies have therefore been developed that can partially overcome this 
problem. In particular, docking and molecular dynamic simulations, performed in silico, can 
overcome experimental limitations and form currently an active area of research with good 
future prospects.
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Scope of this thesis
This thesis describes structural and methodological aspects of the study of macromolecular 
complexes with an emphasis on NMR spectroscopy and focus on a specific and well-controlled 
biological pathway, the ubiquitination pathway. The general ubiquitination mechanisms are 
conserved over all eukaryotic organisms. Deregulation of the interactions involved in this 
pathway often leads to severe diseases among which cancer and various neurodegenerative 
diseases. The ubiquitination of a protein consists of a cascade of enzymatic reactions that 
results in the covalent attachment of the protein ubiquitin to a target protein. Attachment of 
multiple ubiquitin moieties to a protein (poly-ubiquitination) generally targets the protein for 
degradation by the 26S proteasome, while attachment of one ubiquitin (mono-ubiquitination) 
generally acts as a regulation event, in the same manner as phosphorylation or acetylation. 
The cascade involves a number of enzymes, and the various interactions between them 
and with the final substrate have been shown to be highly specific. The molecular basis of 
this specificity is, however, poorly understood. This thesis describes the development of the 
computational methods to study biomolecular interactions and their applications for the 
structure determination of a complex between the RING domain of a human transcription 
factor, CNOT4, and the ubiquitin conjugating enzyme (E2) UbcH5B.
In Chapter 1, a biological introduction is given that describes the RING domain family 
and its role in the ubiquitination pathway. In this Chapter, structural, biological, chemical, and 
medical aspects of this domain and important protein-protein interactions that involve the 
RING domain are discussed. 
Chapter 2 describes various computational and experimental methods for studying 
macromolecular complexes at molecular level with a focus on nuclear magnetic resonance 
(NMR) and docking approaches. Limitations of these two approaches are underlined and new 
methodologies that combine them are discussed in details.
In Chapter 3, a new computational method for docking of biomolecules is presented 
that includes biochemical and/or biophysical information to drive the docking process. The 
method is successfully tested on several protein-protein complexes with known structure and 
for which either NMR or mutational interaction data was available.
Chapter 4 describes the solution structure of the E2 enzyme UbcH5B obtained from 
model-guided automated NOE assignment in combination with diffusion anisotropy derived 
from NMR relaxation measurements. The solution structure is compared with other E2 
enzyme structures and differences are highlighted.
Finally, in Chapter 5, a structural model of the UbcH5B/CNOT4 complex involved in the 
ubiquitination pathway is described. By combining chemical shift perturbation mapping data 
and mutagenesis experiments, a precise definition of the binding interface of both partners 
is obtained. This information is used to dock the two proteins together using the docking 
approach described in Chapter 3. The resulting structural model is compared to the crystal 
structure of an homologous complex, UbcH7/c-Cbl (Zheng et al., 2000) in order to gain 
insight into the specificity of E2-E3 interactions.
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Chapter 1
Abstract
The RING domain is a cysteine-rich sequence motif that can bind two zinc atoms. 
In the canonical RING motif, also called the C3HC4 motif, one zinc is bound to 
four cysteines, and the other ion to three cysteines and a histidine. The tetrahedral 
coordination is atypical and referred to as a “cross-brace” motif. There are now more 
than 380 RING motifs identified in the human genome. The RING domain has been 
shown to mediate a crucial step in the ubiquitination pathway that targets protein 
substrates for degradation by the 26S proteasome. This pathway involves three enzymes 
and the RING finger proteins have been classified in this scheme as ubiquitin ligases. 
There are actually nine structures of RING domains solved by X-ray and NMR. The 
βαβ fold of the RING domain is conserved among all structures. The structures of 
RING domains in complex with other proteins involved in the ubiquitination pathway 
provide considerable insight into the molecular basis of ubiquitination. Recently, 
ubiquitination has been shown to be not only a simple protein removal system but 
also an indispensable regulatory process. This is underscored by the observation that 
many diseases, like cancer and Parkinson’s disease, are due to mutations in RING 
domains that prevent an efficient ubiquitination and degradation process. In this review, 
we compare the different structures of RING domains, analyze their functional 
aspects through structural informations of RING domains in complex with other 
proteins and describe medical aspects of RING finger proteins involved in cancer 
and Parkinson’s disease.  
Functional class
Eukaryotic zinc binding motif; this motif is related to the Zinc finger motif present in many 
transcription factors(Folkers et al., 2001; Schwabe and Klug, 1994), and was found initially 
in the RING1 (Really Interesting New Gene) gene and therefore named RING finger 
(Lovering et al., 1993). Subsequently, this motif was detected in a number of unrelated 
proteins (Freemont et al., 1991; Lovering et al., 1993).
Initially the function of RING domains was not clear, although they were known to 
mediate protein-protein interactions and to be involved in a range of cellular processes, 
including development, oncogenesis, apoptosis, and viral replication (Borden, 2000; Borden 
and Freemont, 1996). By 1999, the function of the RING domain was clarified, with the 
observation that the RING domain of c-Cbl mediates a protein-protein interaction with 
proteins known to be involved in the protein ubiquitination and 26S proteasome degradation 
pathways ( Joazeiro et al., 1999; Waterman et al., 1999; Yokouchi et al., 1999). Thereafter a 
similar function was deduced for a number of RING proteins (Lorick et al., 1999).
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Occurence
RING domains of RING finger proteins are one of the most common zinc binding motifs 
in eukaryotes (Saurin et al., 1996). There have been more than 380 RING motifs identified 
in the human genome and the number of sequences in all eukaryotes corresponding to 
a RING motif is currently more than 1200 (http://www.sanger.ac.uk/Software/Pfam) 
(Bateman et al., 2002). RING finger containing proteins can be found in a large variety of 
different species ranging from yeast to human including double strand DNA viruses and in 
all kind of cells or tissues (Freemont, 2000). RING proteins are not found in bacteria, which 
relates to their unique role in the ubiquitination pathway that is absent in prokaryotes.
Biological function
RING domains have been shown to mediate a crucial step in protein degradation. 
Figure 1 shows how a ubiquitin chain can be covalently linked to protein substrates (Borden, 
2000; Freemont, 2000; Jackson et al., 2000; Joazeiro and Weissman, 2000). These poly-
ubiquitinated substrates will then be recognized by the 26S proteasome and degraded by 
proteolysis (Glickman and Ciechanover, 2002; Pickart, 2001; Weissman, 2001). Three 
enzymes are involved in the ubiquitination pathway. Firstly, an E1 or ubiquitin activating 
enzyme forms a thiol ester with the carboxyl terminal group of the small protein ubiquitin at 
position Gly76. The ubiquitin is then transferred to the ubiquitin conjugating enzyme (E2). 
Finally, ubiquitin ligase (E3) transfers the ubiquitin from E2 to the target protein promoting 
the ubiquitination of the substrate. At least three different classes of E3 ligases have been 
found that mediate substrate ubiquitination. These E3 enzymes differ in the domain that 
recognizes the E2 enzymes, which can be a RING, a PHD (plant homeodomain) or a 
HECT (Homologous to E6AP COOH terminus) domain (Coscoy and Ganem, 2003; 
Glickman and Ciechanover, 2002; Pickart, 2001). In case of the HECT type E3 ligases, the 
small ubiquitin protein is captured from the E2, and covalently bound to the E3, before it 
is transferred to the substrate (Scheffner et al., 1995). In constrast, in the case of RING or 
PHD containing protein ligases, no evidence for a stable E3-ubiquitin intermediate exists; 
therefore, the E3 ligases that contain a RING or a PHD domain are thought to have only a 
role in bringing the E2 and the substrate together. In all cases, the interaction between the 
E2 and E3 enzymes is mainly accomplished by the HECT, PHD or RING domains. 
It is now clear that protein degradation is an important feature in the regulation of cellular 
processes. Many vital functions like signaling, growth, transcription and DNA repair are all 
regulated by the 26S proteasome (Glickman and Ciechanover, 2002). Aberrant expression 
caused by deregulated protein degradation leads to severe diseases. Frequently RING finger 
proteins have been related to such diseases (see below) (Fang et al., 2003; Michael and Oren, 
2003; Shtiegman and Yarden, 2003).
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Figure 1: The ubiquitination pathway. Ubiquitin molecules are represented as stars, ubiquitin 
activating enzyme as E1, ubiquitin conjugating enzyme as E2, ubiquitin ligase as E3 and substrate 
as S.
Recently, another role for ubiquitination has been suggested. Whereas poly-
ubiquitination is generally the marker on a substrate that will be degraded by the proteasome, 
a mono-ubiquitination of a protein can have a regulatory function as for example in signal 
transduction, transcription regulation, chromatin remodeling, and DNA repair (Deng et al., 
2000; Kaiser et al., 2000; Kuras et al., 2002; Mallery et al., 2002; Wang et al., 2001). This 
new role suggests that the ubiquitination pathway is not only involved in degradation but 
might also regulate protein function. This protein modification can, like phosphorylation, 
acetylation and methylation, regulate protein activity, where the ubiquitin moiety is acting 
as a molecular switch in many important cellular processes. 
  
Amino acid sequence information and topology
The only common feature of RING finger proteins is the presence of the cysteine-rich 
sequence motif that has similarities with Zinc fingers. This consensus RING motif, also 
called the C3HC4 motif, can be defined as a unique pattern of cysteine and histidine residues 
at defined positions in a peptide sequence, which is
Cys - X2 - Cys - X9-39 - Cys - X1-3 - His - X2-3 - Cys - X2 - Cys - X4-48 - Cys - X2 – Cys, and 
where X can be any amino acid. It was suggested that the eight cysteine and histine residues 
form a binding site for two zinc atoms. Since these transition metals can also be coordinated 
by other residues, it can be expected that variations on the RING consensus sequence are 
possible. Correspondingly, a second large group of RING finger proteins, the RING-H2 
��
��������
���
��
��
��
��
��
�
��
�
��
��
�
��
����
����
��������
�
�����������
�
��
��
��������������
��
�
��
��
���
13
Biological Introduction: RING domain proteins
family, has been identified where the cysteine at position 4 is replaced by a histidine (Borden 
and Freemont, 1996). Also, a third consensus sequence for RING domains was found which 
consists of the C4C4 motif, in which all the zinc ligating residues correspond to cysteines 
(Hanzawa et al., 2001). In all three cases, the size of RING domains is approximately 70 
amino acids (Figure 2) and representation of all three families have been shown to fold with 
a characteristic topology around the zinc ions. From sequence comparisons, it was proposed 
that the RING domain family also includes the U-box, a domain that is also involved in the 
ubiquitination pathway (VanDemark and Hill, 2002). However, this domain does not bind 
zinc atoms, but models predict a similar structure (Aravind and Koonin, 2000), although 
structure determination is required to confirm that this domain indeed adopts a similar 
fold.
Activity test
The involvement of RING domains in the ubiquination pathway is generally tested using 
an in vitro assay (Belz et al., 2002). The most common method is the so-called in-solution 
ubiquitination essay ( Joazeiro et al., 1999; Koegl et al., 1999; Swanson et al., 2001), that uses 
ubiquitin, the E1, E2 and E3 enzymes, ATP and an ATP-regenerating system in a reaction 
mixture. In cases where the protein substrate for the ubiquitination is known, it is also 
added to the reaction. Ubiquitination will lead to an accumulation of high molecular weight 
polyubiquitin adducts bound to the substrate, or in the case of a substrate-independent assay, 
autoubiquitination of the E3 ligase (Albert et al., 2002; Joazeiro et al., 1999; Lorick et 
al., 1999), The characteristic ladder corresponding to multiple ubiquitin adducts is usually 
detected on polyacrylamide gel using western blot analysis (with anti-ubiquitin or anti-
substrate antibodies) or autoradiography (with radiolabeled  ubiquitin).
IEEHV:  1          MATVAERCPICLEDPSN----YSMALPCLHAF--CYVCITRWIRQNPT---CPLCKVPVESVVHTIESDSEF        63
PML:   49         EEEFQFLRCQQCQAEAKC-----PKLLPCLHTL--CSGCLEASGMQ------CPICQAPWPLGADTPAL           104
RAG1: 281        PAHFVKSISCQICEHILAD-----PVETSCKHLF--CRICILRCLKVMGS---CPSCRYPCFPTDLESP            340
Cbl:  376            STFQLCKICAENDKD-----VKIEPCGHLM--CTSCLTSWQESEGQG--CPFCRCEIKGTEPIVVDPF         434
Not4:   1    MSRSPDAKEDPVECPLCMEPLEI---DDINFFPCTCGYQICRFCWHRIRTDENGL--CPACRKPYPEDPAVYKPLSQEELQRI   78
MAT1:   1            MDDQGCPRCKTTKYRNPSLKLMVNVCGHTL--CESCVDLLFVRGAGN--CPECGTPLRKSNFRVQLFED         65
BRCA1: 21              ILECPICLELIKE-----PVSTKCDHIF--CKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFS         80
BARD1: 49              LLRCSRCTNILRE----PVCLGGCEHIF--CSNCVSDCIGTG-----CPVCYTPAWIQDLKINRQLDSMI     105
Figure 2: Sequence alignment of RING domains. Zinc ligands are displayed bold. Residues involved 
in the binding to an E2 enzyme (c-Cbl and CNOT4) are underlined. Secondary structure elements 
are based on the structure of IEEHV.
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Protein production, purification, and molecular characterization
RING domains are frequently expressed and purified as Glutathione S transferase (GST)-
RING fusion proteins (Gervais et al., 2001; Zheng et al., 2002; Zheng et al., 2000). However, 
also protocols using fusion constructs with the Maltose Binding Protein (MBP) or a His6-
Tag have been described (Bellon et al., 1997; Hanzawa et al., 2001). The recombinant 
RING proteins are overexpressed in Escherichia coli. Since zinc is needed for a proper folding, 
ZnCl2 is added to the bacteria during the protein production. The GST-RING fusion 
proteins are purified using Glutathione affinity chromatography, whereafter the GST part 
is cleaved off by proteases. The RING domains or proteins are then further purified by 
standard methodology such as ion exchange and/or gel filtration chromatography. Buffers 
used for the purification should contain ZnCl2, preferably a low concentration of phosphate, 
EDTA should be absent, and the pH should not be lower than 6-6.5 in order to prevent the 
protonation of the zinc coordinating residues and the subsequent loss of the metals, which 
generally leads to unfolding and precipitation of the RING domain.
 
Metal content
The RING domains comprise eight metal-binding ligands and bind two zinc(II) ions with 
each metal ion in a tetrahedral coordination. In a C3HC4 RING domain, one zinc ion 
is bound to four cysteines, and the other to three cysteines and a histidine, whereas in 
a RING-H2 domain both zinc ions are coordinated to three cysteines and a histidine. 
The metal content of RING domain proteins has been deduced by optical spectroscopy 
(Lovering et al., 1993) and by atomic absorption spectroscopy (Everett et al., 1993; von 
Arnim and Deng, 1993). 
Zinc site geometries
The arrangement of the coordinating residues around the zinc atoms in the RING domain 
has often been erroneously ascribed to two tandemly arranged Zinc finger domains of the 
CCCH and CCCC type. However, the zinc ligation topology of RING fingers is quite 
distinct and is referred to as a “cross-brace” motif (Figure 3). In this motif, the first pair of 
ligands (Cys1 and Cys2) together with the third pair (Cys5 and Cys6) coordinates one zinc 
atom, and the second (Cys3 and His4) and fourth (Cys7 and Cys8) pairs bind the second 
zinc atom. In contrast, in the classical Zinc finger proteins, the first four coordinating 
residues would bind to one zinc atom and the next four to the next zinc atom. Sometimes, 
these sequential Zinc fingers form independent stable folds connected by flexible peptide 
segments as found in several transcription factors. In other cases a stable fold requires the 
close packing of both fingers(Folkers et al., 2001), as is the case in the DNA binding domain 
15
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of the steroid hormone receptor and the LIM domain (Dawid et al., 1998) (Figure 3). 
However, in the case of the “cross-brace” RING motif, it is clear that both zinc atoms are 
required for an intact structure.
Figure 3: Zinc coordination topology for RING, LIM, PHD and FYVE domains.
This “cross-brace” motif is not unique for RING fingers, but can also be found in 
the plant homeodomain (PHD) (Aasland et al., 1995) and in the FYVE (Fab1p, YOTB, 
Vac1p, EEA1) domain (Misra and Hurley, 1999; Stenmark et al., 2002), a domain that 
was originally observed in the Fab1p (formation of aploid and binucleate cells), YOTB 
(Hypothetical Caenorhabditis elegans protein ZK632.12 in chromosome III.), Vac1p (also 
known as VSP19 involved in vacuolar segregation) and EEA1 (early endosome antigen 1) 
proteins (Figure 3).
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The zinc ions of the RING domains are coordinated to the sulfur of the cysteines. The 
coordination to the histidine imidazole ring is unusual. Commonly in zinc fingers, the zinc 
coordinates to the NE2 of the imidazole group, but in the RING domains, coordination 
to the ND1 atom was demonstrated (Barlow et al., 1994; Bellon et al., 1997), This was 
explained by the close spacing between the ligands 3 and 4, which is conserved among all 
C3HC4 RING finger proteins, whereas, in most Zinc finger proteins, a more relaxed two-
residue spacing is found. In the RAG1 (recombination-activating gene protein) structure 
(Bellon et al., 1997), the distances between the cysteine SG and the zinc atoms are between 
2.23 and 2.36 Å, while the distance between the histidine ND1  and the zinc atom is 2.07 
Å (Figure 4).
Figure 4: Zinc coordinating site geometry for the C4 site (site I) (left panel) and the C3H site (site 
II) (right panel) of the RAG1 RING domain. Zinc atoms, cysteine SG and histidine ND1 atoms are 
represented in grey. Distances in Å between the cysteine SG or histidine ND1 and the zinc ion are 
displayed. The figures have been generated with the program Molscript (Kraulis, 1991).
Spectroscopic and metal binding properties of RING finger domains
There are only a few spectroscopic techniques that enable the direct observation of zinc ions. 
In principle, zinc-EXAFS (Extended X-ray Absorption Fine Structure Spectroscopy) allows 
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Biological Introduction: RING domain proteins
the direct study of the metal binding properties of Zinc proteins (Garner et al., 1982) but 
this has not been applied thus far for RING fingers. The spectroscopic properties of RING 
domains can be investigated indirectly using a variety of spectroscopic techniques, due to 
the fact that one can substitute the zinc ion by other metals such as cobalt(II) or cadmium(II) 
(Lovering et al., 1993). The replacement of zinc by cobalt allows the observation of the 
metal site by UV/VIS and fluorescence spectroscopy. Two studies showed that the C3HC4 
RING domains of BRCA1 (Breast cancer type 1) and hdm2 (human double minute 2 
protein) bind the two cobalt atoms in a sequential manner, where the C4 site (site I) has a 
higher affinity than the C3H site (site II), which has been ascribed to an intrinsic differential 
stability of the two sites for the metal binding (Lai et al., 1998; Roehm and Berg, 1997). An 
alternate explanation, however, could be that this differential stability is directly related to a 
lower affinity of the histidine imidazole group for the cobalt ion, decreasing the affinity of 
the second site with respect to that of the first. Similarly, zinc can be replaced by cadmium 
and this allows the analysis of the coordination site by NMR. Hanzawa et al (unpublished 
data) studied the zinc-cadmium exchange by NMR titration experiments using the RING 
domain of CNOT4 (negative on TATA), which has an unusual C4C4 motif as confirmed 
by 113Cd - 1H HSQC experiments. In this case, it was found that the first site exchanges 
the zinc before the second site. These experiments demonstrate that the lower stability of 
the second metal binding site of the RING domain is not a general property of all RING 
domains.
X-ray and NMR structures of RING finger domains
First structural information about RING domains came from the analysis of the NMR 
chemical shifts of the RING domain of the immediate early EHV-1 (IEEHV-1) protein 
from equine herpes virus (Everett et al., 1993). Shortly thereafter, the three-dimensional 
structure of IEEHV was solved by the same group (Barlow et al., 1994) (Table 1). Since 
then, a number of structures of other RING domains have been solved by NMR and X-ray 
crystallography, both in the free state (Bellon et al., 1997; Borden et al., 1995; Gervais et 
al., 2001; Hanzawa et al., 2001) or in complexes with other proteins (Brzovic et al., 2001; 
Zheng et al., 2002; Zheng et al., 2000) (Table 1).
Overall description of the structure
Comparison of the nine RING domain structures shows that all RING fingers adopt a 
similar fold, but significant differences are present. All RING fingers display the so-called 
“cross-brace” motif for the zinc ligation. The overall structure is characterized by a βαβ 
fold but the number of β-strands and the exact position of the β-sheet differ among the 
structures when analyzed with a DSSP algorithm (Kabsch and Sander, 1983) (Figure 5). 
A common feature of all C3HC4 structures is the 14 Å distance between the two zinc 
atoms of the RING motif. In all structures, a hydrophobic cluster is found, that stabilizes 
the ternary structure. The main differences observed among the nine structures relate to the 
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presence and length of the secondary structure elements. 
Structures of the free RING domains
The NMR structure of the IEEHV (Table 1) has a cross-brace coordination and a secondary 
structure that is composed of 3 β-strands and a central α-helix (Figure 5). The first loop 
(residues 1 to 19) contains the first pair of zinc ligating residues (Cys8 and Cys11). This loop 
is followed by two small β-strands (residues 19 to 21 and 26 to 28) connected by a short 
turn containing the second pair of zinc ligating residues (Cys24 and His26). The second 
β-strand is followed by an α-helix (residues 32 to 40) with the third pair of zinc ligating 
residues (Cys29 and Cys32) between both secondary structure elements. The C-terminal 
part of the structure consists of a long loop (residues 33 to 63) containing the fourth pair of 
zinc ligating residues (Cys43 and Cys46) and a third short β-strand (residues 53 to 55).
The C3HC4 RING domain of the promyelocytic leukaemia proto-oncoprotein, PML, 
was the second RING structure that was determined by NMR (Borden et al., 1995) (Table 
1). Although the metal ligation is similar to IEEHV and the distance between the two zinc 
atoms is conserved, the ternary structure is quite different from that of IEEHV, and the 
protein does not possess the central α-helix. 
The first X-ray structure of a RING domain was published two years thereafter (Bellon 
et al., 1997) (Table 1). The structure of the dimerization domain of the protein RAG1 
consists of a N-terminal RING finger domain and a C-terminal Zinc finger. The structure 
of the RING finger domain of RAG1 is highly similar to that of IEEHV (Figure 5). A 
superposition of 40 of the 44 Cα atoms of the RAG1 RING finger onto the corresponding 
Cα atoms of IEEHV finger results in a RMSD of 1.65 Å. The highly conserved hydrophobic 
core residues Phe309 and Ile314 corresponding to Phe28 and Ile33 residues in the IEEHV 
adopt identical conformations in the two structures. However, in the structure of RAG1, 
the third β-strand is missing. 
Table 1: Ring finger protein structures deposited in the PBD. Represented are the PDB code, the 
name of the protein, the type of RING, the technique used (X-Ray or NMR), the resolution of the 
structure (X-Ray) in Å or the backbone RMSD from mean structure (NMR) and the function of 
each RING.
PDB code Protein name Type of RING Technique Res / RMSD Function
1CHC IEEHV C3HC4 NMR 0.55 Regulation of the equine herpes virus gene expression
1BOR PML C3HC4 NMR 0.88 Cellular defense mechanism
1RMD RAG1 C3HC4 X-Ray 2.1 Assembly of antibody and T cell receptor genes
1E4U CNOT4 C4C4 NMR 0.58 Part of a global regulator of RNA polymerase II transcription
1G25 Mat1 C3HC4 NMR 0.67 Subunit of the human transcription/DNA repair factor TFIIH
1JM7 BRCA1 C3HC4 NMR 0.87 DNA repair and transcriptional regulation
1JM7 BARD1 C3HC4 NMR 0.95 DNA repair and transcriptional regulation
1FBV c-Cbl C3HC4 X-Ray 2.9 Negative regulator of  tyrosine kinase-coupled receptors
1LDD/1LDJ Rbx1 RING-H2 X-Ray 3 Part of the SCF E3 ligase complex
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Figure 5: Structures of RING domains: RING finger zinc atoms are represented in black, extra 
zinc atoms (RAG1 and Rbx1) are represented in grey. The figures have been generated with the 
program Molscript (Kraulis, 1991) and Raster3D (Merrit and Murphy, 1994).
The structure of a C4C4 type RING domain of the CNOT4 protein from the human 
CCR4-NOT transcription complex, has been solved using NMR (Hanzawa et al., 2001) 
(Table 1). Despite the fact that the sequence of the N-terminal domain of CNOT4 did not 
show the consensus C3HC4 RING motif, the fold of the domain and the zinc coordination 
topology of CNOT4 resembles that of the RING proteins (Figure 5). The structure of 
CNOT4 RING domain consists of three loops and a α-helix between the second and 
third loop. No regular β-strand could be detected in the structure using the Kabsch-Sander 
algorithm as implemented in the DSSP program. However, despite the differences in 
secondary structure elements, that are likely due to the presence of many prolines in the 
CNOT4 sequence, the overall structure of CNOT4 is similar to the structure of IEEHV 
(Cα RMSD: 1.7 Å) and RAG1 (Cα RMSD: 1.6 Å). The metal binding site was investigated 
by replacing the zinc atoms by 113Cadmium. The 113Cd-1H HSQC spectrum showed the 
presence of two metal binding sites. The cysteines 14, 17, 38 and 41 coordinate one metal 
ion and the cysteines 31, 33, 53 and 56 bind the second metal ion, in both cases via the 
SG atoms, confirming the cross-brace motif of the CNOT4 RING domain. The three 
loops in CNOT4 are stabilized by the coordination with the zinc ions and by hydrophobic 
interactions in a similar manner as for the C3HC4 RING finger structures. Interestingly, 
the distance between the two zinc atoms is slightly longer (15 Å) than the conserved value of 
14 Å as found in the C3HC4 RING finger structures of IEEHV, and RAG1. This difference 
����
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is possible due to the difference in residue spacing between the ligands 4 and 5 of CNOT4 
versus those of the C3HC4 RINGs (Figure 2).
Next to CNOT4, three other structures of C3HC4 RING domain were also solved 
in 2001. One corresponds to the NMR structure of the RING domain of the human 
transcription factor TFIIH MAT1 (ménage a trois) subunit (Gervais et al., 2001) (Table 
1). The structure adopts the ββαβ fold that is typical of RING domains. The core of the 
domain consists of a three-stranded antiparallel β-sheet packed along a two-turn α-helix 
(Figure 5). The other two structures correspond to the NMR structure of the complex 
between two RING domains, the BRCA1-BARD1 heterodimeric RING-RING complex 
(Brzovic et al., 2001) (Table 1). The BRCA1 RING domain is characterized by a short 
three-stranded antiparallel β-sheet, two large zinc-binding loops and a central α-helix 
(Figure 5). The BARD1 (BRCA1-associated RING domain protein 1) is structurally 
homologous but lacks the central helix between the third and fourth pair of zinc ligands 
(Figure 5). The dimerization interface of BRCA1 and BARD1 does not involve the RING 
motifs directly as discussed below and the two structures closely resemble those of the free 
RING domains.
Structures of related domains
A number of domains, such as the PHD domain found in E3 ligases and the FYVE domain 
found in proteins involved in the membrane recruitment of cytosolic proteins, show the 
same zinc cross-brace ligation motif as the RING domain (Aasland et al., 1995; Stenmark 
et al., 2002). The LIM domain found in transcription factors, shows a more conventional 
sequential ligation pattern (Dawid et al., 1998).
The LIM domain is commonly found in transcription factors, like many Zinc fingers. 
The domain is involved in protein-protein interaction with other transcription accessory 
factors. Six structures of LIM domains have been solved thus far, all of them by NMR 
(Hammarstrom et al., 1996; Konrat et al., 1997; Perez-Alvarado et al., 1996; Perez-Alvarado 
et al., 1994; Velyvis et al., 2001; Yao et al., 1999). A comparison shows that the LIM domain 
is less compact than the core structure of the RING domain, probably because of the 
difference in the zinc ligation topology (Figure 6). The conserved central helix in RING 
fingers is not present in LIM domains. However, the fold of the LIM domain resembles that 
of part of the RING domain. A superposition of the structures for the residues around the 
first zinc (site I) and the two first β-strands leads to a backbone RMSD of 3 Å between the 
CRP2 LIM domain and the IEEHV RING finger protein.
Initially, the function of proteins containing a PHD domain was unclear, although there 
was a general consensus that the PHD domains are involved in protein-protein interactions. 
More recently, PHD-containing proteins have been shown to function in the ubiquitination 
pathway as E3 ligases. The PHD domain in these proteins has the same function as the 
RING and the HECT domain, and is involved in the interaction with the E2 ubiquitin 
conjugating enzyme (Coscoy and Ganem, 2003). The structure of the PHD domains from 
the human Williams-Beuren Syndrome transcription factor (WSTF) and from the Kap-
1 transcriptional repressor have been solved by NMR (Capili et al., 2001; Pascual et al., 
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2000). The zinc coordination topology of the PHD domain is similar to that of the RING 
finger domain, but it turns out that the ternary fold is quite different (Figure 6). The 
structure of the PHD domain consists of a N-terminal loop followed by an anti-parallel 
β-sheet, a second loop, and a third β-strand. The site I zinc ligand pairs are located in the 
N-terminal loop (first pair) and at the beginning of the second loop (third pair). The site II 
zinc ligand pairs are located in the turn between the two first β-strands (second pair) and 
at the end of the third β-strand (fourth pair). The arrangement of the site I zinc ligands, as 
well as the two first β-strands are similar to that of the RING domain (a superposition of 
these regions between the Kap-1 PHD domain and the IEEHV RING domain leads to a 
backbone RMSD of 1.3 Å) (Capili et al., 2001). However, the position of the second zinc 
with respect to the first one is different between the two domains and the conserved α-helix 
found in the RING domain is not present in the PHD structures.
Figure 6: Comparison between the structures of the RING domain of the IEEHV protein, the LIM 
domain of the CRP2 protein (PDB:1A7I), the PHD domain of the Kap1 protein (PDB:1FPO) and 
the FYVE domain of the VSP27P protein (PDB:1VFY). The figures have been generated with the 
program Molscript (Kraulis, 1991) and Raster3D (Merrit and Murphy, 1994).
Also the cross-brace motif found in the FYVE domain is very similar to that of the 
RING motif. Since the FYVE domain is found in proteins involved in the membrane 
recruitment of cytosolic proteins and binds to phosphatidylinositol 3-phosphate (PI3P) 
located in membranes (Stenmark et al., 2002), there is clearly no functional resemblance 
with the RING and the PHD domains, involved in ubiquitination. Four structures of 
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FYVE domains have been solved by X-ray (Dumas et al., 2001; Mao et al., 2000; Misra 
and Hurley, 1999) and NMR (Kutateladze and Overduin, 2001). The FYVE domain 
is composed of two central β-strands and a C-terminal α-helix (Figure 6). Despite the 
similarity in zinc coordination topology with the RING and PHD domains, there is no 
structural relationship between the FYVE and these two domains. The secondary structure 
elements of the FYVE domain are located at totally different positions as compared to both 
RING and PHD domains.
Structures of the RING domains in complex with other proteins 
Ubiquitination consists of the covalent attachment of ubiquitin molecules to protein 
substrates. The conjugation of ubiquitin to substrates is accomplished by an enzymatic 
cascade involving three enzymes (see biological function). How these enzymes recognize 
each other and what are the molecular basis of these interactions, are key questions to 
understand the specific mode of action of the ubiquitination pathway. Detailed molecular 
insights into the E2-E3 interaction came from the crystal structure of E6AP, an E3 protein 
ligase containing a HECT domain, bound to UbcH7 (human ubiquitin conjugating 
enzyme 7) an E2 enzyme (Huang et al., 1999). One year later, the crystal structure of 
the RING finger protein c-Cbl (CAS-BR-M murine ecotropic retroviral transforming 
sequence homolog) bound to UbcH7 (Zheng et al., 2000) extended our knowledge to 
the RING-E2 interaction mechanism (Figure 7). E3 protein ligases represent a diverse 
family of enzymes that can either be single proteins or large protein complexes. The SCF 
(Skp1, Cullin, F-box protein) complexes, which consist of 4 different proteins, are one of 
the largest E3 protein ligase complexes. One of the proteins of the SCF complex contains 
a RING domain that is required for the E2 recognition. How the E3 complex spatially 
arranges the transfer of ubiquitin from the E2 to the substrate is an important question 
towards the understanding of the molecular basis of ubiquitination. The crystal structure 
of the SCF complex composed of the cullin gene family member 1 (Cul1), the RING box 
protein 1 (Rbx1), the suppressor of kinetochore protein 1 (Skp1), and the F-box domain of 
the suppressor of kinetochore protein 2 (Fboxskp2) provides considerable insights into this 
issue (Zheng et al., 2002) (Figure 8).
The c-Cbl-Ubch7 complex
The structure of the full length UbcH7 in complex with the N-terminal half of the 100 
kD protein c-Cbl has been solved by X-ray crystallography. The N-terminal half of c-
Cbl corresponds to a TKB (tyrosine kinase binding) domain (residues 47 to 344), a linker 
sequence (residues 345 to 380) and a C3HC4 RING domain (residues 381 to 434) (Zheng 
et al., 2000). The structure of the RING domain in the complex is similar to that of the 
free RING domains. The backbone RMSD between c-Cbl and RAG1 for the 40 core 
residues is 1.9 Å, similar to the RMSD values found between all RING domains (Zheng 
et al., 2000) (Figure 5). The structure of the complex shows how the RING domain of 
the E3 ligase interacts with the E2 conjugating enzyme. The interaction involves the two 
well-conserved zinc-chelating loops and the α-helix of the RING domain (Figure 7). The 
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interaction is stabilized mainly by hydrophobic contacts, in which the aromatic side chain 
of Phe63 of UbcH7 plays a crucial role. This residue makes close van der Waals contacts 
with Ile383 in the loop1 and Trp408, Ser407 and Ser411 in the α-helix of the c-Cbl Ring 
domain. Other important hydrophobic contacts are between Pro97 and Ala98 of Ubch7 
and Ile383, Trp408, Pro417 and Phe418 of c-Cbl. In addition, the charged residues Glu366 
and Glu369 of the linker region of c-Cbl and Arg5 and Arg15 of UbcH7 make electrostatic 
contacts. A comparison of the structure of the c-Cbl-UbcH7 complex and the E6AP-UbcH7 
complex reveals considerable similarities in the interaction surface of UbcH7 with these 
two structurally unrelated E3 ligases. The binding of UbcH7 with both proteins involves 
the same set of residues, even though, in the RING and the HECT domains, the structural 
elements and residues, which are recognized by UbcH7, are different. The importance of 
the loops and α-helix of the RING domain for the interaction with the E2 enzyme are 
underlined by the NMR studies on the CNOT4-UbcH5B complex (Albert et al., 2002). 
The NMR studies showed that the regions of the CNOT4 RING domain involved in 
the interaction with UbcH5B are similar to the ones of c-Cbl in the interaction with 
UbcH7. However, the types of amino acids involved in the interaction are different, which 
possibly explains the differences in specificity in the E2-E3 interaction. Whereas in c-Cbl 
RING domain, the residues Ser407, Trp408 and Ser411 are involved in the interaction with 
UbcH7, in CNOT4 the corresponding residues Arg44, Ile45 and Asp48 are involved in the 
interaction with UbcH5B (Figure 2).
Figure 7: The c-Cbl – UbcH7 
complex. The RING domain 
of c-Cbl and the residues 
important for the interaction 
(Ile383, Cys384, Cys404, 
Ser407, Trp408, Ser411, 
Pro417, Phe418 and Arg420) are 
represented in black. UbcH7 
is represented in light grey. 
The figure has been generated 
with the program Molscript 
(Kraulis, 1991) and Raster3D 
(Merrit and Murphy, 1994).
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The SCF ubiquitin ligase complex
Recently, a second structure of a RING domain containing protein complex has been solved 
by X-ray (Zheng et al., 2002) (Figure 8). This complex consists of the RING-H2 protein 
Rbx1 in association with Cul1, Skp1 and Fboxskp2 and corresponds to the SCF ubiquitin 
ligase complex. In this case, the complex provides information about the mechanism of 
ubiquitin transfer by an E3 ligase. The proteins Rbx1 and Cul1 form the catalytic core of 
this complex. Rbx1 is responsible for the E2 recruitment. Cul1 consists of a long α-helical 
structure composed of three cullin repeats and binds Skp1 via its N-terminus and Rbx1 via 
its C-terminus. The F-box protein Skp2 binds the substrate. Skp1 is an adapter between the 
F-box protein and Cul1. The protein Rbx1 has a RING-H2 domain that adopts the same 
fold as that of the canonical RING motif. The RING-H2 domain of Rbx1 is stabilized by 
two zinc ions, but possess a 20-residue insertion between the first and the second pair of 
zinc ligand. This insertion contains three additional zinc ligands and together with a fourth 
zinc ligand from the RING motif, these residues form a new zinc-binding site (Figure 5). 
The docking of the SCF complex onto the c-Cbl-UbcH7 complex (Zheng et al., 2000) on 
one side and the Skp1-Skp2 complex (Schulman et al., 2000) on the other (Figure 8) shows 
that the binding site of Rbx1 for an E2 enzyme is not affected by this additional Zinc finger 
motif and that the active site Cys86 of UbcH7 and the tip of the F-box protein Skp2 are on 
the same side of the SCF complex. The distance between the E2 enzyme and the substrate 
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Figure 8: The SCF ubiquitin ligase complex. The X-ray complex consists of the Rbx1 RING, the 
Cul1, the Skp1 proteins and the Skp2 F-box domain. The UbcH7 structure has been docked on the 
basis of the c-Cbl-UbcH7 complex (Zheng et al., 2000) as well as the full Skp2 structure on the basis 
of the Skp1-Skp2 complex (Schulman et al., 2000). The arrow indicates the 50 Å gap between the 
active site of the E2 (Cys86) and the tip of Skp2. The figure has been generated with the program 
Molscript (Kraulis, 1991) and Raster3D (Merrit and Murphy, 1994)
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binding site of the F-box protein is about 50 Å. This distance is suitable for the insertion 
of the substrate, p27 between Skp2 and UbcH7 and for the positioning of p27 at a suitable 
topology for its ubiquitination.   
Another interaction involving RING proteins that has been observed is the direct 
interaction between two RING domains in the dimeric BRCA1-BARD1 complex (Brzovic 
et al., 2001). In this heterodimeric complex, the complex formation is mainly governed 
by extensive interactions involving hydrophobic residues of a four-helix bundle formed 
between the two proteins, while there are only few direct contacts between the two RING 
domains. 
 
Medical aspect of RING finger proteins
Many human diseases can be related to a malfunctioning in the regulation of gene expression. 
As ubiquitination is a key step in the protein degradation pathway, it is not surprising that 
alterations of this process leads to severe diseases. Since it has been shown that many RING 
domain proteins function as E3 ligases, there has been a rapid increase in the number of 
articles that link RING domains with disease. For this review, we will focus on only three 
RING domain proteins, two involved in cancer and one involved in Parkinson’s disease, for 
which the mode of action is now well defined. The interested reader is referred to recent 
reviews (Fang et al., 2003; Michael and Oren, 2003; Mizuno et al., 2001; Shtiegman and 
Yarden, 2003) for more details.
The BRCA1 protein
The gene for the putative tumor suppressor BRCA1 (Breast Cancer 1) was first cloned 
in 1990 (Hall et al., 1990). BRCA1 encodes a protein of 220 kDa (1863 amino acids) 
that has a highly conserved amino terminal RING finger and an acidic carboxyl terminal 
domain characteristic of many transcription factors. BRCA1 has been shown to be involved 
in several important cellular functions including DNA repair, regulation of transcription, 
cell-cycle control and ubiquitination (Kerr and Ashworth, 2001). During the last decade, 
researchers have been able to confidently link mutations in the BRCA1 gene to familial 
breast and ovarian cancers (Ford et al., 1994; Miki et al., 1994). It was found that mutations 
in the BRCA1 gene are responsible for about 5 % of the total of these cancers, but it became 
also clear that a woman that inherits one mutant allele of BRCA1 from either her mother 
or father has currently a >80 % risk of developing breast cancer during her life.  It has been 
estimated that between 1/500 and 1/800 woman carry a mutation in their BRCA1 gene 
(Ford et al., 1995). More than 600 different mutations predisposing to a high risk of cancer 
have been identified in the BRCA1 gene, some of them in the RING domain (Lorick et al., 
1999; Serova et al., 1996). In particular mutations of the ligand cysteines 39 (Santarosa et 
al., 1998), 61 (Friedman et al., 1994) and 64 (Castilla et al., 1994) that probably disrupt the 
integrity of the RING structure underscore the importance of the RING for functionality 
of BRCA1. 
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The p53-Mdm2 complex
Exposure to ionizing radiation or ultraviolet light damages the DNA and leads, in the worst 
case, to cellular transformation. For maintaining genomic stability the cell is equipped 
with repair systems, that recognize the DNA damages, initiate repair or direct death of 
the damaged cells. One of the proteins playing a central part in damage recognition, 
signal transduction, initiation of apoptosis and repair is the tumor suppressor protein p53 
(Levine, 1997; Michael and Oren, 2002). It accumulates to high levels after DNA damage 
and this increase in abundance, presumably in combination with activating modifications, 
leads to cell cycle arrest to allow repair of the DNA before the next round of replication 
or it implements cell death by activating transcription of pro-apoptotic target genes. In 
normal cells, p53 is degraded by the 26S proteasome. The multiubiquitin-chain is attached 
to p53 by the onco-protein Mdm2 (murine double minute chromosome clone number 2) 
(Michael and Oren, 2002). The central domain of Mdm2 is constitutively phosphorylated 
and this phosphorylation is essential for p53 degradation. Mdm2 possess a carboxyl terminal 
RING domain (Boddy et al., 1994) that promotes the ubiquitination (Fang et al., 2000), 
and is necessary for the nuclear exclusion (Boyd et al., 2000; Geyer et al., 2000) and the 
degradation of p53. It has been estimated that 50% of human cancers are due to mutations 
of the p53 protein and some of these mutations prevent the Mdm2 mediated degradation 
(Michael and Oren, 2002).
The Parkin protein
Autosomal recessive juvenile parkinsonism (AR-JP) is one of the most common forms 
of familial Parkinson’s disease and is characterized by selective and massive loss of 
dopaminergic neurons, leading to a deficiency of dopamine supplies, and absence of Lewy 
bodies, cytoplasmic inclusions consisting of insoluble protein aggregates. The clinical 
features of the disease consist of resting tremor, cogwheel rigidity, bradykinesia and postural 
instability (Tanaka et al., 2001). It is the second most frequent neurodegenerative disorder 
after Alzheimer’s disease. The causative gene of AR-JP is the Parkin gene that encodes a 
protein of 52 kDa (465 amino acids) that is composed of an amino terminal ubiquitin-like 
domain and a carboxyl terminal RING-IBR-RING motif. The RING-IBR-RING motif 
corresponds to two RING domains separated by an additional Cys/His rich domain termed 
IBR (in between RING) finger (Kitada et al., 1998). The RING-IBR-RING domain 
is necessary and sufficient for binding UbcH7 (Tanaka et al., 2001). Parkin is involved 
in protein degradation as an E3 ubiquitin ligase (Shimura et al., 2000) suggesting that 
dysfunction of the ubiquitin-proteasome pathway plays a role in the Parkinson’s disease. It 
has been shown that Parkin can ubiquitinate itself thereby promoting its own degradation 
(Zhang et al., 2000). Furthermore, Parkin also induces the degradation of the synaptic 
vesicle-associated protein, CDCrel-1 (Cell division control related protein 1). Therefore, 
mutations in Parkin could lead to an accumulation of CDCrel-1 in the brain promoting an 
inhibition of the release of dopamine (Zhang et al., 2000). Some of the Parkin mutations 
that are found in the Parkinson’s disease involve residues within the RING domains (West 
et al., 2002). Concerning the RING2, a mutation of the 6th cysteine ligand may disrupt the 
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integrity of the structure. Interestingly also mutations were found within the RING-1 that 
could, based on sequence homology with c-Cbl, be involved in the E2 recognition. Further 
studies should elucidate the mechanism underlying the relationship between the AR-JP 
form of the familial Parkinson’s disease and the deficiency of the ubiquitin ligase activity 
of Parkin.
Concluding remarks
For many years, the eukaryotic protein degradation pathway by the 26S proteasome, 
and therefore by the ubiquitination pathway, was considered as a simple protein removal 
system of the cells. However, it is now clear that the ubiquitination pathway is involved 
in many regulatory processes. The observation that the RING motif is a key player in the 
ubiquitination pathway as being an E3 ligase not only shed light on the function of RING 
finger-containing proteins but also provided an explanation for the diverse biological 
processes the RING finger proteins participate in. In the last few years, a large body of 
evidence demonstrated that the ubiquitination pathway mediated by RING domains is an 
indispensable regulatory process of the cells. This is further underscored by the observation 
that many diseases, like certain cancers, are due to mutations in RING domains that prevent 
an efficient ubiquitination and degradation process.
The general dogma, ubiquitination leads to protein degradation by the proteasome, was 
recently challenged by the observation that (mono)ubiquitination functions as a protein 
modification that, in the same manor as phosphorylation, acetylation or methylation, 
regulates cellular location and activity of many proteins involved in transcription, chromatin 
remodeling or DNA repair. This new twist raises many questions with respect to the 
function and reaction mechanism of mono-ubiquitination versus poly-ubiquitination and 
the role of RING fingers herein. Recent structures of protein complexes of E2 conjugating 
enzymes and E3 ligases provided clear insight into the reaction mechanism of the ubiquitin 
transfer but many questions remain unanswered. Determination of structures of protein 
complexes containing ubiquitin conjugating enzymes and ubiquitin ligases together with 
specific substrates will provide detailed insight into the reaction mechanism of ubiquitin 
transfer from E2 to the substrates. Such structures could further explain the observed E2-E3 
specificities and might clarify the role of ubiquitination in protein activation or destruction 
and the involvement of RING domains in these processes. 
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For a thorough understanding of the biological function of a macromolecule, knowledge of 
its three dimensional structure is crucial. The determination of structures of macromolecules 
is mainly achieved by two methods: X-ray crystallography and Nuclear Magnetic Resonance 
(NMR) spectroscopy. From the statistics of the Protein Data Bank (PDB) (Berman et al., 
2000) (http://www.rcsb.org/pdb/), almost 20000 X-Ray structures and 3000 NMR 
structures of free proteins have been solved and deposited to date. Most proteins achieve 
their function, however, in interaction with other biomolecules such as other proteins, DNA, 
RNA, lipids or sugars. Although a number of methods are available to study the formation 
of macromolecular complexes (two-hybrid screening, fluorescence spectroscopy, mass 
spectrometry, surface plasmon resonance, calorimetry, etc), only few techniques provide 
information at an atomic level. X-ray crystallography provides a detailed atomic picture 
of molecules, when arranged in a crystalline lattice, whereas NMR spectroscopy provides 
structural information of biomolecules in solution. Both methods, however, have their 
shortcomings, especially when applied to studies on biomolecular complexes. The difficulty 
with crystallography is the co-crystallization of the two macromolecules, especially when 
the complexes have weak association constants and exist only transiently, whereas for NMR 
spectroscopy the size of the resulting complex can be a severe limitation. Because of these 
limitations, the number of macromolecular complexes solved and deposited in the PDB 
is rather low (less than 1000 by X-Ray and 100 by NMR) as compared to the number of 
structures in the free form. 
NMR structure of macromolecular complexes
The traditional approach to solve macromolecular complexes by NMR spectroscopy requires 
the collection of proton–proton NOEs (Nuclear Overhauser Effects), which can be translated 
into distances. When the structures of the separate biomolecules are already known, a 
structure of the complex can be build up by selectively analyzing the intermolecular NOEs. 
In addition to these intermolecular NOEs, also orientational restraints like residual dipolar 
couplings (RDCs), heteronuclear relaxation rates, or paramagnetic pseudo-contact shifts 
can be used, that precisely define the orientation of the two macromolecules in the complex. 
These methods require, however, extensive series of experiments and detailed analysis. 
Another way of studying complex formation by NMR is chemical shift perturbation (CSP) 
mapping. In this procedure, the chemical shifts changes of given atoms are monitored in the 
course of the formation of the complex. This procedure is very straightforward and is widely 
used to map macromolecule–macromolecule interfaces. The information obtained by CSP 
analysis, however, is only qualitative and does not provide precise distance or orientation 
information, and has therefore not been commonly used in structure calculations.
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Intermolecular Nuclear Overhauser Effect
The main structural information for structure calculations of macromolecules by NMR are 
distances obtained from NOEs (Wüthrich, 1986). The NOE originates from dipolar cross-
relaxation between protons and depends on the proton–proton distance and the molecular 
motions of the interproton vector. An approximate relation for the NOE intensity is:
NOE ∝ < 1 / r6 >  f(τc)
where r is the proton-proton distance and f a function that depends, among others, on 
the correlation time (τc) that describes the motion of the interproton vector. For rigid 
molecules, the values of all proton-proton correlation times are defined by the overall 
tumbling of the molecule, which in the simplest case can be described by a single isotropic 
overall rotational correlation time. In that case, ratios of NOE intensities provide ratios 
of distances. These NOE intensities can be easily measured in 2D and 3D NOE spectra. 
Internal mobility attenuates the NOE effect in biomolecules and therefore the NOEs are 
generally translated into an upper bound to the distance rather than into a precise distance. 
In practice the NOE becomes very weak at distances larger than 5-6 Å and often these weak 
NOEs contain contributions from spin diffusion and should be used with care. Therefore, 
only an incomplete set of relatively imprecise distance restraints can be used in structure 
calculations, which then leads to a series of possible solutions. The more precise distance 
restraints and the larger number of distance restraints are obtained, the closer these solutions 
will be. NMR structures are therefore generally presented as an overlay of wireframes, 
where a close overlay represents the well determined regions. 
To solve the structure of a macromolecular complex by NMR, structural information 
is needed in addition to the intramolecular NOEs to define the contacts between the two 
molecules. The most reliable information that can be obtained comes from proton-proton 
distances derived from intermolecular NOEs. If the lifetime of the complex is long enough 
(i.e. a complex with a low dissociation rate), it is possible to observe clear NOEs between 
protons that belong to different molecules. The simplest way to obtain these intermolecular 
NOEs is to record a homonuclear NOESY spectrum of a complex and to search for the 
additional NOEs as compared to NOESY spectra of the free biomolecules. Analysis of such 
spectra, however, is a lengthy process and it is often difficult to discriminate the intra and 
intermolecular NOEs. The use of isotope labeling and filtering can overcome this problem. 
The introduction of 13C and 15N isotopes into one of the biomolecules of the complex 
allows the use of isotope-filtered experiments that unambiguously assign intermolecular 
proton-proton NOEs (reviewed in Breeze, 2000). Isotope-filtered experiments have been 
first introduced by Otting and Wüthrich, (1989) as two-dimensional X-double-half-filtered 
experiments, where X stand for the “NMR-active” heteroatom (15N and 13C for proteins). 
In addition, many hybrid schemes combining purge filters and 3D X-separated NOESY 
spectra have been developed to allow the recording of three-dimensional spectra (Lee et 
al., 1994; Ogura et al., 1996; Zwahlen et al., 1997). These isotope-filtering techniques rely 
on the presence of a scalar coupling between a proton and the attached “NMR-active” 
heteroatom (13C for example) and the absence of a scalar coupling between a proton and an 
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“NMR-inactive” heteroatom (12C for example). The scalar coupling can be exploited to 
discriminate between these two different classes of protons. The classical scheme to measure 
intermolecular NOEs is to study complexes in which one protein is isotopically labeled and 
the other one is unlabeled. The experiment corresponds to a 1H-1H NOE experiment that is 
isotope-filtered in one proton dimension and isotope-edited in the other proton dimension. 
This results in a spectrum containing exclusively intermolecular NOEs providing that 
the scalar coupling is similar for all proton-heteronuclei pairs and that the labeled protein 
contains a high percentage of the “NMR-active” isotope (at least more than 98%). 
The study of macromolecular complexes by NMR has been facilitated enormously by 
these isotope-filtered NOE experiments. A limitation is that the additional time in the 
isotope-filtered experiments leads to lower sensitivity in the NOESY spectra and therefore 
only an incomplete set of NOEs can be obtained by these methods. In most cases a 
conventional analysis of unfiltered NOESY spectra is also necessary. 
Orientational restraints
Residual dipolar couplings 
The use of residual dipolar couplings (RDCs) in protein solution NMR has been described 
for the first time in 1995 (Tolman et al., 1995). The magnetic dipole-dipole coupling 
between the atomic magnetic moments of two nuclei (15N-1H for example) depends on the 
distance between the nuclei, the orientation of the vector defined by the two nuclei with 
respect to the magnetic field, and the dynamics of this vector. In solution, these dipolar 
couplings are generally averaged to zero because of the averaged randomly orientated 
distribution of the interactions. When a slight orientational preference is induced in this 
distribution due to partial alignment of the macromolecules, the dipolar couplings will not 
average anymore to zero resulting in residual dipolar couplings. The induced magnetism 
in macromolecules is generally too weak to lead to observable RDCs. Only in the case of 
paramagnetic molecules and systems with large inducible magnetic moments such as DNA, 
is the alignment sufficiently strong to lead to measurable effects. It was discovered, however, 
that molecules that are dissolved in magnetically aligned crystalline media also obtain a slight 
preferential orientation. Bicelles-containing solutions were the first liquid crystalline media 
that have been reported to result in large RDC effects for proteins in solution (Tjandra and 
Bax, 1997). The degree of this alignment that is due to orienting collisions with the aligned 
bicelles, depends on the bicelle concentration, and this gives the possibility to control the 
strength of the dipolar couplings to be high enough to be measurable and not too high 
to cause excessive line broadening due to unresolved 1H-1H dipolar couplings. After the 
discovery of the bicelles, many media have been described to align macromolecules such 
as bacteriophages, silicate rods, polyacrylamide gels and Helfrich phase media (reviewed in 
Bax, 2003; Bax et al., 2001). These residual dipolar couplings are generally measured for 
one- and two-bonds interactions since in that case the internuclear distance is defined and 
the RDC depends mainly on orientation. The most common and straightforward coupling 
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that can be measured is the 1DNH dipolar coupling but weaker couplings such as 
1DC’Cα, 
1DC’N 
or 2DC’HN can also be measured. Dipolar couplings contain information on the orientation 
of inter-nuclear vectors relative to a molecular alignment axis and therefore restraint the 
orientations of these vectors relative to a common frame, the alignment tensor.
Diffusion anisotropy
Analysis of R1, R2 and heteronuclear NOE rates of amide 
15N nuclei in the backbone of 
a protein allows to characterize the motional behavior of the protein backbone in high 
detail (Kay et al., 1989; Peng and Wagner, 1994). Whereas the R1, R2 and heteronuclear 
NOE rates reflect the internal dynamics, it has been noted that the ratio R2/R1, at least 
when exchange broadening can be excluded, are much less sensitive for internal motions 
and mainly reflect the rotational correlation time of the N-H vector. In the case of a rigid 
anisotropic molecule, this R2/R1 ratio therefore defines the orientation of this vector with 
respect to an anisotropic diffusion tensor. Therefore, the R2/R1 ratios can be translated into 
diffusion anisotropy restraints to define the orientation of the N-H bonds (Tjandra et al., 
1997). 
Orientational restraints for structure calculations
Information derived from residual dipolar couplings and diffusion anisotropy can be used 
to define orientational restraints that can be used in structure calculations. In the case of 
macromolecular complexes, these restraints allow to orient one protein with respect to 
the other one, reducing considerably the number of possible solutions for the structure of 
a complex. The use of RDCs or diffusion anisotropy for orienting the components of a 
complex is based on the assumption that the macromolecular complex is more or less rigid 
and that the two molecules in the complex have a common alignment or diffusion tensor. 
In that case, one can determine a tensor of each individual component of the complex and 
rotate them in a way that the two tensors coincide. Though RDCs can be used alone to 
define macromolecular structures (Hus et al., 2001), orientational restraints are frequently 
combined with other NMR restraints, such as NOEs. The combined use of these restraints 
has large advantages: the conventional restraints (NOE and scalar couplings) define well 
the local geometry while the RDC and the diffusion anisotropy are particularly sensitive 
to a global relative position of structured regions, especially in the case of macromolecular 
complexes (Garrett et al., 1999).
Chemical shift perturbation mapping
Chemical shift perturbation mapping obtained via NMR titration experiment is a 
straightforward NMR technique to define the residues of a protein involved in binding to 
a partner molecule (reviewed in Zuiderweg, 2002). This type of experiment can already be 
performed early in the NMR analysis, at the stage of backbone assignments, and allows to 
identify possible amino acid residues that are involved in complex formation. Its principle 
relies on the fact that the chemical shift of a nucleus is sensitive to its environment. The 
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chemical shift changes are measured in a series of NMR experiments (generally 15N HSQC 
spectra) of the free protein and of the protein with increasing amounts of the partner 
molecule such as ligand, protein, and DNA. The proximity of the partner in the complex 
will modify the environment of the nuclei that are at the interface of the complex. As 
a result, nuclei involved in the binding will have a different chemical shift than in the 
unbound form. Chemical shift perturbations are generally measured on backbone amides 
for a number of reasons. First, only 15N-labeled samples are needed and they can be easily 
obtained by protein expression in E. coli. Next, measuring on backbone atoms implies that 
no side chains assignments are required. Finally, the 15N and 1H chemical shifts of the 
amide protons turn out to be sensitive to environmental changes, partially due to subtle 
changes in the polarization of hydrogen bonds. It is clear that the observed chemical shift 
changes upon binding can also result from indirect conformational changes in the protein 
due to the binding. Cases have been reported in which a protein will completely change 
its conformation upon complex formation; in that case, all chemical shifts are therefore 
perturbed. In most cases, however, complex formation only induces few or minor structural 
rearrangements and chemical shift perturbation can then be used to define the interface 
residues. This technique, however, is generally applied only qualitatively and does not 
allow to unambiguously identify pairs of atoms that are in contact in the complex or to 
get precise intermolecular distance information. Furthermore, it does not provide any 
information about the orientation of one protein with respect to its counterpart. Because 
of that, chemical shift perturbation information results have rarely been used directly for 
structure calculations.
Ab Initio docking
 Next to experimental approaches, theoretical methods are now emerging to study 
macromolecular complexes at a structural level based on docking. Some of these methods 
have been well developed only during the past few years and the methodology is not yet 
as widely established as X-ray crystallography and NMR spectroscopy. Docking embraces 
computational methods, generally based on theoretical knowledge, with the task of 
predicting the assembly of two separate (bio)molecules into their biologically relevant 
complex. There are a number of programs performing ab-initio macromolecular docking 
(without knowledge on the binding properties) mainly focusing on protein-ligand and 
protein-protein complexes (reviewed in Camacho and Vajda, 2002; Halperin et al., 2002; 
Smith and Sternberg, 2002). Most of these programs use the same approach: one protein is 
fixed in space and the second one is rotated and translated around the first one. For each new 
configuration, a score is calculated based on various terms such as surface complementarities, 
electrostatic interactions, van der Waals repulsion. 
Docking protocols can be divided into three main sections:
- The representation of the system and the introduction of flexibility 
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- The search procedure
- The scoring function
The representation of the system depends on the definition of the degrees of freedom for 
the search procedure. There are different approaches to represent the system (see below). An 
important point in the representation of the system is the introduction of some flexibility 
at the interface to account for possible structural rearrangements that can take place during 
binding. The search procedure consists of the algorithm used to dock the two molecules 
together (translation, rotations, ...). Two important elements in a search procedure are speed 
and effectiveness in covering the relevant conformational space. The scoring function is 
based on a function (often expressed in terms of energies) that should discriminate the 
various generated solutions. The evaluation of this function should be fast enough to allow 
its application to a large number of potential solutions and, in principle, the function should 
effectively discriminate between native and non-native docked conformations. These three 
main aspects of docking will be discussed in more details in the following.
Representation of the system and introduction of flexibility
There are two main ways of representing the system, geometrically or chemically. A chemical 
representation can include all atoms, a selected subset or a simplified representation of amino 
acids. Most docking approaches use, however, a surface representation of the molecules. 
The surface is usually represented by its geometric features such as, for example, a Connolly 
surface that consists of the part of the van der Waals surface of the exposed atoms and that is 
connected by a network of convex or concave shape surfaces (Connolly, 1983). To align the 
surfaces of two molecules, one needs to superimpose them without allowing one molecule 
to deeply penetrate or overlap with the other. This is usually performed by aligning triplets 
of ordered non-collinear points that describe the molecular surface from both molecules. 
These points should be computed to accurately represent the maxima (holes) and minima 
(knobs) of the shape function (Norel et al., 1994; Norel et al., 1999). For docking, one of 
the molecules is translated and rotated, while the other is kept fixed, such as the surface 
complementarity (represented by the triplets of points) is maximum, i.e. so that the knobs 
of one molecule face the holes of the other. Physico-chemical features of the molecular 
surface such as electrostatics can also be added into the geometrical description (Nicholls et 
al., 1993; Ritchie and Kemp, 2000).
Introduction of flexibility
When docking unbound structures of the molecules, one should account for a certain degree 
of flexibility at the interface to allow for possible structural rearrangements. The complexity 
and computational cost of docking procedures depends largely on the extent of flexibility 
introduced. Docking approaches can be classified into three levels:
- Rigid body docking
- Semi-flexible docking
- Flexible docking
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Rigid body docking is the simplest because the proteins are considered as two rigid 
bodies. Semi-flexible docking is typically asymmetric and mainly used in protein–ligand 
docking: the ligand is then considered flexible, while the protein is kept rigid. Flexible 
docking treats both molecules as flexible but the extent of flexibility that is allowed is 
limited or simplified. Flexibility in docking algorithms has mainly been introduced for 
protein–ligand complexes for two main reasons. First, ligands are small molecules that are 
likely to undergo conformational changes upon complex formation. Second, the small size of 
most ligands allows computationally affordable flexibility algorithms. Attempts to introduce 
flexibility into proteins have also been described. The two main ways of introducing 
flexibility in protein–protein docking, which are not computationally expensive, are to allow 
intermolecular penetration in the search procedure (Gardiner et al., 2001; Jiang and Kim, 
1991) or to use an ensemble of starting structures (Knegtel et al., 1997). Such ensembles can 
be taken from an NMR ensemble, or an ensemble of X-ray structures of the same molecule 
if available. Otherwise, starting structures can be generated using random thermodynamic 
sampling (Totrov and Abagyan, 1997), genetic algorithms (Blommers et al., 1992; Legrand 
and Merz, 1992; Payne and Glen, 1993), or molecular dynamic or monte-carlo simulations 
(Clarage et al., 1995). 
The search procedure
One of the ab initio docking problems resides in the many possible ways to put the two 
molecules together. There are, indeed, three translational and three rotational degrees of 
freedom in the case of a rigid body docking. Introduction of flexibility increases the number 
of degrees of freedom, the search space, and thus the computational costs. There are two 
main approaches to the search problem in docking: a full search of the solution space or a 
gradual, guided progression through it. The first approach scans the entire solution space 
by systematically rotating and translating one molecule with respect to the other, while the 
second scans only part of the solution space in a partially random, and partially criteria-
guided manner (see the scoring function section). The second approach is generally based 
on Monte-Carlo, molecular dynamics, or genetic algorithms. It has been shown that, in 
general, molecular dynamics algorithms are the most efficient and genetic algorithms the 
least (Vieth et al., 1998). In the case of protein-protein docking, introduction of flexibility 
increases dramatically the number of degrees of freedom and full conformational space 
search becomes impractical. This is why ab initio docking approaches applied to protein 
complexes treat most often the molecules as rigid entities.
The scoring function
Search algorithms typically produce a very large number of possible solutions. The 
challenging step in docking is to identify the native or near-native solutions using scoring 
functions within a reasonable computation time. The scoring of solutions is the major issue 
in docking. In most approaches, a correct solution is ranked within the one hundred to one 
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thousand best solutions. In most cases, however, the highest ranked solutions are often false 
positives. This problem is mainly due to the fact that native complexes do not necessarily 
possess the largest buried surface area, the largest number of hydrogen bonds or the largest 
non-polar buried surface (Norel et al., 1999). The current solution to overcome this problem 
is a two-stage approach in which, first one uses a rapid scoring to predict “good” candidates, 
and second, one uses a more advanced scoring function to discriminate between the selected 
candidates (Hoffmann et al., 1999). 
The scoring approaches can be divided into two groups depending on the stage at which 
scoring is introduced in the search algorithm. Integrated approaches integrate scoring into the 
search procedure and filter emerging solutions, while edge approaches apply scoring functions 
at the end of the search procedure. Some algorithms, such as genetic algorithms, require 
integrated approaches.
Most docking programs use similar scoring parameters. The most common are geometric 
complementarity, intermolecular overlap, number of hydrogen bonds, and number of 
unsatisfied buried charges, although other parameters based on electrostatic potentials, van 
der Waals energies, or solvation energies have also been described. Docking programs, 
however, differ in the way these parameters are implemented in the search algorithms. 
Geometric complementarity criteria were the first parameters used in docking. Many early 
docking programs used exclusively geometric complementarity as scoring function. These 
scoring functions have been quite successful in “bound” docking, that is when the starting 
structures correspond to the bound form of the molecules. In “unbound” docking, however, 
geometric complementarity is not sufficient to discriminate between correct and incorrect 
solutions and the use of other criteria in combination with geometric complementarity is 
thus necessary (Norel et al., 1999). In these cases, geometric complementarity is used as a 
primary filter before introducing other more computationally costly evaluation criteria. 
The degree of intermolecular overlap is then computed and typically penalized in the 
scoring. A way of dealing with flexibility, however, is to allow intermolecular overlap in 
a first stage of the docking and then remove it in a refinement step (Gardiner et al., 2001; 
Palma et al., 2000). In addition to shape complementarity (geometric complementarity and 
intermolecular overlap), hydrogen bonding or electrostatic criteria can be used. Hydrogen 
atoms can be added to crystallographic structures according to standard geometry criteria 
(Barlow and Thornton, 1983; Vriend, 1990). Hydrogen bond formation potentials usually 
consider four classes of atoms, the H-bond donors, the H-bond acceptors, the H-bond 
donors/acceptors, and the non-H bonding atoms (Ausiello et al., 1997; Gardiner et al., 
2001; Jiang and Kim, 1991). The various approaches can differ in their definition of donors 
and acceptors, in the introduction of discrimination between bond types, or in the H-bond 
distance and angular cut-offs used. Electrostatic potentials based on the Poisson-Boltzman 
equation have also been used in scoring schemes (Gabb et al., 1997; Palma et al., 2000). 
Another scoring criterion is the buried surface area or contact area. Based on an analysis of 
known protein-protein complexes, it has been estimated that the average buried surface area 
of a complex is 1600 ± 400 A2 (Lo Conte et al., 1999). This criterion correlates with the 
hydrophobicity at the interface. Many scoring schemes use a hydrophobicity factor (Norel et 
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al., 1999) or a buried surface area criterion (Gardiner et al., 2001). Solvation energies have 
also been described in some cases (Camacho et al., 2000; Jackson et al., 1998).
Scoring of solutions remains the most difficult issue in docking. A possible solution is 
to combine several scoring schemes and derive a consensus scoring in order to reduce the 
number of false positives (Bissantz et al., 2000; Charifson et al., 1999; Terp et al., 2001).
 
Protein–protein docking based on NMR data
The drawback of ab initio docking is that the search through the entire conformational space 
for the geometry of the complex makes the calculation time consuming and rarely resulting 
in a unique solution. The inclusion of experimental data into docking was early described 
by Weber et al., (1992) and a similar approach was followed by Knegtel et al., (1994b) in 
docking studies on protein-DNA complexes. In this study, three protein-DNA complexes 
are docked using MONTY (Knegtel et al., 1994a) based on biochemical information such 
as mutagenesis experiments. Recently, NMR data have been used in different ways in 
combination with docking methods to calculate protein-protein complexes. 
An early example of a protein–protein docking based on NMR data made use of 
chemical shift perturbation mapping and intermolecular pseudocontact shifts combined 
with restrained rigid-body molecular dynamics to solve the structure of the paramagnetic 
plastocyanin-cytochrome f complex (Ubbink et al., 1998). Measurement of pseudo-contact 
shifts is, however, limited to paramagnetic proteins.
Later, intermolecular NOEs and residual dipolar couplings (RDCs) have been combined 
with rigid-body energy minimization to solve the structure of the EIN-HPr complex 
starting from the structures of the two free proteins (Clore, 2000). This method, however, 
relies on the collection of intermolecular NOEs and residual dipolar couplings that can be a 
lengthy and tedious process (see above). 
The same year, Morelli et al. used the ab initio docking program BIGGER (Palma et al., 
2000) incorporating a NMR filter, based on chemical shift perturbation data, to select the 
experimentally relevant solutions (Morelli et al., 2000; Morelli et al., 2001). The approach 
was tested on four complexes and the best solutions had backbone RMSDs between 0.5 
and 2.2 Å from the original structures. This approach allows the use of NMR titration data 
to rank the possible solutions but the docking is not directly driven by these data and thus 
still depends on the performance of the search algorithm, i.e. the correct solution should be 
present in the ensemble of solutions before applying the NMR filter. 
Another protein–protein docking approach based on unassigned one-dimensional 1H 
NMR spectra of complexes was described (Kohlbacher et al., 2001). In this case, a rigid-
body protocol is used to generate an ensemble of complexes in a similar manner as in 
classical ab initio docking. The originality of the method resides in a new scoring scheme. 
For each generated solution, a theoretical one-dimensional spectrum is calculated based on 
statistical and theoretical knowledge such as random coil shift of specific atoms, magnetic 
anisotropy of the peptide bond, ring current effect and electric field effect. This calculated 
43
Methodological Introduction: Modeling of macromolecular interactions based on NMR data
spectrum is then compared to the experimental one and a difference area (difference 
between the experimental and the calculated spectra) term is calculated and added to the 
scoring function. This approach was tested on four complexes. For three of them, the best 
solution of the docking was the closest to the original structure of the complex (backbone 
RMSD between 2 and 5 Å). 
Recently, a new docking program, TreeDock, was developed where the docking is 
driven by anchors points, which can be in principle derived from NMR chemical shift 
perturbation or mutagenesis data (Fahmy and Wagner, 2002). This program performs a rigid-
body docking and the solutions are ranked in function of their Lennard-Jones potentials. 
The approach has been tested on three known complexes starting from the bound structure 
of each molecule. The backbone RMSD between the best solutions and the structures of the 
complexes varied between 0.3 and 0.7 Å. 
McCoy et al. used chemical shift perturbation data in combination with RDCs to 
develop a new docking approach (McCoy and Wyss, 2002), which was tested on the EIN-
HPr complex starting from the unbound forms of the molecules. In that case, the RDC 
data were first introduced to orient the complex. The solutions were then optimized by 
back calculating the chemical shift perturbation with SHIFTS (Xu and Case, 2001) and 
comparing them with the experimental data. The final solutions have a backbone RMSD 
of approximately 2.5 Å from the original structure. 
Later, another docking approach was published using a filtering scheme based on 
experimental data (Dobrodumov and Gronenborn, 2003). In a first step, ab initio rigid-
body docking is performed using the 3D-DOCK package (Moont et al., March 2001). The 
scoring function was modified to incorporate sorting routines based on dipolar couplings (Q 
factor term), on explicit Cα-Cα distances that can be derived from biological information, 
or on mapped contacts derived from NMR chemical shift perturbation data. The method 
was tested on two complexes for which the structures of the free components and of the 
complex were available. The best ranked structures display a backbone RMSD between 2.0 
and 2.5 Å from the original structures. As is the case in BIGGER (Morelli et al., 2000), 
this approach, however, only uses NMR data a posteriori to rank the possible solutions and 
depends therefore on the accuracy of the ab initio search algorithm.
All these methods based on NMR data consist of rigid-body docking algorithm. 
During complex formation, however, some structural rearrangements usually occur. As 
described above, it is important, when docking two proteins, to allow for side chains and/or 
backbone flexibility in order to find the best orientation of the side chains that will lead to 
the minimum energy and the best intermolecular contacts. For this, the side chains at the 
interface should be free to move to adopt their preferential conformation. 
We developed a docking protocol that uses directly NMR data to drive the docking 
process and allows for side chain and backbone flexibility at the interface (Dominguez et 
al., 2003). This approach is described in Chapter 3 of this thesis. NMR or mutagenesis 
data are directly used as ambiguous distance restraints. HADDOCK (High Ambiguity 
Driven DOCKing) makes use of CNS (Brunger et al., 1998) for structure calculation and 
of Python scripts derived from ARIA for automation (Linge et al., 2001). The docking 
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protocol allows for side chains and backbone flexibility at the interface. The solutions are 
scored according to an intermolecular energy term, i.e. sum of electrostatic, van der Waals 
and AIR (Ambiguous Interaction restraint, see Chapter 3) energy terms, although buried 
surface area can also be included. This approach has been tested on three complexes starting 
from both bound and unbound structures. The RMSD between the best solutions and the 
original structures varied between 0.8 and 2.0 Å. This approach has been further improved 
by using ensembles of starting structures instead of a single structure as described in Chapter 
5 of this thesis (Dominguez et al., 2004). 
A very similar approach using highly ambiguous restraints was described (Clore 
and Schwieters, 2003) shortly after HADDOCK has been published. In addition to the 
ambiguous interaction restraints derived from chemical shift perturbation mapping as we 
used, Clore and Schwieters also used RDC data in the calculation. The main differences 
between the two methods reside in the upper bound limit of the AIR restraints (5 Å instead 
of 2-3 Å in HADDOCK) and in the final scoring of the solutions. While, in HADDOCK, 
the solutions are ranked according to an intermolecular energy term (see above and Chapter 
3), in the other case, the solutions are ranked based on the ambiguous distance restraint 
violations and on the R factor of the RDCs. This approach has been tested on three 
complexes and the backbone RMSD between the best solutions and the original structures 
is between 0.5 and 1.5 Å. 
CAPRI (Critical assessment of PRedicted Interactions)
In order to assess the capacity of current docking methods to predict protein-protein 
interactions, CAPRI, a community-wide experiment, was set up as a blind test of docking 
(Janin et al., 2003), similarly to the homology modeling blind test CASP (Critical Assessment 
of methods for protein Structure Prediction) (Venclovas et al., 2003). CAPRI relies on the 
generosity of experimentalists willing to communicate unpublished atomic coordinates of 
protein-protein complexes on a confidential basis. CAPRI started in 2001 with three targets 
and 19 predictor groups. Since then, 5 rounds of CAPRI have been organized (round 5 was in 
progress at the time of writing of this thesis). The various evaluation criteria include the RMSD 
between the predicted and the experimental complex and the number of native intermolecular 
contacts present in the predicted models (Mendez et al., 2003). Evaluation of the CAPRI 
predictions and of the performance of the various docking approaches provides useful insights 
for future developments and improvements of these methods. The CAPRI results until now 
indicate that a major problem is the scoring of solutions. It has become clear that the use 
of experimental information is an important element to discriminate between the various 
solutions. Using HADDOCK, we have participated in round 4 of CAPRI. Our approach, 
HADDOCK, allowed the use of a wide range of different experimental data to drive the 
docking (mutagenesis, conservation of exposed residues, epitope mapping, etc). HADDOCK 
appeared to be very successful in this CAPRI round where our predictions ranked at the top 
for three out of four targets. In particular, we successfully predicted the trimeric form of a 
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flavivirus envelope glycoprotein to within 2.8 Å of the experimental model that was recently 
published (Bressanelli et al., 2004). This was basically the only correct solution out of the 190 
predictions that were deposited.
Concluding remarks
In the current structural genomics era, massive efforts are made to solve macromolecular 
structures. Both X-ray crystallography and NMR are developing new methodologies to 
automate and speed up the structure determination process. These efforts are currently mainly 
focusing on structures of single proteins or domains thereof. Most proteins, however, function 
by interacting with partner molecules that can be another protein, DNA, RNA, sugar or lipids. 
The understanding of protein function highly depends on our knowledge of the interactions 
that are taking place and thus, there is a clear need for models of biomolecular complexes. 
Information on such molecular interactions is also crucial for pharmaceutical applications such 
as drug design. 
Ab initio docking appears to be a complementary approach to X-ray crystallography 
and NMR spectroscopy for predicting structures of complexes in cases where these two 
methods fail. Many improvements have been proposed over the last few years and these 
methods are getting more and more robust. Ab initio docking, however, still suffers from 
important limitations. First, during the search procedure, one should cover the entire 
conformational space. Second and most important, scoring functions need to be improved 
to discriminate between the various solutions from the huge amount of solutions that are 
generated. Third, introduction of flexibility at the interface is crucial but is computationally 
very time consuming, and therefore fully flexible docking is rarely used.
During the last five years, structural biology and theoretical docking approaches have 
been combined to predict more accurately structures of macromolecular complexes. The 
use of NMR data, and also biochemical data, has been introduced into docking algorithms 
and scoring functions. The experimental data optimize the scoring of the solutions and 
secondly reduce the search in the vast conformational space. If the binding interface of a 
macromolecule is known, it is not necessary to generate solutions that do not present this 
interface. The advantage of reducing the space search is that it considerably reduces the 
computation time, allowing for docking algorithms to be optimized to include flexibility 
at the interface. These new methods are clearly limited by the quantity and quality of 
biochemical and/or biophysical information that is needed to generate realistic solutions. 
This new field of information-driven docking is, however, just emerging and will probably 
become even more powerful in a near future. 
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Abstract
The structure determination of protein-protein complexes is a rather tedious and lengthy 
process, by both NMR and X-ray crystallography. Several methods based on docking to 
study protein complexes have also been well developed over the past few years. Most of 
these approaches are not driven by experimental data but are based on a combination of 
energetics and shape complementarity. Here we present an approach called HADDOCK 
(High Ambiguity Driven protein–protein DOCKing) that makes use of biochemical and/
or biophysical interaction data such as chemical shift perturbation data resulting from NMR 
titration experiments or mutagenesis data. This information is introduced as Ambiguous 
Interaction Restraints (AIRs) to drive the docking process. An AIR is defined as an 
ambiguous distance between all residues shown to be involved in the interaction. The 
accuracy of our approach is demonstrated with three molecular complexes. For two of 
these complexes, for which both the complex and the free protein structures have been 
solved, NMR titration data were available. Mutagenesis data were used in the last example. 
In all cases, the best structures generated by HADDOCK, that is, the structures with the 
lowest intermolecular energies, were the closest to the published structure of the respective 
complexes (within 2.0 Å backbone RMSD).
Introduction
For a better understanding of the biological function of a protein, knowledge of its 
three-dimensional structure is crucial. Solving protein structures is mainly achieved by two 
different methods: X-ray crystallography and Nuclear Magnetic Resonance (NMR). From 
the statistics of the Protein Data Bank (PDB) (Berman et al., 2000) (http://www.rcsb.org/
pdb/), approximately 13500 X-ray structures and 2225 NMR structures have been solved 
and deposited at this date. Most of the proteins achieve their function by interacting with 
other proteins and forming an active complex. Although many methods are available to study 
protein complexes at different levels (two-hybrid screening, fluorescence studies, resonance 
energy transfer, etc), only few of these techniques provide high-resolution information at an 
atomic level. X-ray and NMR encounter difficulties in dealing with structures of complexes. 
Indeed, by X-ray, the dynamic of the complex formation makes the crystallization difficult, 
while the size limitation in NMR is a major problem when considering high molecular 
weight complexes. The traditional NMR approach to solving protein-protein complexes 
requires the collection of intermolecular nuclear Overhauser effect (NOE) distances, which 
is typically a lengthy and difficult process. In addition, intermolecular NOEs often involve 
side chain protons, requiring thus a rather complete assignment of all NMR signals. Because 
of these limitations, the number of protein–protein complexes solved and deposited in the 
PDB is rather low (643 by X-ray and 84 by NMR) compared with the number of free 
form structures. NMR, however, is very powerful in mapping protein-protein interfaces 
by titration experiments (reviewed in Zuiderweg, 2002). Such experiments, which can be 
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performed at the stage of backbone assignment already, easily allow us to identify amino 
acids involved in the complex formation but do not provide any information about the 
orientation of one protein with respect to its counterpart. Because of that, this information 
has rarely been directly used as a structural restraint in a structure calculation process. 
Next to these experimental approaches, theoretical methods to study protein complexes at a 
structural level based on docking are now emerging that have been well developed during 
the past few years. There are now a number of programs performing “ab initio” protein-
protein docking (for review, see references Camacho and Vajda, 2002; Smith and Sternberg, 
2002). Most of these programs use the same approach: one protein is fixed in space and the 
second one is rotated and translated around the first one. For each new configuration, a score 
is calculated on the basis of various terms such as surface complementarities, electrostatic 
interactions, van der Waals repulsion, and so forth. The drawback of these methods is that 
the search through the entire conformational space of the complex geometry makes the 
calculation heavy, rarely resulting in an unique solution. Recently, NMR data have been 
used in combination with docking methods in different ways to generate protein-protein 
complexes. Diamagnetic chemical shift changes and intermolecular pseudocontact shifts 
have been combined with restrained rigid-body molecular dynamics to solve the structure of 
the paramagnetic plastocyanin-cytochrome f complex (Ubbink et al., 1998). Intermolecular 
NOEs and residual dipolar couplings (RDCs) have been combined to solve the structure 
of the EIN-HPr complex (Clore, 2000). Intermolecular NOEs can very accurately define 
the interface. Their collection, however, is generally a tedious process. In addition, RDC 
data can be very useful to determine the relative orientation of the two proteins. Morelli 
et al. used the program BIGGER (Palma et al., 2000), which makes use of an NMR 
filter on the basis of chemical shift perturbation data (Morelli et al., 2001). This approach 
allows the use of NMR titration data to rank the possible solutions, but the docking is not 
directly driven by these data. Recently, Fahmy et al. developed a new docking program, 
TreeDock, where the docking is oriented on the basis of anchors points which can be in 
principle derived from NMR chemical shift perturbation or mutagenesis data (Fahmy and 
Wagner, 2002). This program performs a rigid body docking and the solutions are ranked 
in function of their Lennard-Jones potentials. McCoy et al. used chemical shift perturbation 
data in combination with RDCs to develop a new docking approach (McCoy and Wyss, 
2002). In that case, the RDC data are first introduced to orient the complex, and then the 
solutions are optimized by back calculating chemical shift perturbation with the SHIFTS 
software (Xu and Case, 2001) and comparing them with the experimental data. During 
complex formation, usually, some structural rearrangements occur. By NMR titration, it is 
possible to check such rearrangements for backbone atoms, but no information is available 
on the side chain rearrangements that occur frequently at the interface, especially in the 
case of hydrophobic interfaces. It is therefore important, when docking two proteins, to 
consider the best orientation of their side chains leading to the minimum energy and the 
best side chain contacts. For this, the side chains at the interface should be free to adapt their 
conformation.
Here, we present a new high ambiguity driven docking approach (HADDOCK) that 
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makes use of biochemical and/or biophysical interaction data such as, for example, chemical 
shift perturbation data obtained from NMR titration experiments or mutagenesis data. The 
information on the interacting residues is introduced as Ambiguous Interaction Restraints 
(AIR) to drive the docking. After calculation, the structures are ranked according to their 
intermolecular energy, that is, sum of electrostatic, van der Waals, and AIR energy terms. We 
should note that ambiguous distance restraints have first been introduced to solve symmetric 
dimer structures by NMR (Nilges, 1993) and are now commonly used in protein structure 
determination and automated NOE assignment methods (Nilges and Donoghue, 1998). We 
demonstrate the usefulness of the AIRs and the accuracy of our docking approach for three 
different molecular complexes: the N-terminus domain of Enzyme I (EIN) in complex 
with the histidine-containing phosphocarrier protein (HPr), the Enzyme IIAglucose (EIIA) 
in complex with HPr and the HIV protein gp120 in complex with the protein CD4. The 
structures of the first two complexes have been solved by NMR, (Garrett et al., 1999; Wang 
et al., 2000) and their respective free forms are available from X-ray and/or NMR (Jia et al., 
1993; Liao et al., 1996; van Nuland et al., 1994; Worthylake et al., 1991). The NMR titration 
data of each protein upon complex formation to its partner are available (Chen et al., 1993; 
Garrett et al., 1997; van Nuland et al., 1995). For the gp120–CD4 complex, however, only 
the X-ray structures (Kwong et al., 2000; Kwong et al., 1998) of the individual partners of a 
complex were used. Instead of NMR titration data, mutagenesis data (Moebius et al., 1992; 
Olshevsky et al., 1990) were used to define ambiguous interaction restraints. In all three 
cases, starting from the complex or the free state structures, we found that the best solutions 
generated by HADDOCK, that is, the structures with the lowest intermolecular energy 
term, were those that are the closest in terms of backbone root-mean-square deviations at 
the interface (iRMSD) (between 0.8 and 2 Å) to the published structure of the respective 
complexes.
Results
Ambiguous Interaction Restraints (AIR)
The Ambiguous Interaction Restraints are derived from any kind of experimental 
information available concerning residues that are involved in the intermolecular interaction. 
We distinguish here between “active” and “passive” residues. In the case of NMR titration 
data, the active residues correspond to all residues showing a significant chemical shift 
perturbation upon complex formation as well as a high solvent accessibility in the free form 
protein (>50% relative accessibility as calculated with NACCESS (Hubbard and Thornton, 
1993)). The threshold to define significant chemical shift perturbations will differ for each 
protein complex under study and need some optimization by the user. In our examples, 
we used as starting point the residues that the authors of the original papers (Chen et al., 
1993; Garrett et al., 1997; van Nuland et al., 1995) defined as significantly perturbed in the 
complex. These perturbed residues that do not satisfy the high solvent accessibility criterion 
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should be subsequently removed from the active residue list. In the case of mutagenesis 
data, the active residues are those that have been shown by mutations to alleviate complex 
formation and are also solvent exposed. The passive residues correspond to the residues 
that show a less significant chemical shift perturbation and/or that are surface neighbors of 
the active residues and have a high solvent accessibility (>50%). An AIR is defined as an 
ambiguous intermolecular distance (diAB) with a maximum value of 3 Å between any atom 
m of an active residue i of protein A (miA) and any atom n of both active and passive residues 
k (Nres in total) of protein B (nkB) (and inversely for protein B). The effective distance diAB
eff 
for each restraint is calculated using the equation:
where Natoms indicates all atoms of a given residue and Nres the sum of active and passive 
residues for a given protein. In this way, the passive residues do not have direct AIRs to the 
partner protein but can satisfy the partner protein active restraints. A 1/r6 sum averaging 
is used, not by analogy to NOE restraints, but because this mimics the attractive part of a 
Lennard-Jones potential and ensures that the AIRs are satisfied as soon as any two atoms of 
the two proteins are in contact. The 3 Å limit represents a compromise between hydrogen-
hydrogen and heavy atom-heavy atom minimum van der Waals distances. The use of 
ambiguous interaction restraints allows HADDOCK to search through all the possible 
configurations around the interacting site defined by the biochemical and/or biophysical 
data such as NMR chemical shift perturbation data or mutagenesis data and to find the most 
favorable pair of interacting amino acids among the active and passive residues.
Docking Protocol
Our HADDOCK (High Ambiguity Driven protein-protein DOCKing) has been 
implemented in CNS (Brunger et al., 1998) for structure calculations and makes use of 
python scripts derived from ARIA (Linge et al., 2001) for automation (see Material and 
Methods). The docking protocol, which requires the PDB files of the free proteins and 
ambiguous interaction restraints, consists of three stages: i) randomization of orientations 
and rigid body energy minimization (EM), ii) semi rigid simulated annealing in torsion 
angle space (TAD-SA), iii) final refinement in Cartesian space with explicit solvent. 
The three stages are detailed in the Material and Methods section. During the TAD 
simulated annealing and the water refinement, the amino acids at the interface (side chains 
and backbone) are allowed to move to optimize the interface packing. The interface amino 
acids allowed to move are defined by the active and passive amino acids used in the AIRs ± 
2 sequential amino acids. Although no real significant structural changes occur during the 
water refinement stage, it is useful for the improvement of the energetics of the interface. 
This is important for a proper scoring of the resulting conformations. The final structures 
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are clustered using the pairwise backbone RMSD at the interface and analyzed according to 
their average interaction energies (sum of Eelec, Evdw, EAIR) and their average buried surface 
area. The entire docking procedure is performed automatically by HADDOCK and is 
followed by the cluster analysis (for more details, see Material and Methods). For the EIN-
HPr complex (247 and 85 amino acids, 25 AIRs requiring 105000 distance evaluations), 
the entire run required 2 days on 10 1.3 GHz AMD processors. The three docking stages 
required 10 s, 1.5 h and 1 h per structure for the rigid body minimization, the semirigid 
TAD-SA and the final water refinement, respectively.
Validation of the HADDOCK Approach
HADDOCK was tested for three protein-protein complexes using chemical shift perturbation 
data in two cases and mutagenesis data in the third to define the ambiguous interaction 
restraints. As a first test, we performed the docking with ambiguous interaction restraints 
on the EIN–HPr complex (Garrett et al., 1999) starting from the structure of the complex. 
The coordinates of the two proteins in the structure of the complex were separated into 
two distinct pdb files. Although the structures of the two proteins and in particular of their 
interface were already in the geometry of the complex, the side chains and backbone atoms 
at the interface were still allowed to move during the TAD simulated annealing and the 
water refinement process. On the basis of the NMR titration data (Garrett et al., 1997; van 
Nuland et al., 1995), 24 amino acids of EIN  and 19 amino acids of HPr showing significant 
chemical shift perturbation were first identified. The solvent accessibility of these amino 
acids was calculated, and only those that are exposed at the surface of the protein were 
further selected for the active ambiguous interaction restraints. At the end, 16 amino acids 
of EIN (E67, E68, K69, A71, I72, D82, E83, E84, G110, Q111, S113, A114, E116, E117, 
L118 and Y122) and 9 amino acids of HPr (H15, T16, R17, Q21, K24, K49, Q51, T52, and 
G54) were used as active AIRs. By displaying these amino acids on the free form structures, 
we defined five passive amino acids for EIN (M78, L79, L115, L123 and R126) and three 
for HPr (A20, L47 and F48). The interface residues that were allowed to move during the 
TAD simulated annealing and the water refinement process consisted of residues 65 to 
74, 76 to 86 and 108 to 128 for EIN and 13 to 26 and 45 to 56 for HPr. Figure 1 (circles) 
shows the intermolecular energy as a function of the iRMSD (backbone RMSD at the 
interface) from the target, that is, the NMR structure, for the 200 calculated structures 
after water refinement. Five clusters were obtained. Their average intermolecular energies 
are, respectively, -868, -698, -465, -270, and –388 kcal mol-1 and the average iRMSDs 
from the target are 1.4, 2.7, 8.5, 9.0, and 9.5 Å. For reference, the published NMR structure 
that has however not been optimized within our chosen force field and parameters has an 
intermolecular energy of –370 kcal mol-1. Cluster 1 has the lowest intermolecular energy 
as well as the lowest iRMSD from the target. This result demonstrates a nice correlation 
between the intermolecular energy of our solutions and the iRMSD between these solutions 
and the target. The best solution of Cluster 1 (the lowest in energy) has an intermolecular 
energy of -961 kcal mol-1 and an iRMSD of 1.45 Å (the backbone RMSD on both proteins 
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is 1.05 Å) from the reference structure (Figure 2A).
Next, HADDOCK was run, starting from the protein structures in the free form ( Jia 
et al., 1993; Liao et al., 1996). The backbone iRMSD between the free and bound form 
of EIN and HPr are 0.95 and 0.55 Å, respectively. The resulting intermolecular energies 
as a function of the iRMSD from the target for the 200 calculated structures after water 
refinement are shown in Figure 1 (triangles). After analysis, 13 clusters were obtained with 
average energies between -637 and -275 kcal mol-1 and average iRMSDs from the target 
between 1.80 and 9.85 Å. Again, in this case, the lowest intermolecular energy cluster 
corresponds to the lowest iRMSD from the target. The best solution of this cluster has 
an intermolecular energy of –658 kcal mol-1 and an iRMSD from the target of 1.70 Å 
(the backbone RMSD on both proteins is 2.75 Å) (Figure 2C). These results demonstrate 
that HADDOCK could generate the correct docking solution starting from the free form 
protein structures and that, again, the lowest intermolecular energy cluster is the closest one 
to the published NMR structure. Among all protein-protein complexes available in the 
PDB, the average buried interface area is 1600 ± 400 Å2 (Lo Conte et al., 1999). In our case, 
the best solutions have a buried interface area of 2064 Å2 when starting from the complex 
form and 1798 Å2 when starting from the free form proteins, while the buried surface area 
of the NMR structure of the complex is 1996 Å2.
Figure 1: Intermolecular energies versus iRMSDs for the EIN-HPr complex. The energies are 
calculated as the sum of Eelec+ Evdw+EAIR after water refinement. iRMSD corresponds to the backbone 
RMSD at the interface from the pdb structure (3EZA). (Open circles) Single conformations (200) 
and (Filled circles) cluster averages when starting from the complex conformation. (Open triangle) 
Single conformations (200) and (Filled triangle) cluster averages when starting from the free form 
structures.
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As a second test, the structure of the EIIA–HPr complex (Wang et al., 2000) starting from 
the free form protein structures ( Jia et al., 1993; Worthylake et al., 1991) was calculated with 
HADDOCK. The backbone iRMSD between the free and bound form of EIIA and HPr 
are 0.35 and 0.05 Å, respectively. The intermolecular energy of the complex is –207 kcal 
mol-1 and its buried surface area is 1434 Å2. We defined the AIRs as previously described, 
selecting 11 active (D38, V40, I45, V46, K69, F71, S78, E80, D94, V96 and S141) and 4 
passive amino acids (V39, G68, E72 and E86) for EIIA and 9 active (H15, T16, R17, A20, 
F48, Q51, T52, G54 and T56) and 1 passive (N12) amino acid for HPr. The flexible interface 
consisted of amino acids 36 to 48, 66 to 82, 84 to 88, 92 to 98, and 139 to 143 for EIIA and 
10 to 22, and 46 to 58 for HPr. The resulting intermolecular energies as a function of the 
iRMSD from target for the 200 calculated structures after water refinement are shown in 
Figure 3. Clusters (27) were obtained with average intermolecular energies between –453 
and –69 kcal mol-1 and average iRMSDs from the published structure between 2.0 and 9.9 
Å. Again, the lowest energy cluster is the one that is the closest to the reference structure. 
Its best solution has an intermolecular energy of –493 kcal mol-1, an iRMSD from the 
published structure of 2.10 Å (the backbone RMSD on both proteins is 2.30 Å) and a buried 
surface area of 1404 Å2 (Figure 4).
We finally tested the feasibility of using data from mutagenesis studies to define ambiguous 
interaction restraints to drive the docking process. For this, docking was performed on the 
gp120–CD4 complex (Kwong et al., 2000). The intermolecular energy of the complex 
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Figure 2: Comparison of the EIN–HPr solutions generated by HADDOCK with the reference 
structure. A) Best solution of lowest energy cluster when starting from the structures of the complex. 
B) Reference structure (PDB:3EZA). C) Best solution of lowest energy cluster when starting from 
the free form structures. iRMSD corresponds to the backbone RMSD at the interface from the 
reference structure. These figures have been generated with the programs Molscript( Kraulis, 1991) 
and Raster3D (Merrit and Murphy, 1994). HPr is represented in light grey.
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Figure 3: Intermolecular energies versus iRMSDs for the EIIA-HPr complex. Energies and 
iRMSDs as defined in Figure 1. The pdb code of the reference structure is 1GGR. (Open circle) 
Single conformations (200) and (Filled circles) cluster averages when starting from the free form 
structures.
� ��������������������
����������������������
����
�� ��
Figure 4: Comparison of the EIIA–HPr best HADDOCK solution with the reference structure. 
A) Best solution of lowest energy cluster. B) Reference structure (PDB:1GGR). iRMSD as defined 
in Figure 2. HPr is represented in light grey.
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solved by crystallography is –283 kcal mol-1 and the buried surface area is 1990 Å2. To 
speed-up the calculation, the C-terminus domain of CD4 that does not interact with gp120 
was removed and only residues 90 to 492 of gp120 and residues 1 to 97 of CD4 were used. 
The separated forms of the complex were used as the starting point. Mutagenesis data have 
revealed that residues D368, E370, W427, and D457 of gp120 and residues K29, K35, F43, 
L44, K46, G47, and R59 of CD4 were important for the binding (Moebius et al., 1992; 
Olshevsky et al., 1990). These amino acids have been used as active residues in the AIRs. 
In addition, 19 amino acids for gp120 (I109, N280, A281, K362, S365, G367, I371, N425, 
K429, V430, T455, G459, I467, R469, G471, G472, G473, D474 and R476) and 10 amino 
acids for CD4 (H27, Q33, I34, Q40, S42, T45, P48, N52, D53 and D56) were selected as 
passive residues. The flexible interface consisted of amino acids 107 to 111, 278 to 283, 360 
to 373, 423 to 432, 453 to 461, and 465 to 478 for gp120 and 26 to 62 for CD4. The resulting 
intermolecular energies as a function of the iRMSD from target for the 200 calculated 
structures after water refinement are shown in Figure 5. Clusters (8) were obtained with 
average intermolecular energies between –407 and –139 kcal mol-1 and average backbone 
iRMSDs from the target between 0.9 and 11.5 Å. Again, a nice correlation between the 
intermolecular energy and the iRMSD from the target for the clusters is observed. The best 
solution from the lowest energy cluster has an intermolecular energy of –445 kcal mol-1, an 
iRMSD from the published structure of 0.80 Å (the backbone RMSD on both proteins is 
0.80 Å) and a buried surface area of 2148 Å2 (Figure 6).
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Figure 5: Intermolecular energies versus iRMSDs for the gp120-CD4 complex. Energies and 
iRMSDs as defined in Figure 1. The pdb code of the reference structure is 1GC1. (Open circles) 
Single conformations (200) and (Filled circles) cluster averages when starting from the complex 
conformation.
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These results nicely demonstrate that biochemical interaction data such as mutagenesis 
data can also be used to define highly ambiguous restraints to drive the docking with 
HADDOCK.
Discussion
We have developed an approach, HADDOCK, that allows rapid and accurate docking 
of protein complexes based on the use of biochemical or biophysical information. This 
information, which is introduced as ambiguous interaction restraints, is sufficient to drive 
the docking process. It is important to note that to reduce considerably the ambiguity, 
information about the interfaces of  both proteins is needed. On the basis of the intermolecular 
energy, the lowest energy clusters generated by HADDOCK were in all cases the closest to 
the published structure. The fact that the side chains at the interface are allowed to move 
increase the accuracy of our scoring compared with classical rigid body docking. Indeed, 
simulated annealing and water refinement do not improve much the iRMSD from the target, 
but by allowing the side chains to reorient and adopt better conformations, a better scoring 
of the solutions (a good correlation between the intermolecular energy and the iRMSD 
from the target) is obtained. The AIR restraints that we have used in the three examples 
contain, in principle, no information on the relative orientation of the two partners in the 
complex. Indeed, 180˚ rotated solutions are obtained that have quite low intermolecular 
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Figure 6: Comparison of the gp120–CD4 best HADDOCK solution with the reference structure. 
A) Best solution of lowest energy cluster. B) Reference structure (PDB:1GC1). iRMSD as defined in 
Figure 2. CD4 is represented in light grey.
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energies (see for example Figure 3). The discrimination between orientations must therefore 
come mainly from the van der Waals and electrostatic energy terms. This is made possible 
because of some degree of asymmetry at the interface both in shape complementarities and 
in the distribution of hydrophobic and hydrophilic residues. One should thus realize that 
a correct scoring of solutions will depend on the nature of the interface and that, without 
additional experimental information, the scoring might not be as effective in the case of 
complexes lacking some kind of asymmetry in their interface. 
The power of our approach has been demonstrated using chemical shift perturbation 
data and mutagenesis data, but any kind of data that provides information on the interaction 
interface could in principle be used to drive the docking and to improve the validity of the 
solutions. This could be additional NMR restraint such as intermolecular NOEs, RDCs, but 
also, other types of biochemical or biophysical interaction data could be considered. In this 
work, the ambiguous interaction restraints (AIRs) were defined with a conservative fixed 
distance of 3.0 Å. This value could be optimized by differentiating the strength of restraints, 
depending on a scaling of the distance as a function of the chemical shift perturbation in 
hertz and/or the type of amino acid. Though this may provide a more accurate and precise 
scoring, our results show that meaningful structures are already produced with simple and 
conservative restraints, demonstrating the robustness of our approach. It is also clear in the 
case of chemical shift perturbation data that better experimental data can be obtained. By 
using 15N-13C double-labeled proteins, side chain information can be collected that will 
allow a more precise definition of the side chains atoms that are implicated in the interaction. 
This information could be important to refine the ambiguous interaction restraints (AIRs) 
and thus the accuracy of HADDOCK. 
Material and Methods
Structural Coordinates
The coordinates of all proteins in free and bound form were obtained from the protein 
data bank (PDB) (Berman et al., 2000). The accession number for the EIN-HPr complex 
(Garrett et al., 1999), the free EIN (Liao et al., 1996) and the free HPr ( Jia et al., 1993) are 
respectively 3EZA, 1ZYM and 1POH. The accession number of the EIIA-HPr complex 
(Wang et al., 2000) and the free form of EIIA (Worthylake et al., 1991) are, respectively, 
1GGR and 1F3G. The accession number of the gp120-CD4 complex (Kwong et al., 2000) 
is 1GC1.
Docking Protocol
Our HADDOCK (High Ambiguity Driven DOCKing) approach consists of a collection 
of python scripts derived from ARIA (Linge et al., 2001) and makes use of CNS (Brunger 
et al., 1998) for structure calculation. The python scripts take care of setting up the 
system from the PDB files of the free proteins, of carrying and monitoring the structure 
calculations, and of sorting and analyzing the docking solutions. Inter- and intramolecular 
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energies are evaluated using full electrostatic and van der Waals energy terms with an 8.5 Å 
distance cut-off using the OPLS nonbonded parameters ( Jorgensen and Tirado-rives, 1998) 
from a modified version of the parallhdg5.2.pro parameter file (Linge and Nilges, 1999) 
(Marc Williams, University College London, personal communication). The docking 
protocol consists of three stages: i) randomization of orientations and rigid body energy 
minimization (EM), ii) semi rigid simulated annealing in torsion angle space (TAD-SA), 
iii) final refinement in Cartesian space with explicit solvent.
In the randomization stage, the two partner proteins are positioned at 150 Å from each 
other in space and each protein is randomly rotated around its center of mass. Rigid body 
EM is then performed: the first four cycles of orientational optimization are performed 
in which each protein in turn is allowed to rotate to minimize the intermolecular energy 
function. Then both translations and rotations are allowed, and the two proteins are docked 
by rigid body EM. Typically 1000 complex conformations are calculated at this stage. The 
best 200 solutions in terms of intermolecular energies are then refined. The second stage 
consists of three simulated annealing refinements. In the first simulated annealing (1000 
steps from 2000 to 50 K with 8 fs time steps), the two proteins are considered as rigid 
bodies and their respective orientation is optimized. In the second simulated annealing 
(4000 steps from 2000 to 50 K with 4 fs time steps), the side chains at the interface are 
allowed to move. In the third simulated annealing (1000 steps from 500 to 50 K with 2 fs 
time steps), both side chains and backbone at the interface are allowed to move to allow 
for some conformational rearrangements. The resulting structures are then subjected to 
200 steps of steepest descent EM. The final stage consists of a gentle refinement in an 8 
Å shell of TIP3P water molecules ( Jorgensen et al., 1992). A 2 fs time step is used for the 
integration of the equation of motions. The system is first heated to 300 K (500 steps at 
100, 200, and 300 K) with position restraints (kpos = 5 kcal mol
-1 A-2) on all atoms except 
for the flexible side chains at the interface. MD steps (5000) are then performed at 300 K 
with position restraints only on noninterface heavy atoms (kpos = 1 kcal mol
-1 A-2). During 
the final cooling stage (1000 MD steps at 300, 200, and 100 K), the position restraints are 
limited to backbone atoms outside the interface. The final structures are clustered using the 
pairwise backbone RMSD at the interface. A cluster is defined as an ensemble of at least 
two conformations displaying an iRMSD (backbone RMSD at the interface) smaller than 
1.0 Å. The resulting clusters are analyzed and ranked according to their average interaction 
energies (sum of Eelec, Evdw, EACS) and their average buried surface area.
The HADDOCK package will be made available upon request. In a similar manner 
as the ARIA program (Nilges et al., 1997), HADDOCK can be set up via a Web browser 
interface that makes it user-friendly. All the parameters that we used in our examples are set 
up as default parameters but can be modified by the user to possibly optimize the protocols 
for a particular problem.
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Abstract
The structure of the ubiquitin conjugating enzyme (E2) UbcH5B has been solved by a 
combination of homology modeling, diffusion anisotropy derived from NMR relaxation data 
and automated NOE assignment. Comparison with E2 structures present in the PDB and 
solved previously by X-ray crystallography or NMR shows in all cases the same compact 
fold. Differences are observed in the orientation of both the C-terminal α-helices and the 
N-terminal α-helix that is known to be involved in binding to the ubiquitin ligase (E3). In 
addition, the side chain of a conserved asparagine residue (Asn77), that is near the active site 
cysteine and that has been shown to be important for isopeptide bond formation, is solvent 
exposed. This positioning supports the proposed catalytic function of this amino acid (Wu et 
al., 2003). 
Introduction
UbcH5B is a ubiquitin conjugating enzyme involved in the ubiquitination pathway, the 
main pathway for protein degradation in eukaryotes (Glickman and Ciechanover, 2002; 
Pickart, 2001; Weissman, 2001). In this pathway a ubiquitin is covalently attached to a 
substrate protein. The ubiquitinated protein is subsequently recognized and degraded by 
the 26S proteasome. UbcH5B is known to be essential for degradation of many regulatory 
and abnormal proteins (Seufert and Jentsch, 1990). Together with UbcH5A and UbcH5C, 
UbcH5B forms one of the most active class of E2 enzymes. It is associated with the 
degradation of a number of important human transcription factors, such as p53 (Scheffner 
et al., 1994), NF-κB (Gonen et al., 1999), and c-fos (Stancovski et al., 1995). Recently it 
has been noted as well that ubiquitination of proteins also has other regulatory functions in 
for example signal transduction, transcription regulation, chromatin remodeling and DNA 
repair (Aguilar and Wendland, 2003). In all cases the attachment of ubiquitin moieties to 
the substrate is catalyzed by three enzymes: first, an E1, or ubiquitin activating enzyme, 
forms a thiol ester with the carboxyl terminal group of ubiquitin. Second, the ubiquitin 
is transferred to the ubiquitin conjugating enzyme (E2). Finally, an ubiquitin ligase (E3) 
transfers ubiquitin from E2 to the substrate protein. In human cells, one E1, about 30 
E2s and at least 400 putative E3s have been identified. The selectivity and specificity of 
ubiquitination depends on the E2-E3 and E3-target complexes. Comparison of the different 
E2 and E3 structures and their complexes should shed light on the specificity encountered in 
such complex formation. Therefore structures of various E2s and E3s are needed. To date, 
10 structures of E2 enzymes from different species have been solved in their free form, 9 
by X-ray crystallography (Cook et al., 1992; Cook et al., 1993; Cook et al., 1997; Giraud 
et al., 1998; Hamilton et al., 2001; Jiang and Basavappa, 1999; Lin et al., 2002; Tong et 
al., 1997; VanDemark et al., 2001; Worthylake et al., 1998) and one by NMR (Miura et 
al., 2002). Furthermore, five structures of three different E2’s in complex with various 
other proteins have been solved by X-ray crystallography (Bernier-Villamor et al., 2002; 
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Huang et al., 1999; Moraes et al., 2001; VanDemark et al., 2001; Zheng et al., 2000). 
All E2 structures possess the same compact fold corresponding to an N-terminal α-helix, 
followed by a four-stranded anti-parallel β-sheet and three C-terminal α-helices. Moreover 
the long stretch that contains the active site cysteine is very well-defined in all structures. 
The cysteine residue is solvent exposed, is located in a slight depression on the surface and 
is surrounded by loops. It has been previously postulated that the mechanism of transfer 
of ubiquitin from E1 to E2 and from E2 to the substrate resembles that of a thiol protease 
(Pickart, 2001). Based on the crystal structure of Ubc9 (Tong et al., 1997), some residues 
around the active site, among which one highly conserved asparagine residue (Asn77 in 
UbcH5B), have been proposed to catalyze the isopeptide bond formation. The importance 
of the asparagine residue was confirmed by mutagenesis experiments of three other E2s 
that revealed its necessity for efficient isopeptide bond formation in E2-catalyzed ubiquitin 
conjugation (Wu et al., 2003). In the different crystal structures of Ubcs, however, this 
asparagine is hydrogen-bonded to the loop connecting helix H2 and H3 and pointing away 
from the E2 cysteine and therefore can not participate in the enzymatic reaction. This 
implies that a repositioning of this asparagine residue must occur to catalyze the isopeptide 
bond formation (Tong et al., 1997; Wu et al., 2003).
Here we report the NMR structure of the ubiquitin conjugating enzyme UbcH5B using 
a combination of homology modeling, diffusion anisotropy restraints and automated NOE 
assignment. Dynamical properties of UbcH5B were assessed from 15N relaxation measurements, 
which show limited motion for the major part of the protein backbone. The relaxation data 
(R2/R1) have been translated into diffusion anisotropy restraints and used in the automated 
NOE assignment and structure calculations (Bruschweiler et al., 1995; Tjandra et al., 1995; 
Tjandra et al., 1997). The final structure, which is well defined, possesses the canonical E2 fold, 
but differences in the position of the N- and C-terminal helices as compared to the core of the 
protein are observed. Since the N-terminal helix is involved in binding to ubiquitin ligase, the 
position of this helix in the different structures may be important for differentiating between 
various E3 ligases.
Results and Discussion
Assignment of UbcH5B and secondary structure prediction
The assignment of UbcH5B was previously reported (Farrow et al., 2000). However, the 
data were collected at different temperature, pH, and salt concentration than used here. 
Therefore, for the backbone assignment of UbcH5B in our conditions (300K, pH 7.0, 150 
mM KCl), 2D (15N-1H)-HSQC, 2D (13C-1H)-HSQC, 3D HNCO, 3D HNCACB, and 
3D CBCA(CO)NH were recorded. The side chain assignment was performed using 3D 
TOCSY-(15N-1H)-HSQC, 3D H(C)CH-TOCSY and 3D (H)CCH-TOCSY spectra (for 
a review see Sattler et al., 1999). All residues except prolines were assigned. Finally, 85% 
of all observable protons could be assigned and a table with chemical shift is shown in 
Appendix 2 of this thesis. Dihedral angles of UbcH5B were predicted with the program 
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Talos (Cornilescu et al., 1999) based on the Cα and Cβ chemical shifts. These predictions 
correlate well with the consensus secondary structure elements found in known E2 structures 
(data not shown).
Diffusion anisotropy and refinement of the homology model
The amide 15N relaxation rates R1, R2 and 
1H-NOE for 112 out of the 131 non proline 
residues of UbcH5B are shown in Figure 1. Residues that have overlapping peaks in the 
HSQC spectrum were discarded in the analysis, such was Glu122, which has only a very low 
intensity peak. UbcH5B has a rather rigid backbone, with an average heteronuclear NOE 
value of 0.78 ± 0.09 for all residues and 0.80 ± 0.08 for residues located in secondary structure 
elements. The average R1 and R2 values are 1.67 ± 0.13 s
-1 and 10.5 ± 1.1 s-1, respectively, 
for the entire backbone and 1.68 ± 0.12 s-1 and 10.6 ± 0.9 s-1, respectively, for the secondary 
structure elements. The R2/R1 ratios, which are illustrative of the rotational diffusion 
characteristics of a protein, are presented in Figure 1D. The filled bars represent the 87 
R2/R1 ratios that were selected for the determination of the rotational diffusion parameters 
of the protein. From the average R2/R1 ratio (6.3 ± 0.9) the isotropic diffusion tensor 
constant was estimated to be 1.9⋅107 ± 0.3⋅107 s-1, which gives an apparent correlation time 
of 8.6 ± 1.2 ns. The histogram of R2/R1 ratios in Figure 2A, however, immediately reveals 
that UbcH5B does not tumble isotropically in solution. High R2/R1 ratios are found for the 
residues located in helix H2, caused by both their high R2 rates (> 11.6 s
-1) and low R1 rates 
(< 1.54 s-1). The possibility that the high R2 rates in this helix are caused by conformational 
exchange could be excluded, since no differences were observed between the 15N R2 rates 
determined from both CPMG and T1ρ experiments (data not shown). In addition relaxation 
dispersion profiles measured at both 500 and 700 MHz (Loria et al., 1999), that are very 
sensitive to conformational exchange, do not give any indication for such effects in helix 
H2 (data not shown). In a previous study of the interaction of UbcH5B with the RING 
domain of CNOT4 we generated a homology model of UbcH5B based on the structure of 
the highly homologous protein Ubc4 (Dominguez et al., 2004). In this model, helix H2 is 
approximately parallel to the long axis of the protein, which would explain the high R2/
R1 ratios in this part of the protein. However, as shown in Figure 2B, the back-calculated 
R2/R1 values still deviate from the experimental values with a reduced χ2 of 4.59 (for details, 
see Material and Methods). The deviation can be mainly attributed to the orientation of 
helix H2. The homology model was therefore refined in explicit water, using both TALOS-
derived dihedral angles and diffusion anisotropy restraints. Three independent structure 
refinements were performed including the R2/R1 orientational restraints, starting from 
three different estimates of the anisotropy A and rhombicity η of the diffusion tensor: i) 1.61 
and 0.33, ii) 1.68 and 0.27 and iii) 1.64 and 0.31 which were obtained as described in the 
Material and Methods section. The average reduced χ2 value decreased from 4.59 to 2.20 ± 
0.13, 2.21 ± 0.19 and 2.44 ± 0.70 for the three refined sets each consisting of twenty models. 
Using these sixty refined models a grid search was performed to optimize the diffusion 
tensor components, resulting in an anisotropy A of 1.68 and a rhombicity η of 0.30 with 
a reduced χ2 of 2.34 ± 0.38. These were used as starting values for the diffusion tensor in 
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all subsequent structure calculations. The average pairwise backbone RMSD between the 
sixty refined models is 0.7 ± 0.1 Å and the backbone RMSD from the original homology 
model is 0.84 ± 0.02 Å. 
Model-based automated NOE assignment and structure calculations of UbcH5B
In order to facilitate and speed up structure determination by NMR, approaches have been 
developed that combine structure calculations and automated assignment of NOE spectra 
in an iterative manner (Guntert, 2003; Herrmann et al., 2002; Linge et al., 2001). For large 
proteins however, the ambiguity in the assignment increases rapidly due to peak overlap in 
the spectra and makes automated assignment in that case difficult, causing poor convergence 
of the calculated structures to an unique fold. It has been suggested that the use of starting 
models can assist and speed up automated NOE assignment procedures (Duggan et al., 
2001; Guntert et al., 1993; Hare and Wagner, 1999). 
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Figure 1: 15N relaxation parameters of UbcH5B at 300K and 500MHz. A) Heteronuclear NOE 
values, B) R1 relaxation rates, C) R2 relaxation rates from CPMG experiments and D) R2/R1 ratios. 
The filled bars in D) represent the 87 selected ratios. The secondary structure elements with the two 
loops L1 and L2 involved in the interaction with the CNOT4 E3 ligase (Dominguez et al., 2004) are 
indicated on top.
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The automated NOE assignment and structure calculations of UbcH5B were performed 
with a version of ARIA1.2 (Linge et al., 2001) that we modified to include diffusion 
anisotropy restraints (see Material and Methods). This modified version of ARIA has been 
made available via the ARIA homepage (http://www.pasteur.fr/recherche/unites/Binfs/
aria). A total of 5931 NOEs were obtained from a 2D NOE and a 3D (15N-1H)-NOESY-
HSQC spectra recorded on a 900 MHz spectrometer. From the 3D (15N-1H)-NOESY-
HSQC and the 2D NOE spectra 1002 and 4929 (on both sides of the diagonal) NOE peaks 
were extracted, respectively. 404 intra and 284 sequential NOEs were manually assigned 
between the amide and the side chains protons for the 2D NOE spectrum and 350 intra and 
248 sequential for the 3D spectrum. The chemical shift of the corresponding nuclei were 
adjusted based on these assignments, which allowed the use of tighter chemical shift value 
tolerances in the automated NOE assignment protocol: 0.02 ppm for the 1H chemical shift 
values and 0.2 ppm in the 15N dimension. In addition, 76 dihedral angle restraints derived 
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Figure 2: Diffusion anisotropy of UbcH5B. 
A) Histogram of R2/R1 ratios for UbcH5B. The 
shape of the histogram indicates that the diffusion 
tensor of UbcH5B has a rot shape with a small 
rhombic component. Observed versus back-
calculated R2/R1 ratios B) for the homology 
model of UbcH5B and C) for the ensemble of 
20 lowest energy structures of UbcH5B. The 
error-bars correspond to the experimental errors 
(horizontal) and to the standard deviations of 
the back-calculated values over the ensemble 
(vertical). The thick lines represent the linear 
best fit through the data points, with a slope of 
0.78 and 0.90 and a correlation coefficient of 
0.88 and 0.95, respectively.
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from TALOS (Cornilescu et al., 1999) and 87 diffusion anisotropy restraints were used in 
the structure calculation.
Three successive ARIA runs (run1-3) were performed, each consisting of nine iterations 
and a final refinement in explicit water for the last run. In run1, the 60 refined models were 
used to perform the automated assignment of the NOEs. No structures were calculated at 
this level yet. The distance violation tolerance was decreased in the successive iterations 
from 5 to 0.3 Å with a constant value of 0.90 for the ambiguity cut-off. The number of 
assigned unambiguous NOEs was the highest for a tolerance of 0.6 Å (1680 unambiguous 
and 1630 ambiguous NOEs after merging of the two spectra). Based on these assignments 
two subsequent runs of structure calculations were performed including TALOS derived 
dihedral angles and R2/R1 derived diffusion anisotropy restraints. Run2 started from an 
extended structure, using the set of 1680 unambiguous and 1630 ambiguous NOE restraints 
from run1. Run2 consisted of 9 ARIA iterations, in which the structures gradually 
converged and in which these NOE restraints could be reassigned, recalibrated and rejected 
if violated in more than 50% of the 20 best structures of the previous iteration. For the last 
iteration the anisotropy A and rhombicity η of the diffusion tensor were again optimized 
using a grid search  resulting in values of A = 1.72 and η = 0.27. This run resulted in 1902 
unambiguous and 1145 ambiguous NOE restraints and in an already well-defined ensemble 
of structures (average backbone RMSD from the mean structure of 0.86 ± 0.22 Å for the 
secondary structure elements). In the final run, run3, the 1902 unambiguous and 1145 
ambiguous NOE restraints of run2 were fixed. In addition the NOE peaks that were not 
previously converted into either unambiguous or ambiguous restraints were added into the 
calculation. This consisted of a total number of 2318 NOE peaks. The initial automated 
NOE assignment was based on the 20 final structures of run2. The optimized values of 
A and η from run2 were used for the diffusion anisotropy restraints. After each iteration 
the diffusion tensor was optimized, resulting in a final value of 1.76 and 0.22 for A and η, 
respectively. This finally resulted in a total of 2049 unique unambiguous and 1567 unique 
ambiguous NOE restraints (Table 1) derived from 4092 and 859 assigned cross-peaks in the 
NOESY and 3D-NOESY-HSQC spectra, respectively. Figure 3A shows the distribution of 
the unambiguous NOEs over the polypeptide sequence. In general a large number of NOE 
is found in the secondary structure elements.
After water refinement, the average backbone RMSD from the mean for the secondary 
structure elements of the 20 lowest energy structures is 0.56 ± 0.1 Å (all heavy atoms: 1.04 
± 0.12 Å) (Table 1). Figure 3B clearly shows that the RMSD values in the loops between 
the secondary structure elements are significantly higher. This clearly correlates with the 
lower number of NOEs found in those regions. The structural statistics are presented in 
Table 1. The average backbone RMSD between the ensemble of structures and the original 
homology model is 2.32 ± 0.09 Å whereas for the secondary structures, the backbone 
RMSD is 2.06 ± 0.09 Å.  The average reduced χ2 for the diffusion anisotropy restraints 
is 2.93 ± 0.40 for the ensemble and 2.44 for the representative structure. Experimental 
against back-calculated R2/R1 ratios are plotted in Figure 2C. The correlation coefficient 
of 0.95 indicates a good agreement between the calculated and experimental values. The 
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large number of NOEs result in a reduced χ2 which is slightly higher than for the refined 
homology models (see above). The latter would however violate more than 800 NOE 
restraints.
Table 1: Structural statistics of the 20 best UbcH5B structures.
Number of experimental restraints:
Intra-residue unambiguous NOEs 847
 Sequential unambiguous NOEs 442
 Medium-range unambiguous NOEs 301
 long-range unambiguous NOEs 459
 Total unambiguous NOEs 2049
 Total ambiguous NOEs 1567
 Dihedral anglesa 152 (76 φ +76 ψ)
 Diffusion anisotropyb 87
R.m.s.d. (Å) from the mean 
 All backbone atoms 0.68 ± 0.12
 All heavy atoms 1.13 ± 0.13
 Secondary structure backbone atomsc 0.56 ± 0.10
 Secondary structure heavy atomsc 1.04 ± 0.12
Non-bonded energy values d after water-refinement  (kcal mol-1) 
 E vdW -1305 ± 133
 E electrostatic -5043 ± 90
R.m.s.d from idealized covalent geometry 
 Bonds (Å)   0.0063 ± 0.0001
 Angles (°)   0.80 ± 0.01
 Impropers (°)  2.23 ± 0.07
R.m.s.d from experimental data
 Distance (Å) 0.13 ± 0.01
 Dihedral (°) 3.98 ± 0.85
 Diffusion anisotropy 0.37 ± 0.02
Restraint violations in more than 50% of the structurese
 Distance (> 0.3 Å) 2 
 Dihedral (> 5°) 4 
 Diffusion anisotropy (> 0.7) 2 
Ramachandran analysis  
 Residues in most favored region (%) 72.8 ± 2.4
 Residues in additional allowed regions (%) 21.1 ± 2.2
 Residues in generously allowed regions (%) 4.6 ± 2.1
 Residues in disallowed regions (%) 1.4 ± 0.1
a) The dihedral angles are derived from Talos (Cornilescu et al., 1999) prediction based on Cα and Cβ chemical 
shifts.
b) The diffusion anisotropy restraints are derived from the R2/R1 ratios.
c) Secondary structure elements comprise residues 2-15, 21-24, 32-38, 49-55, 66-70, 99-111, 122-128, and 
131-144.
d) The non-bonded energies were calculated with the OPLS parameters using a 8.5 Å cutoff.
e) No NOE distance restraint was violated by more than 0.65 Å, no dihedral angles by more than 6.8° and no 
diffusion anisotropy by more than 0.98.
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Solution structure of UbcH5B
The structure of UbcH5B is composed of a four-stranded anti-parallel β-sheet and four 
α-helices. The N-terminal α-helix (residues 2-15) is followed by the four-stranded β-sheet 
(residues 21-24, 32-38, 49-55, 66-70). A long extended stretch (residues 71-86), a short 310 
helix (residues 87-89) and a loop (residues 90-98) connect the last β-strand to the second α-
helix (residues 99-111). The second α-helix (H2) is parallel to the long axis of the proteins 
in agreement with the diffusion anisotropy data. The C-terminal part of the protein is 
composed of two α-helices (residues 122-128 and 131-144) (Figure 4). The core of the 
protein, which consists of the β-sheet, the long extended stretch that contains the active site 
cysteine and the α-helix H2 is very well defined with an average backbone RMSD from the 
mean of 0.32 ± 0.09 Å (all heavy atoms, 0.87 ± 0.08 Å). The N-terminal α-helix is almost 
as well defined as the core of the protein. The two C-terminal α-helices are slightly more 
disordered probably due to a low number of NOEs in this region.
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Figure 3: Structural and dynamical data of the UbcH5B NMR structure. A) Distribution of the 
number of unambigous NOE restraints over the protein sequence. The number indicated are the 
final numbers used in the structure calculation. B) Average backbone RMSD for each residue from 
the mean. The values shown are the average RMSD calculated from the ensemble of 20 structures. 
C) Generalized order parameter S2 obtained from the model-free analysis of the 15N relaxation data. 
Secondary structure elements and loops L1 and L2 are indicated at the top of the figure.
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Backbone dynamics of UbcH5B 
The average anisotropic rotational diffusion tensor for the ensemble of 20 UbcH5B 
structures was analyzed with the program TENSOR2 (Dosset et al., 2000). This resulted 
in an overall rotational correlation time τc of 8.58 ± 0.02 ns, an anisotropy A of 1.75 ± 
0.02 and a rhombicity η of 0.17 ± 0.04. The overall rotational correlation time corresponds 
nicely with the correlation time expected for a monomeric protein of this size at 300K and 
with the value of 8.5 ns calculated by the program HYDRONMR (Bernado et al., 2002; de 
la Torre et al., 2000). Using the determined anisotropic diffusion tensor the 15N relaxation 
rates (Figure 1) were analyzed in TENSOR2 using the model-free (Lipari and Szabo, 1982) 
approach based on the representative structure. The resulting order parameters S2 are shown 
in Figure 3C and shaded on the structure in Figure 5. The average order parameter is 0.83 
± 0.07. The most flexible parts in UbcH5B are the loop connecting the N-terminal helix 
H1 with the β-sheet and the loop connecting the strands β2 and β3. Some residues with 
lower order parameters are also present in the long extended stretch that contains the active 
site cysteine. In the loop L2, which is known to be involved in binding to E3 ligases (Zheng 
et al., 2000), residue Thr98 has a lower order parameter. Furthermore, flexible residues are 
found in the loop between helix H2 and H3. This loop forms a ‘lid’ on top of the active 
site Cys85 with in particular the side chain of Leu119 in close proximity to the cysteine 
side chain. The flexibility in this loop could therefore affect both ubiquitin binding and 
ubiquitination of the substrate. In the C-terminal part of the protein both Asp130, located 
between the helices H3 and H4, and the C-terminal residue Met147 have a lower order 
parameter. 
Figure 4: NMR structure of UbcH5B. Stereoview of the 20 best structures. This figure was 
generated using the program MOLMOL (Koradi et al., 1996).
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Comparison of UbcH5B with other Ubc enzymes
For comparing the structure and dynamics of UbcH5B with other Ubc enzymes, we focus 
on Ubc4 (Cook et al., 1993), which is highly homologous to UbcH5B and on Ubc9 (Giraud 
et al., 1998; Tong et al., 1997) of which the backbone dynamic has been studied by NMR 
before (Liu et al., 1999). The core domain of UbcH5B is very similar to the X-ray structure 
of Ubc4 (backbone RMSD of 0.99 Å) (Figure 6). This close structural resemblance of the 
core domain is a common feature of all Ubc structures, which all have a RMSD within 1.3 
Å for this part. It is interesting to note that the 310 helix (residues 87-89) is conserved among 
all E2s and that the long extended stretch that contains the active site cysteine (residues 82 
to 89 in UbcH5B) has a very similar conformation in all Ubc structures, in particular at the 
active site cysteine. Clear differences in dynamics between UbcH5B and Ubc9 within this 
extended stretch can be observed, however, on the basis of the 15N relaxation experiments. 
In Ubc9 Leu81, Val86, Ser89 and Leu97 have low order parameters and for both Val86 and 
Leu97 a substantial contribution of conformational exchange Rex to the 
15N R2 relaxation 
rate was detected. The corresponding residues in UbcH5B (Ile73, Ile78, Asn81 and Leu89) 
do not have low order parameters. The residues that do have lower order parameters in 
UbcH5B in this region are Tyr74 and Leu86. Although UbcH5B and Ubc9 are homologous 
proteins, their biological function is quite dinstinct. Whereas UbcH5B is primarily involved 
in ubiquitination of proteins, Ubc9 plays an important role in sumoylation (Muller et al., 
2001). Since the differences in flexibility are mainly on the face of the protein where the 
active site Cys85 is located, this could reflect this different biological function. 
Mutagenesis data previously showed that a highly conserved asparagine is important for 
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Figure 5: Dynamics in UbcH5B. The ribbon 
representation of UbcH5B is shaded according 
to the S2 values derived from the 15N relaxation 
analysis. The grey-scaling is from grey for high 
S2 values to black for low S2 values. Residues 
with low order parameters are labeled. Residues 
for which no S2 was determined are white. The 
active site cysteine 85 is displayed in a space-
filling representation. The α-helices (H1 to 
H4), β-strands (β1 to β4) and the two loops 
(L1 and L2) involved in E2 binding are labeled. 
This figure was generated with the programs 
Molscript (Kraulis, 1991) and Raster3D (Merritt 
and Murphy, 1994).
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the efficient catalytic activity of E2s in transferring ubiquitin to the substrate (Wu et al., 
2003). In all existing X-ray structures the side chain of this asparagine is hydrogen-bonded 
to the backbone of the loop connecting the helices H2 and H3, and is thus pointing away 
from the active site cysteine (Tong et al., 1997; Wu et al., 2003). A structural rearrangement 
should therefore occur upon ubiquitination of the substrate. In the solution structure of 
UbcH5B, however, the corresponding Asn77 side chain, which is not hydrogen-bonded 
to the backbone of the loop connecting the helices H2 and H3, is already solvent exposed 
and in close proximity (within 4 Å) to the active site cysteine. Its orientation in solution is 
thus suitable for isopeptide bond formation (Figure 7). A suitable similar orientation of a 
corresponding asparagine (Asn80) was observed in the only other E2 (UbcH2B) for which 
the structure has been solved in solution as well (Miura et al., 2002). The absence of an 
hydrogen bond between the Asn77 side chain and the backbone of the loop between H2 
and H3 is supported by the presence of flexibility in the latter loop. Indeed Asp117, Leu119 
and Val120 have lower order parameters than average (the two other residues in this loop 
are prolines). In addition, Glu122 at the start of helix H3, for which no reliable relaxation 
parameters could be obtained, shows a low intensity peak in the HSQC spectrum, which 
could be an indication for the presence of conformational exchange. The same loop was also 
shown to be flexible in the NMR relaxation studies of Ubc9 (Liu et al., 1999). 
Other differences between the various Ubc structures are observed in the position of 
the first α-helix and the last two α-helices. Here we find a relatively high backbone RMSD 
of 2.29 Å between UbcH5B and Ubc4. This seems to be a general feature of the Ubc 
family since most differences are observed for these three helices. The first N-terminal 
helix is interesting since it is part of the interacting site with ubiquitin ligases (both HECT 
Figure 6: Overlay of the UbcH5B and Ubc4 
structures (PDB: 1QCQ). The figure shows the 
differential position of helix 1 in the two structures. 
UbcH5B is displayed black and Ubc4 white. This 
figure was generated with the programs Molscript 
(Kraulis, 1991) and Raster3D (Merritt and Murphy, 
1994). 
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and RING finger domains) (Dominguez et al., 2004; Huang et al., 1999; Zheng et al., 
2000). In the UbcH5B structure many NOEs are present between the residues of this helix 
and residues of loop L1 (residues 56-65) and L2 (residues 89-98), which are also part of 
the interacting site. This helix makes thus multiple contacts with these two loops. In the 
structure of UbcH5B, the first helix is in closer proximity to loops L1 and L2 than in the 
Ubc4 structure. The differential position of this helix with respect to the loops L1 and L2 
may contribute to the recognition of various E3 ligases. The loop connecting the first helix 
(H1) and the β-sheet is flexible in both UbcH5B and Ubc9. This may allow for structural 
rearrangements of helix H1 relative to the rather rigid L1 and L2 loops to accommodate 
binding to different E3s. Using NMR chemical shift perturbation experiments, we already 
reported that residues in helix H1 (Ala2, Leu3, Arg5, Ile6, Glu9, Leu10 and Asp12) and 
loop L2 (Thr98, Ile99) are affected by the binding to CNOT4 (Dominguez et al., 2004). 
These residues are, however, not solvent exposed but responsible for the H1-L2 interaction. 
The chemical shift changes of these residues could therefore be due to the displacement of 
the first helix. It is therefore likely that, during binding, E2 enzymes undergo structural 
rearrangements involving the first helix to accommodate the different E3 ligases.
Conclusions
We have described here the solution structure and dynamics of the human UbcH5B, an 
E2 enzyme involved in the ubiquitination pathway. Comparison of this structure with 
�����
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Figure 7: Comparison of the position of the asparagine residue important for oxyanion stabilization in 
E2-catalyzed ubiquitin conjugation. Right: NMR ensemble of UbcH5B (5 structures). Left: Overlay 
of 8 E2 X-ray structures (PDB-codes: 1QCQ, 1A3S, 1AYZ, 1FZY, 1U9A, 2AAK, 2UCZ, 2EZC). 
This figure was generated with the programs Molscript (Kraulis, 1991) and Raster3D (Merritt and 
Murphy, 1994).
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other E2 structures shows striking differences, mainly at the N- and C-terminal parts of 
the proteins. These observed differences may be important for the recognition of different 
partners. Moreover, flexibility was observed in specific loops of the protein, especially close 
to the active site cysteine and in the N-terminal domain. This flexibility of E2s may be 
important to allow for small structural rearrangements when binding to different partners. 
In the surrounding of the active site cysteine, a conserved asparagine residue has been 
shown to be important in the catalysis of the isopeptide bond formation during the transfer 
of ubiquitin to the substrate. In our solution structure, this residue is solvent exposed and in 
close proximity to the active site cysteine, in a position thus suitable for catalysis. 
Material and Methods
Recombinant protein expression and purification
The construction of the plasmid for the expression of the human UbcH5B and the 
overexpression of 15N and 13C/15N isotopically labeled UbcH5B have been described 
previously (Albert et al., 2002; Dominguez et al., 2004). The UbcH5B samples were finally 
concentrated to a final concentration of approximately 0.5 mM in an NMR buffer (150 mM 
KCl, 20 mM KPi pH 7.0, 10 μM ZnCl2).
Homology modeling
The homology model of UbcH5B is based on the structure of yeast Ubc4 (pdb: 1QCQ) 
(Cook et al., 1993) and is generated using Modeller4 (Sali and Blundell, 1993). For details see 
our previous study on the interaction between UbcH5B and the RING domain of CNOT4 
(Dominguez et al., 2004). This model was used here as a starting point for automated NOE 
assignment and structure calculations of UbcH5B in ARIA1.2 (Nilges et al., 1997).
NMR measurements
For the backbone assignment of UbcH5B, 2D (15N-1H)-HSQC, 2D (13C-1H)-HSQC, 3D 
HNCO, 3D HNCACB, and 3D CBCA(CO)NH were recorded on a Bruker AVANCE 
700 MHz spectrometer. The side chain assignment was performed using 3D TOCSY-(15N-
1H)-HSQC, 3D H(C)CH-TOCSY and 3D (H)CCH-TOCSY spectra also recorded on a 
Bruker AVANCE 700 MHz spectrometer (for a review see Sattler et al., 1999). 
The NOESY spectra were recorded on a Bruker AVANCE 900 MHz spectrometer. The 
NOE information was extracted from a 3D NOESY-(15N-1H)-HSQC and a NOESY with 
mixing times of 100 ms. The NOESY was recorded with 768 complex points in the direct 
dimension (spectral width of 15151 Hz) and 384 complex points in the indirect dimension 
(spectral width of 12820 Hz). The 3D NOESY-(15N-1H)-HSQC was recorded with 768 
complex points in the direct dimension (spectral width of 15151 Hz), 160 complex points 
in the 1H indirect dimension (spectral width of 15151 Hz), and 40 complex points in the 
15N dimension (spectral width of 3333 Hz). For Fourier transformation all dimensions were 
zero-filled twice.
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All relaxation experiments were performed at 300K on a Bruker AVANCE 500 MHz 
spectrometer (1H frequency of 500.28 MHz) equipped with a QXI probe with z-gradients 
using a 15N-labeled UbcH5B sample with a concentration of approximately 0.5 mM. 15N T1 
and heteronuclear {1H}-NOE values were determined using the experiments described by 
Farrow et al., (1994). T1 times were extracted from eight spectra with different values for the 
relaxation delay: 100 (2x), 200, 300, 400 (2x), 500, 600, 800 and 1000 ms, giving 180° pulses 
on proton every 5 ms to suppress cross-correlated relaxation. The heteronuclear NOE was 
recorded in an interleaved fashion, recording alternatively one increment for the reference 
and one for the NOE spectrum. In the NOE experiment the protons were saturated using 
120° pulses (20.7 kHz). 15N T2 relaxation times were extracted from both CPMG (Carr and 
Purcell, 1954; Meiboom and Gill, 1958) and T1ρ(Peng et al., 1991) experiments. CPMG 
experiments were recorded using nine different values for the relaxation delay: 0 (2x), 16.1 
(2x), 32.2, 48.2, 64.3 (2x), 80.4, 96.5, 128.6 and 160.8 ms. During the relaxation delay 15N 
180° pulses with a field strength of 7.8 kHz were applied every 0.95 ms (νCPMG = 1 kHz) and 
1H 180° pulses were applied every 7.7 ms, to suppress cross-correlated relaxation pathways 
(Kay et al., 1992). The T1ρ experiments were recorded with varying lengths of the spin-lock 
pulse: 2, 4, 6, 8, 10 (2x), 20, 30, 50 (2x), 70, 100, 150 ms. An adiabatic spin-lock pulse, as 
described by Mulder et al., (1998), was used to align the magnetization of the individual 
amides along their effective field. The pulse was applied on-resonance with a field-strength 
of 2.5 kHz. The number of 1H 180° pulses during the relaxation period was adapted to the 
used relaxation delay (Korzhnev et al., 2002). No 1H 180° pulses were applied up to 30 ms, 
one 1H 180° pulse was applied in the middle of the 50 and 70 ms delays, two pulses in the 
case of 100 ms and three for the 150 ms delay.
All spectra were processed with NMRPipe (Delaglio et al., 1995) and analyzed using 
NMRView5.0.4 ( Johnson and Blevins, 1994). Relaxation parameters were extracted and 
analyzed with the program Curvefit (Palmer et al., 1991): (http://cpmcnet.columbia.edu/
dept/gsas/biochem/labs/palmer/software/curvefit.html), using a 2-parameter fitting and a 
Monte Carlo simulation to estimate the errors.
Diffusion anisotropy
In the absence of large amplitude internal motions and conformational exchange, the ratio 
of the 15N transverse and longitudinal relaxation rate (R2/R1) is dependent on the angles θ 
and φ between the amide bond vector and the diffusion tensor of the protein. Given a good 
estimate of the diffusion tensor components (Dxx, Dyy and Dzz), the R2/R1 ratios can thus 
be used to refine the orientation of the amide bond vectors (Tjandra et al., 1997).  These 
ratios are included in CNS (Brunger et al., 1998) as diffusion anisotropy restraints (DANI) 
as described by Tjandra et al., (1997). The diffusion tensor components are defined by the 
overall rotational correlation time (τc), the anisotropy (A) and the rhombicity (η):
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In CNS (Brunger et al., 1998) the geometric content of the R2/R1 ratios is incorporated 
in the simulated annealing protocol for the structure calculation by minimizing the 
harmonic potential energy term Edani
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where kdani is the force constant for the diffusion anisotropy restraints and (R2/R1)calc and 
(R2/R1)obs are the back-calculated and observed R2/R1 ratios, respectively. 
The selection of R2/R1 ratios to determine the diffusion tensor components and to 
define diffusion anisotropy restraints is as follows. All residues are selected that have both 
an heteronuclear NOE value higher than 0.65 and a R2 rate smaller than the average rate 
plus one standard deviation. In addition, residues with a high R2 rate and a corresponding 
R1 rate lower than the average rate minus one standard deviation are also selected. This 
selection procedure keeps the residues with high R2 values caused by the anisotropy of 
the system (Pawley et al., 2001). In this way, 87 R2/R1 ratios were selected. The diffusion 
tensor components were determined in three different ways: 
i) From the average of the highest, the lowest and the most occurring R2/R1 ratios in the 
distribution (Figure 2A) the tensor components can be estimated as has been described 
by Clore et al., (1998). This gave a value of 1.61 for the anisotropy A and 0.33 for 
the rhombicity η. 
ii) Since an average of the extreme values is used in the first approach, the anisotropy is 
rather under- than overestimated. Therefore a more extreme estimate, using the averages of 
the two minimum and maximum values minus and plus the standard deviation, respectively, 
gives a value of 1.68 for A with a corresponding η of 0.27. 
iii) When a proper structural model is available, TENSOR2 (Dosset et al., 2000) can be 
used to determine the rotational diffusion tensor, based on the selected set of relaxation 
rates. Using the homology model of UbcH5B the computed values are 1.64 for A and 0.31 
for η, respectively. These three sets of values for the diffusion tensor were used to refine the 
homology model of UbcH5B (see below).
The rotational diffusion parameters of a molecule can also be estimated by hydrodynamic 
modeling. This has been implemented in the program HYDRONMR (de la Torre et al., 
2000), which uses a bead shell method to perform the hydrodynamic calculations. An 
important parameter in these calculations is the radius a of the spherical elements that are 
used to replace each nonhydrogen atom to build the initial shell model. For most proteins 
this atomic element radius a has a value between 2.8 Å and 3.8 Å, with a distribution 
centered at 3.3 Å (Bernado et al., 2002). To calculate the hydrodynamic properties of 
� � ��� � ���� �����
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UbcH5B we used a value of 3.2 Å for a and a solvent viscosity of 0.8 cP at a temperature 
of 300 K.
The agreement between back-calculated and experimental R2/R1 ratios can be expressed 
by the reduced χ2:
� � � �
�
��� ������� � ��� ��������� ��
��� ���
�
�
�
�
��
�
�
�
��
�
        
        (5)
where σ is the error in the ratios and N the number of observables.
Structure calculation
The automated assignment and structure calculations of UbcH5B were performed with 
ARIA1.2 (Linge et al., 2001) using CNS (Brunger et al., 1998).  The topallhdg5.3.pro 
(Linge et al., 2003) topology and parameter set was used based on the PROLSQ parameters 
(Engh and Huber, 1991). The ARIA1.2 scripts were modified to allow the use of diffusion 
anisotropy restraints as defined in CNS (Tjandra et al., 1997). A grid search procedure 
to optimize the initial values for the anisotropic (A) and rhombic (η) components of the 
diffusion tensor, based on the calculated structures, was introduced. Herein the sum of the 
restraint energy term Edani over the ensemble of structures is minimized by a grid search of 
± 0.1 and ± 0.05 around the starting values of the diffusion tensor components A and η, in 
steps of 0.02 and 0.01, respectively.
First, the homology model of UbcH5B was refined using both TALOS dihedral and 
diffusion anisotropy restraints in explicit water. This refinement was performed starting 
from three different sets of estimated values of the rotational diffusion tensor, resulting in 
three ensembles of each 20 structures. The force constants for the diffusion anisotropy and 
TALOS dihedral angle restraints were set to 10 kcal mol-1 and 200 kcal mol-1 rad-2, respectively. 
Based on the resulting 60 models the diffusion tensor components were optimized using the 
grid search described above and the resulting values were used in the subsequent structure 
calculation runs. The automated NOE assignment was performed in three steps as described 
below.
i) First the 60 models were used to create an initial set of NOE assignments, without 
calculating any structure. Because of the sensitivity of the 900 MHz spectrometer and the 
size of the protein, the upper bound limit for the NOE calibration was set to 7 Å and spin 
diffusion correction (Linge et al., 2004) was used in all runs.
ii) In the second run, consisting of 9 ARIA iterations, the assigned peaks from the first run 
were used to calculate an initial ensemble of structures, including both diffusion anisotropy 
and TALOS dihedral restraints. After each iteration the NOEs were reassigned and 
recalibrated based on the 20 lowest energy structures and rejected if violated in more than 
50% of the structures. The ambiguity cut-off was reduced from 1.01 in the first iteration to a 
final value of 0.90 in the last iteration. The violation tolerance was set to 1000 Å for the first 
two iterations and then progressively reduced to 0.1 Å in the last iteration. In the last two 
iterations, the tensor components were optimized using a grid search as described above. For 
the structure calculations a simulated annealing (SA) protocol consisting of four stages was 
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used starting from an extended conformation using both torsion angle dynamics (TAD) and 
Cartesian dynamics. i) The high temperature TAD stage consisted of 10000 steps at 10000 
K. This was followed by ii) a 8000 steps TAD cooling stage with a final temperature of 2000 
K, iii) a 5000 steps first Cartesian cooling stage to 1000 K, and iv) a 10000 steps second 
Cartesian cooling stage to 50 K. During the SA protocol the force constants for the TAD 
stages, first Cartesian cooling stage and second Cartesian cooling stage were set to 10, 10 and 
50 kcal mol-1 Å-2 for the NOE restraints, to 50, 100 and 200 kcal mol-1 rad-2 for the dihedral 
restraints and to 1, 1 and 10 kcal mol-1 for the diffusion anisotropy restraints, respectively. 
The number of calculated structures in the iterations was 100 (50) for iterations 1 and 2, 20 
(20) for iterations 3 to 7, 50 (20) for iteration 8 and 100 (50) for the final iteration, with the 
structures that were kept in the subsequent iteration indicated between brackets.
iii) In the third and last run the final ensemble of structures was calculated, starting in 
the first iteration from the ensemble of 20 lowest energy structures of run2. The 
NOE assignments of run2 were used and kept fixed. In addition the peak lists containing 
the remaining unassigned NOEs were introduced, to allow the assignment of more NOEs. 
The ambiguity cut-off was 0.90 in all iterations and the violation tolerance was reduced 
from 1.0 to 0.1 Å during the nine iterations, with only an increased value of 1.0 for iteration 
6. The SA protocol described above was used for the structure calculations. The number 
of calculated structures was 50 (25) for iteration 2 to 8 and 100 (50) for the last iteration, 
with the structures that were kept in the subsequent iteration between brackets. After each 
iteration an optimization of the diffusion tensor components was performed, based on the 
ensemble of 20 lowest energy structures. The 50 final lowest energy structures were refined 
in explicit water using the OPLS parameters ( Jorgensen and Tirado-rives, 1988).
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Abstract
The protein CNOT4 possesses an N-terminal RING finger domain that acts as an E3 ubiquitin 
ligase and specifically interacts with UbcH5B, a ubiquitin conjugating enzyme. The structure 
of the CNOT4 RING domain has been solved and the amino acids important for the binding 
to UbcH5B have been mapped. Here, the residues of UbcH5B important for the binding to 
CNOT4 RING domain were identified by NMR chemical shift perturbation experiments 
and these data were used to generate structural models of the complex with the program 
HADDOCK. Based on the chemical shift perturbation mapping and the docking results, 
mutagenesis experiments were performed that identified several basic residues of UbcH5B 
important for binding to CNOT4. Importantly, concomitant charge-alteration of Glu49 
of CNOT4 and Lys63 of UbcH5B restored binding indicating an electrostatic interaction 
between these two residues. Together with the NMR data, these additional biochemical data 
were included in a second docking and comparisons of the resulting model with the structure 
of the c-Cbl/UbcH7 complex reveal some significant differences, notably at specific residues, 
and give structural insights into the E2/E3 specificity. 
Introduction
The RING finger protein CNOT4 is a component of the CCR4-NOT complex, a global 
repressor of RNA polymerase II transcription (Collart, 2003; Denis and Chen, 2003). The 
structure of the RING finger domain of CNOT4, consisting of the 78 N-terminal residues has 
been solved by NMR (Hanzawa et al., 2001). Recently, CNOT4 has been identified as an E3 
ubiquitin-protein ligase, and the RING domain of CNOT4 has been shown to be necessary 
and sufficient to specifically interact with the ubiquitin conjugating enzyme, UbcH5B (Albert 
et al., 2002). These results link CCR4-NOT mediated transcription repression with the 
ubiquitination pathway. Whether this ubiquitination is related to degradation of transcription 
complexes by the 26S proteasome or other regulatory functions is unclear. 
Ubiquitination of a substrate involves three enzymes: a ubiquitin activating enzyme (E1), 
a ubiquitin conjugating enzyme (E2) and, finally, a ubiquitin protein ligase (E3) (Glickman 
and Ciechanover, 2002; Pickart, 2001; Weissman, 2001). Different classes of E3 ligases have 
been found that mediate substrate ubiquitination. E3 enzymes can be distinguished by their 
E2-interacting domains, which include the HECT and the RING domains (Glickman and 
Ciechanover, 2002; Pickart, 2001). Therefore, specific E2/E3 pairs are thought to be responsible 
for mediating target recognition and subsequent ubiquitination. Structures of nine E2 enzymes 
from different species in the free form have been solved by X-ray crystallography (Cook et 
al., 1992; Cook et al., 1993; Cook et al., 1997; Hamilton et al., 2001; Jiang and Basavappa, 
1999; Lin et al., 2002; Tong et al., 1997; VanDemark et al., 2001; Worthylake et al., 1998) 
and one was solved by NMR (Miura et al., 2002). The structure of the human E2 enzyme 
UbcH5B, however, has not been determined. Furthermore, five structures of E2 in complex 
with various other proteins have been solved by X-ray crystallography (Bernier-Villamor et al., 
91
Structural model of the UbcH5B/CNOT4 complex
2002; Huang et al., 1999; Moraes et al., 2001; VanDemark et al., 2001; Zheng et al., 2000). All 
structures possess the same fold corresponding to an N-terminal α-helix, followed by a four-
stranded anti-parallel β-sheet, and three α-helices. The ternary fold is well conserved among 
the structures both in free form and in complex with other proteins. 
Among the E2 structures in complex, two are of particular interest for the E2/E3 
recognition: the X-ray structures of the ubiquitin conjugating enzyme UbcH7 in complex 
with the E6AP ubiquitin ligase (Huang et al., 1999) and of UbcH7 in complex with the c-Cbl 
ubiquitin ligase (Zheng et al., 2000). E6AP contains a HECT domain and c-Cbl possesses a C-
terminal RING finger domain. Both domains are responsible for the interaction with UbcH7. 
Besides the RING finger domain of c-Cbl, a second domain, the so-called linker region, also 
makes contacts with UbcH7. The two structures give considerable insights into the molecular 
basis of the E2/E3 recognition. Although the RING domain of c-Cbl and the HECT domain 
of E6AP are structurally unrelated, they both bind UbcH7 in a very similar manner. In both 
complexes the same residues of UbcH7 are involved in the interaction and these residues 
are highly conserved within the E2 enzymes suggesting that other E2/E3 complexes could 
follow a similar arrangement. There are a limited number of E2 enzymes (13 in Saccharomyces 
cerevisiae and more in higher organisms) whereas the number of E3 protein ligases is still 
increasing (more than 350 RING domains have been identified in human). This suggests 
that one E2 can recognize different E3s and that one E3 will only recognize one or few E2s. 
Correspondingly, it has been shown, that the E2/E3 interaction is highly specific: for example 
the RING domain of CNOT4 interacts functionally with UbcH5B but not with several other 
E2 enzymes (Winkler et al., 2004). Similarly, it has recently been shown that the RING protein 
BRCA1 can interact both with UbcH5C and UbcH7 but that only UbcH5C is functional 
in BRCA1-mediated substrate independent Ub-ligase assay (Brzovic et al., 2003). The c-Cbl/
UbcH7 and UbcH7/E6-AP complexes involving the same E2 enzyme are thus not sufficient 
to understand the molecular basis of the E2/E3 specificity and structural information from 
complexes involving other ubiquitin conjugating enzymes is crucial to understand the E2/E3 
specificity at a molecular level. 
It has been previously reported that the CNOT4 RING finger domain interacts with 
UbcH5B, and the amino acids of CNOT4 important for the binding to UbcH5B have been 
determined by NMR (Albert et al., 2002). Now, we performed the complementary NMR 
titration experiments to identify the amino acids of UbcH5B that are involved in the binding 
to the CNOT4 RING finger domain. Using data from the two titrations we applied a docking 
approach HADDOCK (Dominguez et al., 2003), that we have recently developed, to generate 
a structural model of the UbcH5B/CNOT4 RING complex. The initial docking calculations 
resulted in two possible models of the UbcH5B/CNOT4 complex. Based on the docking 
results, we mapped by site-directed mutagenesis a number of basic UbcH5B residues important 
for the interaction with CNOT4 RING domain. We show that reciprocal substitution of 
charged amino acids of the UbcH5B-CNOT4 interface result in a functional E2/E3 pair. This 
additional biochemical information was used together with the NMR titration restraints in a 
second docking calculation resulting in a uniquely defined complex. Our final experimentally 
based model of the UbcH5B/CNOT4 complex reveals significant differences in terms of 
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intermolecular contacts as compared to the c-Cbl/UbcH7 complex, especially in terms of 
hydrogen bonding and salt-bridges. These differences indicate that, although similar and 
well-conserved regions of different E2 enzymes and E3 ligases are involved in binding, the 
intermolecular interactions involve different amino acids and different kinds of forces that can 
explain the observed E2/E3 specificity of the UbcH5B/CNOT4 complex.
Results and Discussion
Assignment of UbcH5B and secondary structure prediction
The assignment of UbcH5B was previously reported (Farrow et al., 2000). However, the 
data were collected at different temperature, pH and salt concentration than used here. 
Therefore, 3D TOCSY-(1H,15N) HSQC, 3D NOESY-(1H,15N) HSQC, 3D HNCACB and 
3D CBCACONH were recorded to assign the backbone chemical shifts in our conditions 
(300 K, pH 7.0, 150 mM KCl). Side chain protons were assigned from 3D (H)CCH 
TOCSY and H(C)CH TOCSY experiments. Talos (Cornilescu et al., 1999) was used to 
predict the dihedral angles of the protein based on the Cα and the Cβ chemical shifts. These 
predictions correlate well with the consensus secondary structure elements found in the 
known E2 structures (data not shown).
Structural model of UbcH5B
Although the structure of UbcH5B is not available in the protein data bank (PDB), the 
amino acid sequence of UbcH5B is highly homologous to that of other E2 enzymes. All 
E2 structures already described are structurally very similar and our secondary structure 
prediction based on the NMR Cα and Cβ chemical shifts of UbcH5B correlates well with 
the E2 consensus structure. We therefore decided to generate a structural model of UbcH5B 
based on homologous structures. A Blast search of the UbcH5B sequence against the protein 
data bank identified the most homologous E2 enzymes. In particular, UbcH5B displays 
90% homology and 80% identity with yeast Ubc4 (PDB: 1QCQ). Therefore, yeast Ubc4 
was used to build a homology model of UbcH5B. The Ramachandran plot of the generated 
model shows 89.8% of the residues in the most favoured regions, 9.5% in the additional 
allowed regions, 0.6% in the generously allowed region and 0.2% in the disallowed regions. 
The backbone RMSD between the model and the yeast Ubc4 structure is 0.20 Å. A 5 
nanoseconds molecular dynamic simulation in explicit solvent was performed in order to 
assess the stability of the model and to obtain an ensemble of starting structures for the 
docking by extracting PDB files from the trajectory (see Material and Methods). Analysis of 
these PDB files shows that few structural rearrangements occur during the simulation. The 
mean RMSD among all structures extracted from the trajectory is 1.2 Å for the backbone 
atoms (Figure 1) and 1.7 Å for all heavy atoms.
Mapping of the CNOT4-N78 binding site of UbcH5B
The UbcH5B binding site of the CNOT4 RING domain has been previously determined by 
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NMR chemical shift perturbations in a titration of 15N-labeled CNOT4-N78 (comprising 
the 78 N-terminal amino acids of CNOT4) with unlabeled UbcH5B (Albert et al., 2002). 
The residues of CNOT4-N78 having the highest chemical shift perturbation upon binding 
to UbcH5B are Leu16, Cys17, Met18, Cys41, Asp48, Glu49 and Arg57. The mapping of 
these residues onto the CNOT4 RING finger NMR structure (PDB: 1E4U) (Hanzawa et 
al., 2001) reveals three distinct regions. The first region defines the shallow groove of the α 
helix (residues 16 to 18) and the two other regions correspond to two zinc chelating loops 
(residues 48, 49 and 57).
In this study, we carried out the reciprocal experiment using 15N-labeled UbcH5B and 
unlabeled CNOT4-N78 to identify the residues of UbcH5B involved in the interaction 
with the CNOT4 RING finger. The NMR titration was performed by increasing the 
UbcH5B/CNOT4 RING finger molar ratio up to a final 1:2 molar ratio. We analyzed 
the UbcH5B chemical shift perturbation upon binding to CNOT4-N78 and characterized 
the amino acids potentially involved in the interaction (Figure 2). The largest combined 
chemical shift differences (higher than 0.1 ppm) are observed in the first α helix (Ala2, Leu3, 
Arg5, Ile6, Glu9, Leu10, Asn11, and Asp12), the L1 loop connecting the third and fourth 
strand of the β-sheet (residue Thr58, Asp59, Tyr60 and Lys63) and the L2 loop connecting 
the fourth β-strand and the H2 α-helix (residues Ser94, Ala96, Thr98, and Ile99). These 
residues define three distinct interacting regions of UbcH5B, which are located on one side 
of the molecule. This is consistent with previous data showing that CNOT4-N78 displays 
three distinct interacting regions upon binding to UbcH5B, which are localized around a 
hydrophobic cleft (Albert et al., 2002).
������
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Figure 1: X-ray structure of yeast Ubc4 and ensemble of UbcH5B models during the 5ns molecular 
dynamic simulation. Figures were generated with the programs Molscript (Kraulis, 1991) and Raster3D 
(Merrit and Murphy, 1994).
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Figure 2: Titration of CNOT4 with UbcH5B. Chemical shifts perturbation of 15N-labeled UbcH5B 
upon titration of CNOT4-N78 as a function of the UbcH5B amino acid for the A) amide proton and B) 
the amide nitrogen. C). Combined chemical shift differences (Δδ= [(δHN)2 + (δN/6.51)2]1/2). D) Sequence 
alignment of UbcH5B, yeast UBC4 and UbcH7 encompassing the α1 helix and the L1 and L2 loops. The 
amino acids of UbcH5B displaying a Δδcomp>0.1ppm (*), and the amino acids of UbcH7 involved in 
the binding with c-Cbl (+) are marked.
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Ensemble docking of the UbcH5B/CNOT4 RING finger complex
We used HADDOCK (Dominguez et al., 2003) to generate a structural model of the 
UbcH5B/CNOT4 RING finger domain based on the NMR titration data. A new feature 
that we added to HADDOCK consists of the possibility of starting from ensembles of 
structures instead of a single structure. The structure of a protein free in solution is usually 
different than when forming a complex with a partner. Even when very small structural 
rearrangements occur (that can be monitored by NMR or circular dichroism for example) 
the side chain orientation at the interface may be much more different. In HADDOCK, 
the proteins are treated as rigid bodies at the first stage of the docking. Since no flexibility 
is allowed at this stage, no side chains or loop rearrangement can occur which might lead 
to wrong initial orientations of the complex. Such orientations are generally not corrected 
during the subsequent HADDOCK semi-flexible molecular dynamic refinement stages. A 
solution to overcome this problem can be to start from an ensemble of structures instead 
of a single molecule. An NMR ensemble of structures will reflect flexibility in loops and 
will show slight differences in side chain orientation especially for solvent exposed residues. 
The different side chain and/or backbone orientations allow a better sampling of all 
conformational possibilities during the rigid body docking step. However, also in the case 
that an ensemble of NMR models or different X-ray structures or homology models are not 
available, an ensemble can be generated by applying a short molecular dynamics simulation. 
The different structures can then be extracted from the trajectory of the simulation. 
The performance of ensemble docking was tested on the EIIA-HPr complex (Wang et 
al., 2000) starting from the X-ray structure of EIIA (Worthylake et al., 1991) and the 30 
NMR structures of HPr (van Nuland et al., 1994). After the water refinement, only two 
clusters were obtained using a 1.5 Å cut-off for the ensemble docking instead of 14 when 
starting from single structures (Dominguez et al., 2003). The model obtained starting from 
an ensemble of structures is closer to the target complex than the single structure docking 
solution as can be seen from Table 1. In order to get more insights into the validity of our 
docking approach, we also analyzed the intermolecular contacts presents in our best models 
and compared them with the contacts presents in the NMR structure. The analysis was 
performed using LIGPLOT (Wallace et al., 1995) on the 10 best solutions of the best cluster 
for the ensemble docking (this cluster contains 87 solutions) and on the 7 solutions of the 
best cluster for the original docking (see Table 1). The HADDOCK solutions reproduced 
100% of the hydrogen bonds and/or salt bridges found in the NMR structure and 63% of 
the non-bonded contacts (Table 1). Note that for the NMR structure the analysis was based 
on a single structure, the deposited minimized average, and no contact statistics could thus 
be obtained. This structure was also calculated in the absence of any attractive non-bonded 
energy term. Next to those “native” contacts, 5 additional intermolecular hydrogen bonds/
salt bridges were detected in the HADDOCK models (Table 1). For the docking of the 
UbcH5B/CNOT4 RING complex, 30 NMR structures of the CNOT4 RING domain 
deposited in the PDB (PDB:1E4U) (Hanzawa et al., 2001) and 11 models of UbcH5B 
obtained during the molecular dynamic simulations (the initial homology model and 10 
molecular dynamic structures taken at 0.5 ns intervals) (see Material and Methods) were used. 
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Based on the NMR titration data, we first selected all residues having a combined chemical 
shift perturbation upon complex formation higher than 0.1 and 0.05 ppm for UbcH5B 
and CNOT4, respectively. The cut-off of 0.1 and 0.05 ppm was defined as all residues 
having a chemical shift perturbation higher than the average chemical shift perturbation 
along the sequence plus one standard deviation, in combination with a solvent accessibility 
criteria. In total, 12 and 8 active residues and 7 and 12 passive residues for CNOT4 and 
UbcH5B, respectively, were used to define 20 ambiguous interaction restraints (AIRs) to 
drive the docking process (Table 2) (see Material and Methods). After water refinement, 
two clusters were obtained (Figure 3) containing 61 and 127 structures, respectively. 
The best 10 structures of these two clusters have average total interaction energies of 
Table 1: Performance of ensemble docking with HADDOCK for EIIA-HPr complex
Original
protocol
Ensemble
docking
NMR
structure
Backbone RMSD 
from NMR structure (Å)
2.5 ± 0.2 1.4 ±0.2 -
Backbone interface RMSD from 
NMR structure (Å)a
2.1 ± 0.1 1.7 ± 0.2 -
Intermolecular energy 
(kcal mol-1)b
-392 ± 49 - 443 ± 92 -
Buried surface area (Å2)c 1453 ± 114 1676 ± 150 1365
Intermolecular contactsd
Number of H bonds / % of native 
H bond
9 / 40% 10 / 100% 5
Number of non bonded contacts 
/ % of native contact
11 / 21% 18 / 63% 19
Total number of intermolecular 
contacts / % of native contacts
20 / 25% 28 / 71% 24
% of total native contact present 
in at least one structure
58% 96%
a) The interface consists of residues 36 to 48, 66 to 82, 84 to 88, 92 to 98 and 139 to 143 for EIIA and residues  
 10 to 22 and 46 to 58 for HPr.
b) The intermolecular energy consists of the sum of the van der Waals, the electrostatic and the AIR energy  
 terms.
c) Calculated with NACCESS (Hubbard and Thornton, 1993) using a 1.4 Å radius probe.
d) Intermolecular contacts were analyzed with DIMPLOT (Wallace et al., 1995) (see Material and methods) and  
 are reported if present in at least half of the analyzed structures. The percentages correspond to the percentage  
 of native hydrogen bond or non-bonded contact in the NMR structure that are also present in at least half of  
 the analyzed structures
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–522 ± 17 and –487 ± 29 kcal mol-1, AIR energies of 2.23 ± 2.07 and 1.28 ± 0.72 kcal 
mol-1 and buried surface areas of 1388 ± 81 and 1523 ± 83 Å2, respectively. The second 
cluster is the most populated, satisfies best the experimental restraints and possesses the 
largest interface. Its total intermolecular energy is somewhat higher than the first cluster, 
due mainly to differences in electrostatic energies. In order to differentiate between these 
two clusters, we analyzed them in details. The two clusters correspond to models with ~180 
degrees rotation of CNOT4 around the intermolecular axis defined by the two proteins 
(Figure 3). The difficulty in distinguishing between them is due to the symmetry of the 
charge distribution at the interface. Two residues of CNOT4 showing a significant chemical 
shift perturbation upon complex formation are the amino acids Asp48 and Glu49. We thus 
investigated the hydrogen bond pattern in the two clusters. In the best solution of cluster 1, 
Asp48 and Glu49 of CNOT4 form salt-bridges with the Lys4 and Lys8 of UbcH5B, while in 
the best solution of cluster 2, these two residues pair with Lys63 of UbcH5B (Figure 3). 
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Figure 3: Docking results of the UbcH5B/CNOT4 complex when using NMR perturbation data only. 
Plot of the intermolecular energy as a function of the RMSD from the lowest energy structure for the 
200 calculated solutions. Two clusters are defined. Asp48 and Glu49 of CNOT4 are hydrogen bonded 
to Lys4 and Lys8 of UbcH5B in the first cluster (left) and to Lys63 of UbcH5B in the second cluster 
(right).
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Table 2: Active and passive residues of UbcH5B and CNOT4-N78
 UbcH5B CNOT4 
 Activea Passiveb Activea Passiveb
 
 Leu3 Met1 Leu16 Glu13 
  Arg5 Lys4 Cys17 Pro15 
 Thr58 His7 Met18 Pro20 
 Asp59 Lys8 Glu19 His43 
  Lys63 Asp29 Phe40 Arg44 
 Ser94 Met30 Asp48 Thr47 
  Ala96 Phe31 Glu49 Pro54
 Thr98 His55 Asn50
  Phe62 Leu52
  Lys66 Ala55
  Gln92 Cys56
  Pro95 Arg57
a) The active residues correspond to the residues having a significant NMR chemical shift perturbation during 
 the NMR titration experiments and that are high solvent accessible.
b) The passive residues correspond to all surface neighbors of the active residues that are solvent accessible.
Identification of basic residues essential for UbcH5B/CNOT4 interactions
Consistent with the chemical shift perturbation of Asp48 and Glu49 of CNOT4 in the 
interaction with UbcH5B, substitution of Glu49 by a lysine (E49K) abolished binding to 
UbcH5B (Albert et al., 2002). We investigated whether one or several of the basic UbcH5B 
residues were required for the interaction with CNOT4. Thus, basic amino acids located 
in the α1 helix and loop L1 were mutated and tested in combination with the CNOT4 
RING in a yeast two-hybrid interaction assay. Similar levels of all proteins were present in 
the transformants as determined by immunoblotting (Figure 4A). Remarkably, alteration 
of residue Lys4 or Arg5 into either alanine or glutamic acid abolished all binding with the 
CNOT4 RING (Figure 4A and B). Notably, the substitution Lys8Ala did only partially 
interfere with CNOT4 binding, although substitution Lys8Glu severely disrupted the 
interaction, indicating that Lys8 may be involved in an electrostatic interaction. As expected 
from these results, no interaction was observed when both Lys4 and Lys8 were substituted 
with acidic residues. Interestingly, substitution of loop L1 residue Lys63 with either alanine 
or glutamic acid also severely reduced CNOT4 binding, but alterations of residue Lys66 did 
not (Figure 4A and B). This analysis suggests important roles for basic residues in the α1 
helix and loop L1 in the association of UbcH5B and CNOT4. Notably, Arg5 and Lys63 are 
present in multiple E2 enzymes while the presence of lysine at positions 4, 8, and 66 is less 
conserved.
Compensatory amino acid substitutions in CNOT4 restore binding to an interaction-
deficient UbcH5B mutant
Next, we investigated whether any of the UbcH5B basic residues in the α1 helix and/or loop 
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L1 interacted directly with the acidic patch on the interaction surface of CNOT4. Therefore, 
the panel of UbcH5B mutants in which basic amino acids were substituted with acidic residues 
was tested for binding with the CNOT4 RING domain containing substitutions Asp48Lys 
and/or Glu49Lys in the yeast two-hybrid assay. In contrast to the single Asp48Lys alteration, 
which had no significant effect on UbcH5B binding compared to the wild type interaction, 
substitution Glu49Lys of CNOT4 severely affected binding with wild type UbcH5B. This was 
even more pronounced when the substitution Glu48Lys was additionally present (Figure 5A and 
B). Remarkably, the interaction was restored when specific reciprocal amino acid substitutions 
were introduced in UbcH5B. Thus, when the Lys63Glu substitution in loop L1 was present or 
when both Lys63Glu and Lys66Glu were concomitantly altered, the interaction was comparable 
with the interaction between the wild type proteins. This effect was specific, because alterations 
in the UbcH5B N-terminal α-helix of the solvent exposed residues Lys4Glu and/or Lys8Glu 
did not result in restoration of the interaction with any of the CNOT4 mutants (Figure 5A and 
B). In all experiments, similar amounts of the LexA-UbcH5B variants and the B42-CNOT4 
N63 partners were present (Figure 5A). These results indicate that CNOT4 Glu49 and 
UbcH5B Lys63 are directly interacting. Although Asp48 of CNOT4 does not seem a primary 
determinant, we note that the interaction between UbcH5B with CNOT4Asp48Lys,Glu49Lys is lower 
compared to the single mutant CNOT4Glu49Lys. This suggests that residue Asp48 can partially 
compensate for the absence of Glu49. Additionally, interactions involving CNOT4Glu49Lys and 
CNOT4Asp48Lys,Glu49Lys with UbcH5BLys63Glu,Lys66Glu seem to be restored to a slightly higher level 
compared to that obtained with UbcH5BLys63Glu. Thus, substitution of Lys66Glu generates an 
additional charge contribution to UbcH5B. The important conclusion of these experiments, 
�� ��
Figure 4: Essential role for basic residues in the interaction between UbcH5B and CNOT4. 
A) Staining of yeast two-hybrid transformants on X-gal plates representing interactions between 
UbcH5B fused to the LexA DNA-binding domain and the B42 activation domain or B42 fused to 
CNOT4 N63 as indicated. Shown in the lower panels are immunoblot analyses of LexA-UbcH5B 
(α-LexA) and B42-CNOT4 N63 (α-HA) proteins. B) Quantitative β–galactosidase reporter assay of 
yeast two-hybrid interactions shown in A). Activities are represented as a percentage of the activity 
obtained using wild type UbcH5B and CNOT4 N63, which was arbitrarily set to 100%.
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however, is that a single conserved lysine residue located in loop L1 of UbcH5B and an acidic 
residue on the interaction surface of the CNOT4 RING domain can dominantly influence 
the interaction between an E2 enzyme and a RING domain E3 ligase.
Ensemble docking based on NMR chemical shift perturbation and mutagenesis data
We performed a new docking by defining, in addition to the previous ambiguous restraints 
derived from NMR chemical shift perturbation experiments, a restraint between any atom 
of Glu49 of CNOT4 and any atom of Lys63 of UbcH5B. Now, only one cluster could be 
detected containing 168 structures out of the 200 calculated when using a 2.5 Å RMSD 
(199 structures belong to this cluster when using a 3.0 Å RMSD) (Figure 6A). The complex 
is well defined with an average energy of the 10 best structures of –515 ± 65 kcal mol-1, and 
an average backbone RMSD of 1.70 ± 0.56 Å at the interface (Table 3). The best solution 
of the cluster in terms of intermolecular energy (-653 kcal mol-1) is displayed in Figure 6B 
and is very similar to the best structure of the second cluster in the previous docking (total 
backbone RMSD of 1.2 Å while the total backbone RMSD between this model and the 
best model of the first cluster is 9.5 Å). In this cluster, salt-bridges are found between Lys63 
��
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Figure 5: Compensatory mutations in CNOT4 restore binding with UbcH5B containing specific 
amino acid substitutions. A) Staining of yeast two-hybrid transformants on X-gal plates representing 
interactions between LexA-UbcH5B proteins and B42-CNOT4 N63 proteins as indicated. Shown in 
the lower panels are immunoblot analyses of LexA-UbcH5B (α-LexA) and B42-CNOT4 N63 (α-HA) 
proteins. B) Quantitative β–galactosidase reporter assay of yeast two-hybrid interactions shown in A). 
Activities are represented as a percentage of the activity obtained using wild type UbcH5B and CNOT4 
N63, which was arbitrarily set to 100%.
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of UbcH5B with Asp48 and Glu49 of CNOT4, but also between Lys4 and Lys8 of UbcH5B 
with Glu13 of CNOT4, and Asp59 of UbcH5B with Arg44 of CNOT4 (Table 4). In addition 
to this salt-bridges network, a number of van der Waals contacts occur at the interface 
between residues 1, 4, 5, and 8 of UbcH5B corresponding to the H1 helix and residues 15, 
17, 18, 40, and 41 of CNOT4, between residues 62 of the L1 loop of UbcH5B and residues 
44, and 45 of CNOT4 and finally between residues 92, 94, 95, and 96 of the L2 loop of 
UbcH5B and residues 49, 54, and 57 of CNOT4 (Table 4). Concerning the H1 helix, the 
first residue is not visible in the HSQC spectrum, residue 5 shows a significant perturbation 
in the NMR titration experiment and residues 4 and 8 have been shown to be involved in 
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�� Figure 6: Docking results 
of the UbcH5B/CNOT4 
complex after incorporation of 
the mutagenesis data. A) Plot 
of the intermolecular energy as 
a function of the RMSD from 
the lowest energy structure for 
the 200 calculated solutions. B) 
Stereo view of the best solution 
generated by HADDOCK after 
incorporation of mutagenesis 
data. This Figure has been 
generated with the program 
MOLMOL (Koradi et al., 
1996).
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the interaction by mutagenesis experiments. Concerning the loop L1, in addition to the salt 
bridges involving Asp59 and Lys63 of UbcH5B, both showing a significant perturbation, 
Phe62 is in van der Waals contact with residues of CNOT4. However, Phe62 does not show 
a significant perturbation. This could be due to the fact that all contacts between Phe62 and 
residues of CNOT4 involve the side chain aromatic ring and the perturbation is detected on 
the amide backbone atom. Finally, concerning loop L2, residues 94 and 96 show significant 
perturbation while Pro95 is not observed. On the CNOT4 side, all the residues involved in 
the van der Waals contacts show significant perturbation except for Arg44. The absence of 
perturbation for Arg44 is striking since this residue in our structural model is salt-bridged to 
Asp59 of UbcH5B. The NMR titration data also showed that significant perturbation of the 
Table 3: Structural statistics of the 10 best UbcH5B/CNOT4 model structuresa
 
Backbone r.m.s.d. (Å) with respect to mean 
 Flexible interface backboneb 1.70 ± 0.56
 All Backbone 2.69 ± 1.46
Number of ambiguous interaction restraints (AIRs)
 From UbcH5B  12
 From CNOT4 8
 Total AIRs 20
CNS intermolecular energies after water refinementc 
 Evdw (kcal mol
-1) -54 ± 14 
 Eelec (kcal mol
-1) -461 ± 75
Buried surface area (Å2)d 1551 ± 117
R.m.s.d from idealized covalent geometry 
 Bonds (Å) 0.003 ± 0.00
 Angles (°) 0.43 ± 0.01
 Impropers (°) 0.36 ± 0.01
Ramachandran analysis  
 Residues in the favoured region (%) 81.1 ± 2.4
 Residues in additional allowed regions (%) 16.8 ± 2.8
 Residues in generously allowed regions (%) 1.3 ± 1.1
 Residues in disallowed regions (%) 0.7 ± 0.3
a) Based on 10 structures, obtained after flexible docking with HADDOCK followed by refinement in explicit 
 water using ambiguous interaction restraints derived from chemical shift perturbation data (see Material and 
 Methods).
b) The flexible interface comprises segments M1-P18, V26-W33, T53-A68 and R90-L103 for UbcH5B and V12- 
 E22 and C38-P59 for CNOT4.
c) The non-bonded energies were calculated with the OPLS parameters ( Jorgensen and Tirado-rives, 1988) 
 using a 8.5 Å cut-off.
d) The buried surface area was calculated with CNS (Brunger et al., 1998) using a 1.4 Å radius water probe and 
 0.05Å accuracy.
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H1 helix of UbcH5B occurred up to residues Asp12. The structural model shows, however, 
that the last residue of this helix contacting CNOT4 is Lys8. This is consistent with the 
maximum length of the interacting area defined by the active and passive residues and by 
the shape of the molecules. The longest distance found in the interacting area of CNOT4 is 
between Glu19 and Arg57 and is about 27 Å. This distance fits the distance between Lys63 
of UbcH5B and Lys8 in the H1 helix. Therefore, we assume that the perturbation observed 
for residues Glu9, Leu10, Asn11, and Asp12 of UbcH5B are due to an indirect effect of the 
binding to CNOT4.
Towards the molecular basis of the E2/E3 specificity
Finally, we compared our structural model of the UbcH5B/CNOT4 complex with the X-
ray structure of c-Cbl/UbcH7 (Zheng et al., 2000). The two complexes are structurally 
homologous with a total backbone RMSD of 3.1 Å (UbcH5B/CNOT4 versus c-Cbl/
Table 4: Intermolecular contactsa statistics calculated over the ensemble of the ten best structures of 
cluster 1 for the second HADDOCK run 
 Interacting residues Hydrogen bonds Non bonded occurrence
 UbcH5B CNOT4 M-M S-S M-S contacts
 M1 C17 0 0 0 1 5
 M1 P40 0 0 0 1 5
 M1 C41 0 0 0 1 6
 K4 E13 0 1 0 0 5
 K4 M18 0 0 0 1 7
 R5 P15 0 0 1 0 6
 R5 M18 0 0 0 1 8
 K8 E13 0 1 0 0 7
 K8 M18 0 0 0 1 7
 D59 R44 0 1 0 1 9
 P62 R44 0 0 0 1 9
 P62 I45 0 0 0 1 9
 K63 D48 0 1 0 0 8
 K63 E49 0 1 0 0 10
 Q92 E49 0 1 0 0 5
 Q92 R57 0 0 1 1 6
 S94 P54 0 0 1 1 5
 S94 R57 0 1 0 1 5
 P95 E49 0 0 0 1 5
 P95 P54 0 0 0 1 5
 A96 P54 0 0 0 1 8
a) Intermolecular contacts were analyzed with DIMPLOT (Wallace et al., 1995) (see Material and methods) 
and are reported if present in at least 5 of the 10 best structures. The occurrence of main chain-main chain 
(M-M), side chain-side chain (S-S) and side chain-main chain (S-M) hydrogen bonds is reported. The number 
of occurrences of a given interaction over the ensemble of 10 best structures is reported in the Table.
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UbcH7) and the orientation of the RING domain with respect to the E2 enzyme is similar 
in both complexes (Figure 7A). It has been shown, however, that the CNOT4 RING 
finger interacts specifically with UbcH5B and not with UbcH7 despite the fact that in both 
complexes, the same regions of the E2s are involved in the interaction with the RING. 
This suggests that although the three regions of UbcH5B and UbcH7 involved in the 
binding (helix H1, loops L1 and L2) are similar (Figure 2D), the binding properties must 
be different. It has already been reported that the L2 loop of E2 enzymes plays a role in the 
E2/E3 specificity (Martinez-Noel et al., 2001). In the UbcH7/c-Cbl crystal structure, the 
highly conserved Pro96 and Ala97 residues are involved in the binding. When comparing 
the residues of the L2 loop in UbcH5B and UbcH7, however, it can be noted that the 
other residues are not conserved between the two E2 enzymes: of these, Ser94, Leu97, 
Thr98 and Ile99 of UbcH5B, which show significant NMR chemical shift perturbations, 
are replaced by two lysines (Lys96 and Lys100) and two threonines (Thr99 and Thr101) in 
UbcH7 (Figure 2D). In our model, we also observe the contacts involving the conserved 
Pro95 and Ala96. In addition, Ser94 makes a hydrogen bond with Arg57 of CNOT4 and 
a van der Waals contact with Pro54 (table 4). No direct contact involving Thr98 or Ile99, 
however, could be detected in our model and, thus we explain the observed chemical shifts 
to an indirect effect of the complex formation. None of these non-conserved residues in 
UbcH7 are involved in direct contact with c-Cbl in the crystal structure. These results are 
in agreement with mutagenesis experiments in which a triple mutant of ubcM4 (Lys96Ser, 
Thr99Leu, Lys100Thr), that is highly homologous to UbcH7, was able to change the 
specificity from UbcM4 to UbcH5, demonstrating that one or more of these residues are 
important for the specificity (Martinez-Noel et al., 2001).
A more detailed comparison of the UbcH5B/CNOT4 structural model with the X-ray 
structure of the c-Cbl/UbcH7 complex gives further insights into how the E2/E3 specificity 
occurs. Our NMR titration experiments suggest that the first α-helix of UbcH5B makes many 
direct contacts with the CNOT4 RING domain whereas in the c-Cbl/UbcH7 complex, this 
helix provides only a minor contact with the c-Cbl RING finger domain through Arg5 and 
mainly interacts with the linker region located just N-terminal of the RING domain of c-Cbl 
(Zheng et al., 2000). Many residues of the first helix of UbcH5B show a significant chemical 
shift perturbation upon complex formation and mutagenesis data showed that Lys4 and to a 
lesser extent Lys8 are critical residues for the binding to CNOT4-N78. The CNOT4 RING 
domain is located at the N-terminus of the protein and does not possess this linker region.  As 
a control, we performed a titration of 15N-UbcH5B with unlabeled CNOT4-N227 (the 227 
N-terminal amino acids) containing the RRM (RNA recognition motif) domain to investigate 
whether another region of CNOT4 is involved in the interaction with the UbcH5B H1 helix. 
However, we did not observe any additional perturbation in the HSQC spectra (data not shown) 
indicating that, contrary to the c-Cbl/UbcH7 complex, CNOT4 interacts with UbcH5B only 
through its RING finger domain, and that the H1 helix of UbcH5B is interacting with the 
CNOT4 RING finger and not with another region of the protein. This is further supported 
by the fact that the structural model of the UbcH5B/CNOT4 complex shows several contacts 
between the H1 helix of UbcH5B and the RING domain of CNOT4 that are not present in 
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Figure 7: Comparison between the UbcH5B/CNOT4 docking model and the c-Cbl/UbcH7 crystal 
structure (Zheng et al., 2000). A) The orientation of the RING domain compared to the E2 enzyme is 
similar in both complexes.  B) The helix α1 of UbcH5B makes many contacts with the CNOT4 RING 
domain, whereas the helix α1 of UbcH7 interact mainly with the linker region of c-Cbl. Residues of 
UbcH5B, UbcH7, CNOT4 and c-Cbl that are involved in the interaction are labeled. C) In the L1 loop 
of UbcH5B, residue Lys63 interacts with CNOT4 Asp48 and Glu49 whereas the corresponding and 
conserved residue of UbcH7 (Lys64) is not in contact with c-Cbl. Figures have been generated with the 
programs Molscript (Kraulis, 1991) and Raster3D (Merrit and Murphy, 1994).
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the c-Cbl/UbcH7 complex (Figure 7B). Furthermore, the contacts that govern the binding 
of UbcH7 to c-Cbl involve mainly hydrophobic or uncharged residues making multiple van 
der Waals contacts. In the case of the UbcH5B/CNOT4 complex, however, many charged 
residues could be detected in the NMR titration experiments suggesting that hydrogen bonds, 
salt-bridges and thus electrostatic interactions are important in the binding. In the c-Cbl/
UbcH7 complex, indeed, residues Pro62 and Phe63 of the L1 loop make close contact with 
the c-Cbl RING domain. In contrast, our titration of UbcH5B shows significant chemical 
shift perturbations for Thr58, Asp59, Tyr60, and Lys63, while Phe62 is not affected and Pro61 
cannot be observed. The presence of salt bridges in the UbcH5B/CNOT4 complex is further 
supported by the results of site-directed mutagenesis. Though the residues Lys63 of UbcH5B 
and Glu49 of CNOT4 are conserved in UbcH7 (Lys64) and c-Cbl (Glu412), they do not form 
a contact in the crystal structure (Figure 7C). 
Taken together, these results give insights into how two different E2/E3 complexes can 
interact in two distinct ways although their interaction regions are similar with rather high 
sequence homology. Our present work provides new insight into the origin of the specificity 
within a given E2/E3 complex in that it indicates that electrostatic interactions are of crucial 
importance. Other E2/E3 complexes will, however, need to be studied to fully understand the 
preference of ubiquitin-protein ligases for specific ubiquitin conjugating enzymes.
Material and methods
Recombinant proteins expression, purification and mutagenesis
The bacterial expression plasmids for UbcH5B, CNOT4-N78, and CNOT4-N227 have been 
described (Albert et al., 2002; Hanzawa et al., 2001). Overexpression of 15N and 15N/13C-
labeled GST-UbcH5B was accomplished by growing Escherichia coli BL21(DE3) containing 
the pGEX2T-UbcH5B plasmid in a synthetic medium (6.0 g/liter Na2HPO4•2H2O, 3.0 
g/liter KH2PO4, 0.5 g/liter NaCl, 1 mM MgSO4, 20 μM CaCl2, 36 nM FeSo4•7H2O, 
20 μM ZnCl2, and 5 mg/liter Thiamine) containing 0.5 g/liter 15NH4Cl as the sole 
nitrogen source and either 4.0 g/liter [12C]glucose or 2.0 g/liter [13C]glucose as the only 
carbon source. Induction took place at A600 = 0.7-0.75 by addition of 0.4 mM isopropyl-β-
thiogalactopyranoside (IPTG) and bacteria were grown 3 h at 30ºC and lysed in buffer LB 
(300 mM KCl, 50 mM Tris-HCl pH 8.0, 2 mM EDTA, 0.1% Triton X-100, 20% sucrose) 
containing 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 
protease inhibitor cocktail (Roche) and 250 μg/ml lysosyme. After freeze-thawing and 
sonication, lysates were centrifuged at 25 K rpm in a SW40 rotor for 90 minutes at 4°C. 
Supernatant was bound to gluthatione-agarose in LB buffer without sucrose, washed with 
buffer WB (150 mM KCl, 20 mM KPi pH 7.0, 10 μM ZnCl2, protease inhibitors) and 
eluted with buffer WB plus 10mM gluthatione. The GST tag was cleaved by addition 
of 3 U of thrombin (Sigma) per mg protein at 37ºC for 3 h. Thrombin was inactivated 
by addition of 0.5 mM PMSF (final concentration) and, subsequently, removed by batch 
binding to benzamidine-Sepharose6B (Amersham). The UbcH5B sample was concentrated 
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using a stirred Amicon ultrafiltration cell (Millipore) and further purified by gel filtration 
chromatography using a Superdex75 16/60 column (Amersham) using WB buffer. Fractions 
containing UbcH5B were concentrated to a final concentration of 1 mM.
The expression and purification of unlabeled CNOT4-N78 and CNOT4-N227 were as 
described (Hanzawa et al., 2001). The samples were then dialyzed against NMR buffer (150 
mM KCl, 20 mM KPi pH 7.0, 10 μM ZnCl2) and concentrated by ultrafiltration to a final 
concentration of 1 mM.
Site-directed mutagenesis of UbcH5B was carried out using plasmid pEG202-UbcH5B 
and standard overlap PCR procedures. Mutations in CNOT4 were also generated using 
PCR techniques with plasmids pJG4-5-N63 and pHis6-CNOT4 as templates (Albert et al., 
2002; Hanzawa et al., 2001). All plasmid constructs were verified by DNA sequencing.
Yeast two-hybrid interaction assay
Growth and manipulation of yeast strain EGY48 was carried out as described (Albert et al., 
2000). Proteins were extracted for immunoblotting from yeast transformants using the method 
of Kushnirov (Kushnirov, 2000). For quantitative determination of β-galactosidase activities, 
yeast transformants were disrupted with zirconia/silica beads using a mini beadbeater (Biospec 
Products, 1 min maximum speed at room temperature) in buffer containing 100 mM Tris-
HCl pH 8.0, 20% (v/v) glycerol, 1 mM β-mercaptoethanol, 0.5% sodium dodecyl sulphate, 
and protease inhibitors. After removal of insoluble material by centrifugation, β-galactosidase 
activities were determined using the Galacto-Light Plus chemiluminescent reporter assay 
(Tropix) essentially according to the manufacturer’s instructions and normalised to total protein 
content as determined by a Bradford protein assay (Biorad).
UbcH5B modeling
UbcH5B displays 90% homology and 80% identity with the yeast Ubc4 (PDB: 1QCQ) (Cook 
et al., 1993). We used Modeller4 (Sali and Blundell, 1993) to generate 10 structural models of 
UbcH5B based on the structure of yeast Ubc4. 
Molecular dynamic simulation of UbcH5B
We selected the best model based on Procheck (Laskowski et al., 1993) analysis and applied 
a 5 nanoseconds molecular dynamic simulation in explicit solvent. PDB files were extracted 
from the trajectory every 0.5 ns so that, at the end of the simulation, 11 PDB files (the original 
+ 10 from the molecular dynamic) were available as starting structures for the docking. The 
molecular dynamic simulations were run with the GROMACS3.0 molecular dynamic package 
(Lindahl et al., 2001) using the GROMOS96 force field (Scott et al., 1999). The structure was 
solvated in a cubic box of SPC water (Berendsen et al., 1981) using a minimum distance of 14 
Å between the protein and the box edges. After a first steepest descent energy minimization 
with positional restraints on the solute, one chloride counter ion (Cl-) was introduced to 
obtain an electro-neutralized system. A second energy minimization was performed, followed 
by five successive 20 ps molecular dynamic equilibration runs. During these, the position 
restraints force constant on the solute Kposre was decreased progressively (1000,1000, 100, 
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10, 0 kJ mol-1 nm-2). A 5 ns production run was then performed at constant temperature 
(300K) and pressure (1 atm) with weak coupling (0.1 and 1ps-1) to reference T and P baths 
(Berendsen et al., 1984) using a 4 fs time step for the integration of the equations of motion. 
Non-bonded interactions were calculated using twin range cut-offs of 0.8 and 1.4 nm. Long 
range electrostatic interactions beyond the cut-off were treated with the generalized reaction 
field model using a dielectric constant of 54 (Tironi et al., 1995). The LINCS algorithm (Hess 
et al., 1997) was used for bond length constraining in conjunction with dummy atoms for the 
aromatic rings and amino  group in side chains (Feenstra et al., 1999) allowing the use of the 
longer integration time step of 4 fs.
NMR measurements
NMR experiments have been carried out at 300K and pH 7.0 on a Bruker AVANCE600 and 
AVANCE700 equipped with a triple-resonance z-gradient probe. 
For the backbone assignment of UbcH5B, 2D (15N-1H)-HSQC, 2D (13C-1H)-HSQC, 3D 
HNCO, 3D HNCACB, and 3D CBCA(CO)NH were recorded. The side chain assignment 
was performed using 3D TOCSY-(15N-1H)-HSQC, 3D H(C)CH-TOCSY and 3D (H)CCH-
TOCSY spectra (Sattler et al., 1999).
Concerning the chemical shift perturbation experiments, (15N-1H)-HSQC spectra 
were recorded on 15N-UbcH5B alone and in complex with different ratios of CNOT4-
N78 (1:1/8 to 1:2). For all (15N-1H)-HSQC spectra, 2048 points with a spectral width of 
8012 Hz in the direct dimension and 512 points with a spectral width of 2200 Hz in the 
indirect dimension were recorded. The number of scans varied between 16 and 64 during 
the titration and the relaxation delays were set to 1 s. All NMR spectra were processed using 
the NMRPipe package (Delaglio et al., 1995) and analyzed using the program NMRView 
( Johnson and Blevins, 1994).
Docking
Docking of the UbcH5B/CNOT4 complex was performed using the software HADDOCK1.1 
(Dominguez et al., 2003) in combination with CNS (Brunger et al., 1998) based on the 
chemical shift perturbation data observed for UbcH5B and for CNOT4 (Albert et al., 2002) 
upon complex formation. The starting structures for the docking were the 30 structures of 
CNOT4 deposited in the PDB (PDB:1E4U) (Hanzawa et al., 2001) and the 11 models of 
UbcH5B generated during the molecular dynamic simulation. For the first docking, the 
active and passive residues defined for HADDOCK were chosen based on the chemical shift 
perturbation data and solvent accessibility (Table 2). We first selected all the residues having 
a combined chemical shift perturbation upon complex formation higher than 0.1 and 0.05 
ppm for UbcH5B and CNOT4, respectively. We calculated the solvent accessibility using the 
program NACCESS (Hubbard and Thornton, 1993) over the ensemble of structures and 
selected as active residues all the amino acids showing an average relative solvent accessibility 
(plus standard deviation) higher than 50%. We then selected all surface neighbors amino acids 
having a high solvent accessibility (>50%) as passive residues.  A 2 Å distance was used to define 
the Ambiguous Interaction Restraints (AIR). Residues 1-18, 26-33, 53-68, 90-103 of UbcH5B 
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and 12-22, 38-59 of CNOT4 were defined as flexible. In the second docking, an additional 
restraint between any atoms of Lys63 of UbcH5B and any atoms of Glu49 of CNOT4 was 
defined based on mutagenesis experiments (Winkler et al., 2004). During the rigid body 
energy minimization, 1320 structures were calculated (4 calculations for each combination 
of starting structures). For each of the 1320 combinations, 10 rigid body docking trials were 
performed and only the solution with lowest energy was kept amounting to a total of 13200 
rigid body minimization trials. The 200 best solutions based on the intermolecular energy 
were used for the semi-flexible simulated annealing followed by a refinement in explicit water. 
finally, the solutions were clustered using a 2.5 Å RMSD based on the pairwise backbone 
RMSD matrix after superposition on the backbone of UbcH5B. 
Analysis of the intermolecular contacts
Intermolecular contacts (hydrogen bonds and non-bonded contacts) were analyzed with 
DIMPLOT which is part of the LIGPLOT software (Wallace et al., 1995) using the default 
settings (3.9 Å heavy-atoms distance cut-off for non-bonded contacts; 2.7 Å and 3.35 Å 
proton-acceptor and donor-acceptor distance cut-offs respectively with minimum 90° angles 
(D-H-A, H-A-AA, D-A-AA) for hydrogen bonds (McDonald and Thornton, 1994).
Coordinates 
The coordinates of the five best structural models of the UbcH5B/CNOT4 complex have 
been deposited in the Protein Data Bank (accession code 1UR6) together with the AIR 
restraints.
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Appendix
(15N-1H)-HSQC spectrum of UbcH5B at 300K, pH 7.0. Backbone assignment is indicated.
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List of chemical shifts (in ppm) for UbcH5B at 300K, pH 7.0
Res Num N (HN) C  Cα (Hα) Cβ (Hβ) Others
Met 1  178.7 58.5 (4.34) 32.4 (2.35, 2.35) Cγ 32.4 (2.74, 2.84)
Ala 2 124.7 (8.53) 179.6 56.0 (4.33) 19.6 (1.90) 
Leu 3 117.1 (8.36) 178.6 58.0 (3.78) 42.4 (1.80, 1.93) Cγ 32.8 (1.95), Cδ 29.1, 24.1 (1.03, 0.94)
Lys 4 118.2 (7.85) 179.7 59.9 (4.14) 32.5 (2.03, 2.03) Cγ 25.2 (1.54, 1.54), Cδ 29.1 (1.81, 1.81), Cε 36.4 (3.09, 3.09)
Ar� 5 120.8 (7.79) 177.5 57.7 (4.38) 28.8 (2.11, 2.27) Hγ (1.70, 1.70)
Ile 6 122.6 (8.89) 178.2 66.9 (3.27) 38.3 (1.31) Cγ 29.8, 18.2 (1.43, 1.43, 0.58), Hδ (-0.37)
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His 7 117.6 (8.54) 178.4 60.7 (4.21) 30.1 (3.14, 3.29) 
Lys 8 121.3 (7.84) 178.8 59.8 (4.21) 32.4 (2.29, 2.29) Cγ 25.2 (2.14, 2.14), Cδ 25.2 (1.64, 1.64), Cε 42.5 (3.10, 3.10)
�lu 9 119.3 (8.68) 180.0 60.6 (4.27) 29.4 (2.38, 2.38) 
Leu 10 120.5 (8.69) 180.3 58.3 (4.25) 41.7 (1.84, 2.08) Cγ 26.9 (1.65), Cδ 25.9, 23.7 (0.67, 0.59)
Asn 11 118.7 (8.18) 178.2 56.5 (4.32) 38.7 (2.35, 3.79) Nδ 111.5 (7.42, 6.76)
Asp 12 121.5 (8.73) 178.7 57.6 (4.50) 40.4 (2.89, 3.01) 
Leu 13 122.0 (8.28) 178.1 58.0 (4.06) 42.4 (1.81, 2.04) Cγ 27.3 (1.82), Cδ 26.1, 25.3 (1.14, 1.04)
Ala 14 118.4 (7.84) 179.7 53.8 (4.18) 18.3 (1.57) 
Arg 15 116.1 (7.55) 176.4 57.7 (4.24) 31.2 (1.96, 1.97) Cγ 27.5 (1.76, 1.81), Cδ 43.4 (3.31, 3.31)
Asp 16 117.0 (7.77)  51.8 (5.09) 41.4 (2.44, 2.78) 
Pro 17     
Pro 18  176.4 62.0 31.3 
Ala 19 125.5 (8.53) 178.2 53.9 (4.21) 18.6 (1.49) 
Gln 20 112.7 (8.62) 174.9 57.5 (4.11) 28.3 (2.43, 2.60) Cγ 35.2 (2.45, 2.35), Nε 111.2 (7.42, 6.83)
Cys 21 114.3 (7.69) 173.2 57.2 (5.49) 31.8 (2.70, 2.86) 
Ser 22 114.5 (8.60) 172.5 57.3 (4.67) 65.6 (3.76, 3.76) 
Ala 23 121.9 (8.40) 174.7 52.3 (5.37) 23.2 (1.57) 
Gly 24 104.4 (8.14)  45.1 (2.59, 3.75)  
Pro 25  176.6 62.6  32.5  
Val 26 122.9 (8.57) 176.7 62.6 (3.95) 31.7 (1.84) Cγ 21.1, 21.1 (0.64, 0.84)
Gly 27 116.1 (8.76) 174.0 46.5 (3.83, 3.83)  
Asp 28 123.2 (8.57) 175.2 54.2 (4.59) 40.9 (2.75, 2.83) 
Asp 29 119.9 (7.96) 176.3 53.0 (4.91) 41.4 (2.76, 3.50) 
Met 30 122.3 (8.69) 175.7 55.7 (4.40) 31.5 (1.66, 1.88) Hγ (2.55, 2.63)
Phe 31 112.0 (8.47) 175.3 59.5 (4.42) 38.4 (3.19, 3.58) (Hδ 7.39, Hε 7.12, Hζ 7.42)
His 32 121.2 (7.93) 172.4 54.3 (5.57) 31.7 (3.05, 3.40) 
Trp 33 124.3 (9.78) 175.8 54.2 (5.63) 33.6 (3.01, 3.16) Hδ (6.87), Nε 128.4 (9.33), Hζ (7.24), Hη (6.87)
Gln 34 119.1 (8.79) 174.2 54.0 (5.26) 32.4 (2.05, 2.10) Cγ 34.1 (2.37, 2.44), Nε 111.3 (7.43, 6.80)
Ala 35 124.5 (8.84) 175.5 50.5 (5.54) 24.0 (1.40) 
Thr 36 113.3 (8.91) 173.8 60.4 (5.12) 71.5 (3.68) Hγ (0.61)
Ile 37 122.1 (9.15) 175.5 60.1 (4.73) 42.4 (1.65) Cγ 27.2, 17.5 (1.05, 1.44, 0.85), Cδ 14.5 (0.73)
Met 38 125.1 (8.33) 177.0 54.2 (5.10) 32.8 (2.02, 2.21) Cγ 32.4 (2.61,2.70)
Gly 39 110.4 (9.24)  44.3 (3.91, 4.05)  
Pro 40  177.9 63.4 32.8 
Asn 41 122.8 (9.00) 175.4 55.2 (4.46) 38.5 (2.81, 2.81) Nδ 113.1 (7.68, 7.01)
Asp 42 116.8 (8.89) 174.1 55.1 (4.60) 39.0 (2.86, 2.95) 
Ser 43 114.6 (7.91)  57.1 (5.25) 66.2 (3.98, 4.49) 
Pro 44  174.7 63.8 32.2  
Tyr 45 116.9 (7.38) 175.4 55.7 (5.38) 38.4 (2.47, 3.83) Hδ (7.28), Hε (6.70)
Gln 46 121.6 (7.30) 176.3 58.0 (3.77) 28.9 (2.18, 2.18) Cγ 33.4 (2.46, 2.56), Nε 112.2 (7.59, 6.95)
Gly 47 116.5 (9.26) 174.1 45.2 (3.70, 4.39)  
Gly 48 106.8 (8.52) 172.8 44.9 (3.35, 4.32)  
Val 49 125.1 (8.84) 173.3 62.6 (4.38) 33.3 (1.82) Cγ 21.4, 21.4 (0.57, 0.91)
Phe 50 123.9 (8.76) 174.1 56.5 (4.74) 41.5 (2.90, 3.01) Hδ (7.18), Hε (7.64), Hζ (7.54)
Phe 51 121.1 (9.30) 176.0 57.0 (5.35) 40.7 (3.09, 3.09) Hδ (7.24), Hε (7.27), Hζ (7.24)
Leu 52 120.6 (9.16) 176.8 54.6 (5.38) 46.0 (1.13, 1.40) Cγ 26.6 (1.04), Cδ 25.1, 25.1 (0.28, 0.01)
Thr 53 114.6 (9.27) 173.2 60.5 (4.97) 71.4 (4.13) Hγ (1.31)
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Ile 54 123.1 (8.39) 173.9 60.0 (4.67) 41.7 (1.32) Cγ 17.4 (0.66), Cδ 14.6 (-0.29)
His 55 126.0 (9.03) 175.6 53.9 (5.49) 32.6 (2.89, 3.09) Hδ (6.93), Hε (8.31)
Phe 56 126.9 (9.23)  56.4 (4.30) 40.2 (2.44, 2.81) Hδ (7.39), Hε (7.31)
Pro 57  176.9 62.1 32.1 
Thr 58 110.4 (8.49) 173.6 64.8 (3.98) 68.7 Hγ (1.1)
Asp 59 113.4 (8.21) 176.3 52.1 (4.98) 39.0 (2.61, 3.00) 
Tyr 60 123.4 (7.64)  58.2 (4.64) 39.9 (2.82, 3.50) 
Pro 61  175.0 63.6 32.8 
Phe 62 124.7 (9.09) 175.4 60.8 (4.40) 38.0 (3.22, 3.42) Hδ (7.40), Hε (7.71), Hζ (7.60)
Lys 63 118.6 (7.09)  52.1 (4.47) 34.9 (1.36, 1.79) Cγ 25.6 (1.37, 1.65), Cδ 28.7 (1.83, 183), Cε 42.4 (3.07, 3.07)
Pro 64     
Pro 65  175.0 61.4 30.9 
Lys 66 120.7 (8.31) 175.8 55.2 (4.50) 33.1 (1.78, 1.83) Cγ 24.7 (1.34, 1.45), Cδ 29.1 (1.66, 1.66), Cε 42.1 (2.96, 2.96)
Val 67 127.5 (8.75) 173.3 60.7 (4.89) 33.9 (1.75) Hγ (0.58, 0.97)
Ala 68 127.3 (8.53) 177.0 50.9 (5.01) 22.3 (1.29) 
Phe 69 122.4 (9.82) 177.3 59.2 (4.80) 40.2 (3.01, 3.51) Hδ (7.30), Hε (6.77), Hζ (6.54)
Thr 70 116.5 (9.56) 175.4 63.2 (4.50) 68.6 (4.33) Hγ (1.27)
Thr 71 121.7 (7.58) 173.8 63.7 (4.51) 71.4 (4.24) Hγ (1.17)
Arg 72 127.8 (8.62) 175.0 57.2 (4.19) 30.5 (1.24, 1.34) Cγ 26.9 (1.40, 1.56), Cδ 42.8 (2.35, 2.52)
Ile 73 120.3 (8.39) 171.0 60.4 (4.80) 41.1 (1.66) Hγ (0.45, 0.55), Hδ (-0.05, 0.24)
Tyr 74 131.8 (8.72) 173.3 57.9 (3.95) 38.0 (2.77, 2.77) Hδ (7.45), Hε (6.67)
His 75 129.2 (8.50)  55.7 (4.90) 35.6 (2.89, 2.89) 
Pro 76  177.3 64.7 32.3  
Asn 77 118.3 (11.53)  54.1 (4.20) 41.6 (1.57, 1.57) 
Ile 78 120.3 (7.24) 174.5 60.2 (5.27) 42.2 (1.10) Cγ 27.2, 22.9 (0.55, 0.82, -0.41), Hδ (-0.70)
Asn 79 121.5 (7.99)  50.6 (4.96) 40.1 (2.67, 3.66) Nδ 111.5 (7.85, 7.42)
Ser 80  175.2 60.8 63.1  
Asn 81 118.1 (7.62) 175.4 53.2 (4.98) 39.0 (2.82, 3.04) Nδ 112.9 (7.60, 7.00)
Gly 82 109.8 (8.46) 174.6 46.1 (3.81, 4.99)  
Ser 83 115.3 (7.79) 172.1 59.2 (4.59) 63.5 (3.71, 3.85) 
Ile 84 119.7 (8.52) 175.8 59.6 (4.63) 41.9 (1.65) Cγ 27.2, 17.5 (0.70, 1.57, 0.81), Cδ 15.3 (0.77)
Cys 85 127.6 (8.67) 171.9 57.6 (4.56) 26.2 (2.68, 3.01) 
Leu 86 126.8 (7.32) 176.9 53.9 (4.72) 46.1 (1.40, 1.61) Cγ 27.5 (1.61), Cδ 24.7, 25.9 (0.98, 0.88)
Asp 87 129.4 (9.35) 180.3 58.7 (4.46) 39.4 (2.69, 2.69) 
Ile 88 116.1 (8.46) 173.4 64.9 (3.85) 37.9 (2.16) Cγ 26.8 (1.21, 1.99, 0.97), Hδ (1.05)
Leu 89 113.5 (7.19) 176.8 54.1 (4.71) 41.8 (1.92, 1.96) Cγ 27.1 (1.61), Cδ 25.0, 23.7 (0.91, 1.05)
Arg 90 121.2 (7.93) 176.5 56.4 (4.65) 31.4 (2.15, 2.15) Hγ (1.76, 1.72), Cδ 43.8 (3.29, 3.29)
Ser 91 117.3 (8.29) 175.3 61.1 (4.52) 63.6 (4.11, 4.11) 
Gln 92 117.6 (7.86) 174.6 54.5 (4.64) 28.4 (1.35, 1.33) Cγ 33.7 (2.32, 2.42), Nε 112.4 (7.45, 6.81)
Trp 93 121.1 (7.45) 176.4 69.7 (4.51) 30.0 (2.91, 3.56) Hδ (6.71), Nε 130.3 (9.70, 7.12), Hζ (7.11, 6.81), Hη (6.64)
Ser 94 120.8 (5.58)  54.6 (4.54) 65.2 (3.39, 3.92) 
Pro 95  175.4 63.7 31.6 
Ala 96 118.4 (7.29) 178.9 52.6 (4.13) 18.8 (1.21) 
Leu 97 119.4 (7.36) 173.1 54.8 (4.04) 42.4 (1.10, 1.10) Cγ 27.2 (1.38), Cδ 27.2, 27.2 (0.76, 0.85)
Thr 98 101.7 (6.13) 176.4 58.1 (5.17) 73.1 Hγ (1.22)
Ile 99 122.5 (10.41)  61.0 (4.12) 36.2 (2.17) Cγ 27.8, 19.0 (1.22, 1.56, 1.08), Hδ (0.49)
Ser 100 116.8 (8.50) 175.6 62.6 (3.97) (4.04, 4.04) 
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Lys 101 119.5 (7.55) 180.2 58.9 (4.14) 32.3 (2.04, 2.04) Cγ 25.6 (1.58, 1.58), Cδ 29.0 (1.74, 1.74), Cε 42.0 (3.00, 3.00)
Val 102 121.8 (8.43) 177.5 66.9 (3.59) 31.6 (2.51) Cγ 21.3, 23.1 (0.85, 1.27)
Leu 103 119.0 (8.70) 179.3 58.6 (3.93) 40.9 (1.91, 1.91) Hγ (2.04), Hδ  (0.80, 0.64)
Leu 104 119.5 (8.39) 180.4 58.6 (4.12) 41.7 (1.67, 1.94) Cγ 27.1 (1.88), Cδ 23.6, 23.6 (1.00, 0.97)
Ser 105 117.4 (8.28) 177.3 62.6 (4.37) 63.8 (4.00, 4.00) 
Ile 106 124.4 (8.37) 177.2 66.1 (3.58) 37.5 (2.02) Cγ 30.3, 18.0 (2.03, 2.03, 0.82), Cδ 14.9 (0.64)
Cys 107 118.7 (8.28) 177.3 65.4 (3.93) 26.2 (2.94, 3.29) 
Ser 108 114.2 (8.16) 176.2 62.0 (4.31) 62.7 (4.10, 4.10) 
Leu 109 124.0 (7.86) 179.9 56.6 (4.19) 42.5 (1.65, 2.04) Cγ 26.8 (1.55), Cδ 25.7, 23.4 (0.72, 1.06)
Leu 110 118.8 (7.98) 177.4 58.8 (3.94) 41.1 (1.58, 2.10) Hγ (1.41), Cδ 26.2, 21.7 (0.79, 0.64)
Cys 111 113.6 (7.26) 178.8 61.7 (4.41) 27.9 (3.17, 3.17) 
Asp 112 118.8 (8.19)  58.3 (5.17) 38.5 (2.49, 2.68) 
Pro 113   173.9 62.4 32.6 
Asn 114 114.9 (8.64)  49.2 (5.39) 38.9 (2.81, 2.99) Nδ 112.2 (7.63, 7.16)
Pro 115  174.3 63.7 32.2 
Asp 116 118.0 (7.75) 175.3 55.4 (4.63) 40.6 (2.65, 2.81) 
Asp 117 118.4 (6.72)  51.5 (4.96) 41.1 (2.24, 2.76) 
Pro 118  177.1 62.6 33.1  
Leu 119 117.9 (8.67) 177.2 55.4 (4.74) 44.2 (1.41, 1.60) Cγ 27.0 (1.62), Cδ 25.0, 25.0 (0.87, 0.87)
Val 120 118.0 (7.47)  59.0 (4.72) 31.9 (2.22) Cγ 19.9, 23.1 (0.96, 1.10)
Pro 121   178.6 65.4 32.6 
Glu 122 118.1 (9.58) 178.5 59.8 (4.21) 29.3 (1.98, 2.20) Cγ 36.5 (2.35, 2.42)
Ile 123 117.2 (6.86) 178.0 65.2 (3.74) 38.7 (1.46) Cγ 21.0, 17.4 (1.31, 1.31, 0.35), Cδ 14.29 (0.22)
Ala 124 121.6 (7.59) 177.9 55.6 (3.72) 18.7 (1.60) 
Arg 125 116.4 (8.10) 179.0 59.8 (4.09) 30.1 (1.96, 1.96) Cγ 27.5 (1.60, 1.77), Cδ 43.3 (3.29, 3.29)
Ile 126 121.9 (8.32) 176.7 65.3 (3.54) 38.0 (0.99) Cγ 28.4, 16.6 (1.66, 1.66, 0.80), Cδ 13.8 (-0.36)
Tyr 127 119.2 (8.62) 176.7 60.5 (3.38) 38.4 (2.46, 2.93) 
Lys 128 112.7 (7.89) 178.5 59.2 (4.01) 33.7 (1.95, 1.95) Cγ 25.9 (1.55, 1.55), Cδ 29.3 (1.68, 1.68), Cε 41.5 (2.93, 2.93)
Thr 129 108.6 (7.90) 174.9 63.1 (4.44) 71.5 (4.21) Hγ (1.32)
Asp 130 125.6 (9.04) 174.1 52.9 (4.78) 40.5 (2.49, 2.96) 
Arg 131 125.1 (8.64) 178.1 57.4 (4.77) 28.7 (1.81, 1.81) Cγ 25.6 (1.49, 1.49), Cδ 42.1 (3.00, 3.00)
Glu 132 116.3 (8.44) 179.2 59.4 (4.18) 29.0 (2.12, 2.12) Cγ 36.4 (2.33, 2.43)
Lys 133 122.9 (7.58) 177.5 59.7 (3.96) 32.4 (1.87, 1.87) 
Tyr 134 118.5 (8.17) 175.7 62.2 (4.50) 38.4 (2.95, 3.02) 
Asn 135 117.1 (8.77) 177.6 55.8 (4.09) 37.8 (2.75, 2.98) Nδ 112.7 (7.64, 6.89)
Arg 136 120.2 (7.96) 179.9 59.9 (3.99) 30.2 (2.00, 2.00) Cγ 28.8 (1.59, 1.80), Cδ 43.7 (2.96, 2.96)
Ile 137 122.4 (7.70) 177.6 65.3 (3.73) 38.0 (2.17) Cγ 29.4, 17.6 (1.32, 1.32, 1.17), Cδ 12.7 (0.96)
Ala 138 121.2 (8.58)  55.8 (3.95) 17.4 (1.11) 
Arg 139 120.8 (8.32) 178.8 60.1 (3.99) 30.4 (2.04, 2.04) 
Glu 140 123.4 (8.43) 180.4 59.9 (4.14) 29.4 (2.33, 2.46) Cγ 36.6 (2.33, 2.59)
Trp 141 120.0 (9.63) 181.0 61.6 (4.44) 29.0 (3.61, 3.76) Hδ (7.32), Nε 130.3 (10.22, 7.35), Hζ (7.71, 7.09), Hη (7.43)
Thr 142 124.8 (8.60) 175.8 68.6 (4.38)  Hγ (1.34)
Gln 143 119.6 (8.16) 177.5 58.5 (4.23) 28.5 (2.14, 2.26) Cγ 34.0 (2.49, 2.59)
Lys 144 115.8 (7.97) 178.5 58.8 (3.93) 33.4 (0.91, 1.23) Cγ 25.0 (0.66, 1.07), Cδ 29.4 (1.18, 1.27), Cε 41.9 (2.72, 2.72)
Tyr 145 112.6 (8.07) 176.3 58.0 (5.08) 40.6 (2.80, 3.61) (Hδ 7.22, Hε 6.01)
Ala 146 123.0 (8.26) 175.2 51.4 (4.95) 21.6 (1.11) 
Met 147 122.6 (7.25)  57.0 (4.58) 35.5 (1.97, 2.27) Cγ 33.4 (2.56, 2.56)
Summary
Understanding the molecular and functional interactions among macromolecular complexes, 
as well as their changes associated with time, cell type or disease state will be invaluable for 
human health, and will have direct implications, for example, in pharmaceutical research 
to identify and select potential targets, and design efficient and specific drugs. Structural 
studies of macromolecular complexes, however, suffer from some limitations, especially in 
the case of weak and transient complexes. Because of that, it will not be possible to study all 
macromolecular interactions at an atomic level. New and complementary methodologies, 
such as docking, have therefore been developed. The current computational approaches, 
however, also suffer from limitations and new developments and improvements are 
needed.
This thesis, as outlined in a short general introduction, describes structural studies on 
the UbcH5B-CNOT4 complex involved in the ubiquitination pathway and furthermore 
introduces a new docking approach in which the docking of two macromolecules is driven 
by biophysical and/or biochemical information.
Chapter 1 gives an introduction to the RING motif and its role in the ubiquitination 
pathway. Structural and chemical properties as well as biological and medical implications 
of the RING finger domain family of proteins and a number of related systems are 
described. Differences in the structure of various RING domains and related domains are 
also discussed. 
Chapter 2 focuses on structural studies of macromolecular complexes using NMR and 
docking approaches. First, the structure determination of complexes by NMR methods is 
presented, various restraints commonly used in NMR to study complexes are described 
and limitations are discussed. Secondly, a general overview of docking approaches is 
described. Finally, new methods that combine NMR restraints and docking approaches 
are described.
Chapter 3 describes HADDOCK, a new docking approach that allows for flexibility 
at the interface and that is based on biophysical and/or biochemical information. This 
information, derived for example from NMR chemical shift perturbation or site-directed 
mutagenesis experiments, is converted into highly ambiguous intermolecular distance 
restraints that are directly used to drive the docking process. The docking protocol allows 
for side chains and backbone flexibility at the interface and the solutions are scored according 
to an intermolecular energy term. The method is tested on three complexes. For two of 
these complexes, intermolecular distance information is derived from NMR chemical shift 
mapping and for the third complex, derived from mutagenesis data. We demonstrate that, 
in all cases, the lowest energy structures generated by HADDOCK are the closest from the 
original structure.
Chapter 4 describes the solution structure of UbcH5B, an E2 ubiquitin conjugating 
enzyme, which is solved using a combination of homology modeling, NMR automated 
NOE assignment and diffusion anisotropy data. UbcH5B is 90% homologous to Ubc4 for 
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which an X-ray structure is available. We therefore created a homology model of UbcH5B 
based on the Ubc4 structure. NMR relaxation measurements are performed on UbcH5B. 
They show limited motions for the major part of the protein backbone. This information is 
translated into diffusion anisotropy restraints and used to refine the homology model. This 
refined model serves as starting point to the automated NOE assignment process. The final 
structure is well defined. We compare the structure of UbcH5B with other E2 structures. The 
global fold of all E2s is very similar. Some differences are, however, observed and correlate 
well with the dynamical properties of E2s. Importantly, the position and orientation of the 
N-terminal α-helix as compared to the core of the protein differ in the various structures. 
This is in agreement with our observation that the loop that connects this helix to the core 
of the protein is flexible. This flexibility may be determinant in E3 ubiquitin ligase binding 
and recognition. Furthermore, a highly conserved asparagine residue was previously shown 
to be important for the ubiquitin transfer by catalyzing an isopeptide bond formation. In 
crystal structures, this asparagine, however, points away from the active site cysteine and 
can not accomplish its catalytic role. Analysis of the structure of UbcH5B and another Ubc 
structure also solved by NMR shows that in solution, this asparagine is in close proximity 
to the active site cysteine, in a conformation suitable for its catalytic role.
In Chapter 5, HADDOCK is used to generate a structural model of the UbcH5B-
CNOT4 complex. It has previously been reported that CNOT4 is involved in the 
ubiquitination pathway as an E3 ubiquitin ligase and specifically interacts with UbcH5B, an 
E2 ubiquitin conjugating enzyme. The residues of the CNOT4 RING domain important 
for the interaction with UbcH5B were previously reported. In this Chapter, the residues of 
UbcH5B important for the binding to CNOT4 RING are identified from NMR chemical 
shift perturbation experiments. These data are used to generate a structural model of the 
UbcH5B-CNOT4 complex. Two sets of solutions are, however, obtained that can not be 
discriminated. Based on these docking results, mutagenesis experiments are performed and 
identify several basic residues of UbcH5B important for the binding to CNOT4. More 
importantly, charge-altered mutants of CNOT4 (Glu49Lys) and of UbcH5B (Lys63Glu) 
can restore the binding indicating an electrostatic interaction between these two residues. 
Once this information is included in the docking, a unique set of solutions is obtained. The 
structural model of the UbcH5B-CNOT4 complex is compared with the X-ray structure of 
the homologous UbcH7-c-Cbl complex and significant differences at specific residues give 
structural insights into the mechanisms of the E2-E3 specificity.
Samenvatting
Inzicht in de interacties en functies van macromoleculaire complexen en in hun veranderingen 
in de tijd en in relatie tot celtype of ziektestadium is belangrijk voor medisch onderzoek. 
Dit kan zeer nuttige informatie geven voor het selecteren van targets voor de ontwikkeling 
van specifieke en effciënte medicijnen. Het structuuronderzoek aan deze macromoleculaire 
complexen is echter lastig, vooral als het gaat om zwakke interacties en kortlevende complexen. 
Er zijn daarom computermethoden voor het bepalen van structuren van onder andere eiwit-
eiwit complexen ontwikkeld, maar aangezien deze dokkingmethoden ook hun beperkingen 
hebben, zijn verbeteringen en vernieuwingen in dit gebied nog steeds nodig.
In dit proefschrift wordt een studie beschreven naar de structuur van het UbcH5B-
CNOT4 complex dat een rol speelt in ubiquitinering. Daarnaast wordt een nieuwe methode 
om twee macromoleculen te dokken belicht, waarbij biofysische en/of biochemische 
informatie de drijvende kracht is. Een korte introductie is gegeven in de algemene 
inleiding.
Hoofdstuk 1 geeft een introductie in het RING-vinger motief en de rol dat het speelt in 
het ubiquitineringsproces. Zowel de structuur en chemische eigenschappen van de eiwitten 
in de RING-vinger familie en vergelijkbare systemen, als ook de biologische en medische 
toepassingen worden beschreven. Ook worden de verschillen in structuur van een aantal 
RING- en vergelijkbare domeinen besproken.
Hoofdstuk 2 concentreert zich op het bepalen van structuren van macromoleculaire 
complexen met zowel NMR spectroscopie als dokkingmethoden. Als eerste wordt 
ingegaan op de structuurbepaling van eiwitcomplexen met behulp van NMR. Verschillende 
experimentele NMR data, die worden gebruikt bij het bestuderen van complexen met NMR, 
en hun beperkingen worden besproken. Ten tweede wordt een algemeen overzicht gegeven 
van bestaande dokkingmethoden. Als laatste worden nieuwe methoden beschreven die NMR 
informatie en dokken combineren.
HADDOCK, een nieuwe dokkingmethode die flexibiliteit aan het complexgrensvlak 
toestaat en gebaseerd is op biofysische en/of biochemische informatie, wordt in hoofdstuk 
3 beschreven. Deze informatie, verkregen uit bijvoorbeeld veranderingen in NMR 
chemische verschuivingen of specifieke mutatie experimenten, wordt vertaald in zeer 
ambigue intermoleculaire afstanden, die direct gebruikt worden om het dokkingsproces te 
leiden. Het dokkingprotocol staat flexibiliteit van zowel de hoofdketen als de zijketens aan 
het complexgrensvlak toe en de oplossingen worden gescoord op basis van intermoleculaire 
energie. De methode is getest op drie complexen. In het geval van twee van deze complexen 
was de intermoleculaire afstandsinformatie gebaseerd op veranderingen in NMR chemische 
verschuivingen en voor het derde complex op specifieke mutatie data. We laten zien dat in 
alle gevallen de HADDOCK structuren met de laagste energie het beste overeenstemmen 
met de werkelijke structuur.
In hoofdstuk 4 wordt de NMR structuur van UbcH5B, een E2 ubiquitine conjugerend 
enzym, besproken. Voor de structuurbepaling is gebruik gemaakt van een homoloog 
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model, geautomatiseerd toekennen van NOEs en diffusie-anisotropie data. UbcH5B is 
90% homoloog aan Ubc4, waarvan een kristalstructuur bekend is. Op basis van de Ubc4 
structuur werd daarom een homoloog model voor UbcH5B gecreëerd. Er werden NMR 
relaxatie-experimenten uitgevoerd met UbcH5B. Deze laten zien dat het overgrote deel 
van de eiwithoofdketen weinig beweeglijk is. Deze informatie is vertaald naar diffusie-
anisotropie data en is gebruikt om het homologe model te verfijnen. Dit verfijnde model 
werd vervolgens gebruikt als startpunt voor het geautomatiseerde NOE-toekenningsproces. 
De uiteindelijke structuur is goed gedefinieerd. We vergelijken de structuur van UbcH5B 
met andere E2 structuren en de globale vouwing van alle E2’s is erg vergelijkbaar. Er zijn 
echter een aantal verschillen aanwezig, die correleren met de dynamische eigenschappen 
van E2’s. Voornamelijk de positie en oriëntatie van de N-terminale α-helix ten opzichte 
van de kern van het eiwit zijn anders in de verschillende structuren. Dit stemt overeen met 
de waarneming dat de lus, die deze helix met de kern van het eiwit verbindt, flexibel is. Deze 
flexibiliteit zou bepalend kunnen zijn voor de interactie met E3 ubiquitine ligases. Verder is in 
het verleden aangetoond dat een zeer geconserveerd asparagine residu erg belangrijk is voor 
het doorgeven van ubiquitine, omdat het de vorming van een isopeptidebinding katalyseert. 
In alle E2 kristalstructuren heeft deze asparagine echter een oriëntatie weggedraaid van de 
cysteïne in het actieve centrum en kan in deze positie niet zijn katalyserende rol vervullen. 
Analyse van zowel de UbcH5B structuur als een andere Ubc structuur, die ook met NMR 
werd bepaald, laat zien dat in oplossing deze asparagine zich in de nabijheid van de cysteïne 
in het actieve centrum bevindt, in een conformatie die zich dus wel leent voor katalyse.
In hoofdstuk 5 is HADDOCK gebruikt om een structuurmodel voor het UbcH5B-
CNOT4 complex te genereren. Eerder is reeds beschreven dat CNOT4 de rol van een 
E3 ubiquitine ligase heeft in het ubiquitineringsproces en specifiek een interactie aangaat 
met UbcH5B, dat een E2 ubiquitine conjugerend enzym is. De residuen in het CNOT4 
RING-domein die belangrijk zijn voor de interactie met UbcH5B werden reeds elders 
gerapporteerd. Op basis van veranderingen in NMR chemische verschuivingen zijn in dit 
hoofdstuk de residuen van UbcH5B die belangrijk zijn voor de binding met het RING-
domein van CNOT4 geïdentificeerd. Deze data zijn gebruikt om een structuurmodel voor 
het UbcH5B-CNOT4 complex te genereren. In eerste instantie werden echter twee clusters 
van oplossingen verkregen, waartussen geen onderscheid gemaakt kon worden. Gebaseerd 
op deze resultaten zijn specifieke mutatie experimenten uitgevoerd, waaruit blijkt dat 
een aantal basische residuen in UbcH5B belangrijk zijn voor de interactie met CNOT4. 
Daarnaast kunnen de mutanten van CNOT4 (Glu49Lys) en UbcH5B (Lys63Glu) waarin 
een omkering van lading is aangebracht de binding herstellen, hetgeen betekent dat er een 
elektrostatische interactie tussen de gemuteerde residuen moet zijn. Door deze informatie 
toe te voegen aan het dokkingprotocol wordt één unieke set van oplossingen verkregen. 
Het model voor het complex tussen UbcH5B en CNOT4 wordt vergeleken met de kristal 
structuur van het homologe UbcH7-c-Cbl complex. Een aantal specifieke en significante 
verschillen geven inzicht in het mechanisme van de E2-E3 specificiteit.
Résumé
La compréhension des interactions moléculaires et fonctionnelles parmi les complexes 
macromoléculaires, ainsi que leurs changements associés au temps, au type cellulaire ou à 
un état pathologique sera inestimable pour la recherche médicale et aura des implications 
directes, par exemple, dans la recherche pharmaceutique pour identifier et sélectionner des 
cibles potentielles, et créer des médicaments efficaces et spécifiques. Toutefois, les études 
structurales de complexes macromoléculaires souffrent de certaines limitations, en particulier 
dans le cas de complexes transitoires. A cause de cela, il ne sera pas possible d’étudier toutes 
les interactions macromoléculaires à un niveau atomique. Des méthodologies nouvelles et 
complémentaires, comme l’arrimage moléculaire, ont donc été développées. Toutefois, ces 
approches informatiques actuelles souffrent aussi de limitations et de nouveaux développements 
sont nécessaires.
Cette thèse, comme indiqué dans une courte introduction générale, décrit l’étude 
structurale du complexe UbcH5B-CNOT4 impliqué dans la voie de l’ubiquitination et, en 
outre, introduit une nouvelle approche d’arrimage moléculaire dans laquelle l’arrimage est 
dirigé par des informations biochimiques ou biophysiques.
Le premier chapitre présente une introduction sur le motif protéique ’RING’ et son 
rôle dans la voie de l’ubiquitination. Les propriétés structurales et chimiques ainsi que 
les implications biologiques et médicales de la famille de protéines contenant le domaine 
’RING’ et d’un nombre de domaines apparentés sont décrites. Les différences de structure 
entre plusieurs domaines RING et d’autres domaines sont discutées.
Le deuxième chapitre se concentre sur les études structurales de complexes 
macromoléculaires utilisant la RMN et des approches d’arrimage moléculaire. D’abord, 
la détermination de structures de complexes par RMN est présentée, diverses contraintes 
communément utilisées en RMN pour étudier des complexes sont décrites et les limitations 
sont discutées. ensuite, une vue générale des approches d’arrimage moléculaire est présentée. 
enfin, de nouvelles méthodes qui combinent des contraintes RMN et des approches 
d’arrimage moléculaire sont décrites.
Le troisième chapitre décrit HADDOCK, une nouvelle approche d’arrimage moléculaire 
permettant l’introduction de flexibilité à l’interface et basée sur des informations biophysiques 
et/ou biochimiques. Ces informations, dérivées de perturbation de déplacements chimiques 
par RMN ou de données de mutagénèse dirigée, sont converties en contraintes de distances 
intermoléculaires ambiguës qui sont utilisées directement pour diriger le processus d’arrimage 
moléculaire. Le protocole d’arrimage permet une flexibilité des chaînes latérales et de la 
chaîne principale à l’interface et les solutions sont classées en fonction d’un terme d’énergie 
intermoléculaire. La méthode est testée sur trois complexes. Pour deux de ces complexes, 
l’information de distance intermoléculaire est dérivée de données de perturbation de 
déplacements chimiques par RMN et pour le troisième complexe, dérivée de données de 
mutagénèse dirigée. Nous démontrons que dans tous les cas, les structures de plus faible 
énergie générées par HADDOCK sont les plus proches de la structure originale.
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Le quatrième chapitre décrit la structure en solution d’UbcH5B, une enzyme de 
conjugaison de l’ubiquitine (E2) résolue en utilisant une combinaison de modèle par 
homologie, d’attribution automatique des NOEs et de données d’anisotropie de diffusion. 
UbcH5B possède 90% d’homologie avec Ubc4 dont la structure cristallographique est 
connue. Nous avons donc créé un modèle par homologie de UbcH5B basé sur la structure 
d’Ubc4. Des mesures de relaxation par RMN sont effectuées sur UbcH5B. Ces mesures 
montrent des mouvements limités pour la majeure partie de la chaîne principale de la 
protéine. Cette information, traduite en contraintes d’anisotropie de diffusion est utilisée 
pour affiner le modèle par homologie. Ce modèle affiné sert de point de départ pour le 
processus d’attribution automatique des NOEs. La structure finale est bien définie. Nous 
comparons la structure d’UbcH5B avec celle d’autres enzymes E2 et le repliement global 
est très similaire. Toutefois, quelques différences sont observées et sont en accord avec les 
propriétés dynamiques des E2s. La position et l’orientation de l’hélice N-terminale par 
rapport au coeur de la protéine sont différentes dans les diverses structures. Ceci est en 
accord avec notre observation que la boucle qui connecte cette hélice au coeur de la protéine 
est flexible. Cette flexibilité peut être importante dans la reconnaissance et la fixation des 
ligases de l’ubiquitine E3s. De plus, il a été montré précédemment qu’une asparagine très 
conservée est importante pour le transfert de l’ubiquitine en catalysant la formation de la 
liaison isopeptidique. Dans les structures cristallographiques, cette asparagine pointe dans 
une direction opposée à la cystéine du site actif et ne peut pas accomplir son rôle catalytique. 
L’analyse de la structure d’UbcH5B et d’une autre structure d’Ubc résolue aussi par RMN 
montre que, en solution, cette asparagine est proche du site actif, dans une conformation 
favorable pour son rôle catalytique.
Dans le cinquième chapitre, HADDOCK est utilisé pour générer un modèle structural 
du complexe UbcH5B-CNOT4. Il a été démontré précédemment que CNOT4 est impliqué 
dans la voie de l’ubiquitination en tant que ligase de l’ubiquitine (E3) et interagit de manière 
spécifique avec UbcH5B, une enzyme de conjugaison de l’ubiquitine (E2). Les résidus 
du domaine ’RING’ de CNOT4 importants pour l’interaction ont été définis dans une 
étude précédente. Dans ce chapitre, les résidus d’UbcH5B importants pour l’interaction 
avec le domaine ’RING’ de CNOT4 sont identifiés par des expériences de perturbation 
des déplacements chimiques par RMN. Ces données sont utilisées pour générer un modèle 
structural du complexe UbcH5B-CNOT4. Toutefois, deux ensembles de solutions sont 
obtenus et ne peuvent être discriminés. Basées sur ces résultats d’arrimage moléculaire, 
des expériences de mutagénèse dirigée sont réalisées et permettent d’identifier plusieurs 
résidus basiques d’UbcH5B importants pour l’interaction avec CNOT4. De plus, des 
mutants avec une inversion de charge de CNOT4 (Glu49Lys) et d’UbcH5B (Lys63Glu) 
restaurent l’interaction indiquant une interaction électrostatique entre ces deux résidus. 
Une fois cette information introduite dans l’arrimage moléculaire, un ensemble unique de 
solutions est obtenu. Le modèle structural d’UbcH5B-CNOT4 est comparé à la structure 
cristallographique du complexe homologue UbcH7-c-Cbl et des différences significatives 
impliquant des résidus spécifiques donnent des explications structurales sur les mécanismes 
de spécificité dans les complexes E2-E3.             
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